Gaps and bounties
Where the map is thin, computed from the corpus at build time. 2781 open items across seven checks. Claim one by opening a pull request; the check disappears when the fix lands.
- Pick a row. Click edit file to open the data file on GitHub, or fork and edit locally.
- Add the source URL, the missing links (ids of related objects), or the missing rows. Keep the TL;DR plain and the summary technical.
- Run
npm testand open a PR. Mention the gap name in the title. Contributors are credited in the changelog.
Counts by kind: 64 cancers, 19 fronts, 348 technologies, 92 targets, 377 drugs, 295 companies, 421 institutions, 44 pathways, 357 terms, 401 trials, 85 pairings, 13 roadmaps, 1,107 ideas, 110 collections, 464 people, 67 journals, 146 key papers, 45 bottlenecks.
Targets with no product
19A target with no drug, tracer, or cell therapy linked to it is either a research target (say so in the summary) or a documentation gap.
- TargetATRno product links to this targetedit file
- TargetCD52no product links to this targetedit file
- TargetCD7no product links to this targetedit file
- TargetCD70no product links to this targetedit file
- TargetCD73 / adenosine axisno product links to this targetedit file
- TargetClaudin 6no product links to this targetedit file
- TargetCXCR4no product links to this targetedit file
- TargetEpCAMno product links to this targetedit file
- TargetGlypican-3no product links to this targetedit file
- TargetGRPR (gastrin-releasing peptide receptor)no product links to this targetedit file
- TargetLIV-1 (SLC39A6)no product links to this targetedit file
- TargetMDM2no product links to this targetedit file
- TargetMesothelinno product links to this targetedit file
- TargetMUC16 (CA-125)no product links to this targetedit file
- TargetPRMT5 (MTAP-deleted cancers)no product links to this targetedit file
- TargetTIM-3no product links to this targetedit file
- TargetVISTAno product links to this targetedit file
- TargetWEE1no product links to this targetedit file
- TargetWRN helicase (MSI-high cancers)no product links to this targetedit file
Products with no trial
154Approved and late-stage products should link to at least one trial record. Add the trial or link an existing one.
- Product5-Aminolevulinic acid (oral, for glioma surgery)no trial recordededit file
- ProductADU-S100 (MIW815)no trial recordededit file
- ProductAfamitresgene autoleucelno trial recordededit file
- ProductAfatinibno trial recordededit file
- ProductAK146D1no trial recordededit file
- ProductAldesleukin (high-dose IL-2)no trial recordededit file
- ProductApalutamideno trial recordededit file
- ProductArsenic trioxideno trial recordededit file
- ProductArteraAI Breastno trial recordededit file
- ProductArteraAI Prostateno trial recordededit file
- ProductAsciminibno trial recordededit file
- ProductAsparaginase (pegaspargase, calaspargase pegol, Erwinia asparaginase)no trial recordededit file
- ProductAutogene cevumeranno trial recordededit file
- ProductBelinostatno trial recordededit file
- ProductBelumosudilno trial recordededit file
- ProductBempegaldesleukinno trial recordededit file
- ProductBendamustineno trial recordededit file
- ProductBicalutamideno trial recordededit file
- ProductBleomycinno trial recordededit file
- ProductBosutinibno trial recordededit file
- ProductBrexucabtagene autoleucelno trial recordededit file
- ProductBrigatinibno trial recordededit file
- ProductCapmatinib & tepotinibno trial recordededit file
- ProductCarfilzomibno trial recordededit file
- ProductCeritinibno trial recordededit file
- ProductCetuximab sarotalocanno trial recordededit file
- ProductCladribineno trial recordededit file
- ProductCobimetinibno trial recordededit file
- ProductCopanlisibno trial recordededit file
- ProductCosibelimabno trial recordededit file
- ProductCrizotinibno trial recordededit file
- ProductCyclophosphamideno trial recordededit file
- ProductDacomitinibno trial recordededit file
- ProductDactinomycin (actinomycin D)no trial recordededit file
- ProductDCVax-Lno trial recordededit file
- ProductDegarelixno trial recordededit file
- ProductDisitamab vedotinno trial recordededit file
- ProductDordaviproneno trial recordededit file
- ProductDuvelisibno trial recordededit file
- ProductElironrasibno trial recordededit file
- ProductElotuzumabno trial recordededit file
- ProductEnasidenibno trial recordededit file
- ProductEnsartinibno trial recordededit file
- ProductEntrectinibno trial recordededit file
- ProductEpacadostatno trial recordededit file
- ProductEprenetapoptno trial recordededit file
- ProductEribulinno trial recordededit file
- ProductErlotinibno trial recordededit file
- ProductEtoposideno trial recordededit file
- ProductFAP-2286 (177Lu / 68Ga)no trial recordededit file
- ProductFedratinibno trial recordededit file
- ProductFlotufolastat F-18no trial recordededit file
- ProductFluciclovine F-18no trial recordededit file
- ProductFluoroestradiol F-18 (FES PET)no trial recordededit file
- ProductFluorouracil (5-FU)no trial recordededit file
- ProductFoundationOne CDx / Liquid CDxno trial recordededit file
- ProductGallium-68 DOTATATE (and Cu-64 DOTATATE)no trial recordededit file
- ProductGallium-68 gozetotide (PSMA-11)no trial recordededit file
- ProductGedatolisibno trial recordededit file
- ProductGefitinibno trial recordededit file
- ProductGemcitabineno trial recordededit file
- ProductGlasdegibno trial recordededit file
- ProductHydroxyurea (hydroxycarbamide)no trial recordededit file
- ProductIberdomideno trial recordededit file
- ProductIdelalisibno trial recordededit file
- ProductImetelstatno trial recordededit file
- ProductIniparibno trial recordededit file
- ProductInterferon alfa-2a/2bno trial recordededit file
- ProductIrinotecan (and liposomal irinotecan)no trial recordededit file
- ProductIxazomibno trial recordededit file
- ProductLarotrectinibno trial recordededit file
- ProductLeuprolide (leuprorelin) and GnRH agonistsno trial recordededit file
- ProductLomustine (CCNU)no trial recordededit file
- ProductLuspaterceptno trial recordededit file
- ProductLuveltamab tazevibulinno trial recordededit file
- ProductMagrolimabno trial recordededit file
- ProductMargetuximabno trial recordededit file
- ProductMasofanitenno trial recordededit file
- ProductMelphalan (including hepatic delivery system)no trial recordededit file
- ProductMelphalan flufenamideno trial recordededit file
- ProductMethotrexateno trial recordededit file
- ProductMezigdomideno trial recordededit file
- ProductMifamurtideno trial recordededit file
- ProductMitomycin Cno trial recordededit file
- ProductMitotaneno trial recordededit file
- ProductMobocertinibno trial recordededit file
- ProductMogamulizumabno trial recordededit file
- ProductMomelotinibno trial recordededit file
- ProductMoxetumomab pasudotoxno trial recordededit file
- ProductMRTX1133no trial recordededit file
- ProductNadofaragene firadenovecno trial recordededit file
- ProductNeratinibno trial recordededit file
- ProductNilotinibno trial recordededit file
- ProductOdronextamabno trial recordededit file
- ProductOlomorasibno trial recordededit file
- ProductOlutasidenibno trial recordededit file
- ProductOxaliplatinno trial recordededit file
- ProductPacritinibno trial recordededit file
- ProductPafolacianineno trial recordededit file
- ProductPanobinostatno trial recordededit file
- ProductPasritamigno trial recordededit file
- ProductPazopanibno trial recordededit file
- ProductPegulicianineno trial recordededit file
- ProductPegylated liposomal doxorubicinno trial recordededit file
- ProductPenpulimabno trial recordededit file
- ProductPexidartinibno trial recordededit file
- ProductPiflufolastat F-18 / Pylarify TruVuno trial recordededit file
- ProductPivekimab sunirineno trial recordededit file
- ProductPomalidomideno trial recordededit file
- ProductPralatrexateno trial recordededit file
- ProductProgestins (megestrol acetate, medroxyprogesterone, levonorgestrel IUD)no trial recordededit file
- ProductPuxitatug samrotecanno trial recordededit file
- ProductRelugolixno trial recordededit file
- ProductRepotrectinibno trial recordededit file
- ProductRetifanlimabno trial recordededit file
- ProductRomidepsinno trial recordededit file
- ProductRopeginterferon alfa-2bno trial recordededit file
- ProductRovalpituzumab tesirineno trial recordededit file
- ProductRusfertideno trial recordededit file
- ProductRuxolitinibno trial recordededit file
- ProductSacituzumab tirumotecanno trial recordededit file
- ProductSatricabtagene autoleucelno trial recordededit file
- ProductShieldno trial recordededit file
- ProductSipuleucel-Tno trial recordededit file
- ProductSodium thiosulfate (otoprotectant)no trial recordededit file
- ProductSonidegibno trial recordededit file
- ProductSunvozertinibno trial recordededit file
- ProductTagraxofuspno trial recordededit file
- ProductTaletrectinibno trial recordededit file
- ProductTalimogene laherparepvecno trial recordededit file
- ProductTazemetostatno trial recordededit file
- ProductTechnetium-99m tilmanoceptno trial recordededit file
- ProductTemsirolimusno trial recordededit file
- ProductThalidomideno trial recordededit file
- ProductTilatamig samrotecanno trial recordededit file
- ProductTiragolumabno trial recordededit file
- ProductTovorafenibno trial recordededit file
- ProductTrabectedinno trial recordededit file
- ProductTrastuzumab biosimilarsno trial recordededit file
- ProductTrastuzumab duocarmazineno trial recordededit file
- ProductTreosulfanno trial recordededit file
- ProductTretinoin (all-trans retinoic acid, ATRA)no trial recordededit file
- ProductTusamitamab ravtansineno trial recordededit file
- ProductUmbralisibno trial recordededit file
- ProductVinblastineno trial recordededit file
- ProductVincristineno trial recordededit file
- ProductVinorelbineno trial recordededit file
- ProductVismodegibno trial recordededit file
- ProductVusolimogene oderparepvecno trial recordededit file
- ProductZelenectide pevedotinno trial recordededit file
- ProductZenocutuzumabno trial recordededit file
- ProductZidesamtinibno trial recordededit file
- ProductZoldonrasibno trial recordededit file
- ProductZongertinibno trial recordededit file
Companies with no product
193Link the company's products, or add them.
- Company10x Genomicsno product linkededit file
- Company3DHISTECHno product linkededit file
- CompanyAbzenano product linkededit file
- CompanyAdaptive Biotechnologiesno product linkededit file
- CompanyAgilent Technologies (Dako)no product linkededit file
- CompanyAidocno product linkededit file
- CompanyAignosticsno product linkededit file
- CompanyAkoya Biosciencesno product linkededit file
- CompanyAktis Oncologyno product linkededit file
- CompanyAldevron (Danaher)no product linkededit file
- CompanyAllogene Therapeuticsno product linkededit file
- CompanyAraris Biotech (Taiho)no product linkededit file
- CompanyArsenal Biosciencesno product linkededit file
- CompanyAvenzo Therapeuticsno product linkededit file
- CompanyB. Braunno product linkededit file
- CompanyBaxter Internationalno product linkededit file
- CompanyBD (Becton, Dickinson and Company)no product linkededit file
- CompanyBioLife Solutionsno product linkededit file
- CompanyBioptimusno product linkededit file
- CompanyBoehringer Ingelheim BioXcellenceno product linkededit file
- CompanyBoston Scientificno product linkededit file
- CompanyBostonGeneno product linkededit file
- CompanyBrainlabno product linkededit file
- CompanyBruker (Bruker Spatial Biology)no product linkededit file
- CompanyBulsara Bioworksno product linkededit file
- CompanyC4 Therapeuticsno product linkededit file
- CompanyCalyxno product linkededit file
- CompanyCancer Commonsno product linkededit file
- CompanyCanon Medical Systemsno product linkededit file
- CompanyCardinal Health Nuclear & Precision Health Solutionsno product linkededit file
- CompanyCaribou Biosciencesno product linkededit file
- CompanyCaris Life Sciencesno product linkededit file
- CompanyCatalent (Novo Holdings)no product linkededit file
- CompanyCellaresno product linkededit file
- CompanyCelldex Therapeuticsno product linkededit file
- CompanyChai Discoveryno product linkededit file
- CompanyChampions Oncologyno product linkededit file
- CompanyChan Zuckerberg Initiative (Biohub)no product linkededit file
- CompanyCharles River Laboratoriesno product linkededit file
- CompanyCircle Pharmano product linkededit file
- CompanyCivica Rxno product linkededit file
- CompanyClariono product linkededit file
- CompanyClarity Pharmaceuticalsno product linkededit file
- CompanyComecer (ATS)no product linkededit file
- CompanyConcertAIno product linkededit file
- CompanyCOTAno product linkededit file
- CompanyCradleno product linkededit file
- CompanyCryoportno product linkededit file
- CompanyCuresponseno product linkededit file
- CompanyCytiva (Danaher)no product linkededit file
- CompanyDatavantno product linkededit file
- CompanyDebiopharmno product linkededit file
- CompanyDELFI Diagnosticsno product linkededit file
- CompanyDiscovery Life Sciencesno product linkededit file
- CompanyDNAnexusno product linkededit file
- CompanyDuality Biotherapeuticsno product linkededit file
- CompanyEckert & Zieglerno product linkededit file
- CompanyElektano product linkededit file
- CompanyElement Biosciencesno product linkededit file
- CompanyElucidate Biono product linkededit file
- CompanyEpic Systemsno product linkededit file
- CompanyEvolutionaryScaleno product linkededit file
- CompanyFate Therapeuticsno product linkededit file
- CompanyFinalDoseno product linkededit file
- CompanyFlatiron Health (Roche)no product linkededit file
- CompanyFlorida Cancer Specialists & Research Instituteno product linkededit file
- CompanyForesight Diagnosticsno product linkededit file
- CompanyFortreano product linkededit file
- CompanyFresenius Kabino product linkededit file
- CompanyFrontier Medicinesno product linkededit file
- CompanyFUJIFILM Diosynth Biotechnologiesno product linkededit file
- CompanyGalapagosno product linkededit file
- CompanyGenesis Molecular AI (formerly Genesis Therapeutics)no product linkededit file
- CompanyGoogle (Health, DeepMind, Verily)no product linkededit file
- CompanyGoogle DeepMind (and Google Research)no product linkededit file
- CompanyGritstone biono product linkededit file
- CompanyHamamatsu Photonicsno product linkededit file
- CompanyHarbinger Healthno product linkededit file
- CompanyHistAIno product linkededit file
- CompanyHistoSonicsno product linkededit file
- CompanyHUB Organoidsno product linkededit file
- CompanyIambic Therapeuticsno product linkededit file
- CompanyIBA (Ion Beam Applications)no product linkededit file
- CompanyICON plcno product linkededit file
- CompanyIlluminano product linkededit file
- CompanyImmaticsno product linkededit file
- CompanyIndica Labsno product linkededit file
- CompanyIndivumedno product linkededit file
- CompanyInsightecno product linkededit file
- CompanyInsilico Medicineno product linkededit file
- CompanyInterius BioTherapeuticsno product linkededit file
- CompanyIntuitive Surgicalno product linkededit file
- CompanyIQVIAno product linkededit file
- CompanyIsomorphic Labsno product linkededit file
- CompanyJubilant Radiopharmano product linkededit file
- Companykaiko.aino product linkededit file
- CompanyKaiku Health (Elekta)no product linkededit file
- CompanyKomodo Healthno product linkededit file
- CompanyKymera Therapeuticsno product linkededit file
- CompanyLabcorpno product linkededit file
- CompanyLatent Labsno product linkededit file
- CompanyLeica Biosystems (Danaher)no product linkededit file
- CompanyLila Sciencesno product linkededit file
- CompanyLimbus AIno product linkededit file
- CompanyLonzano product linkededit file
- CompanyLunitno product linkededit file
- CompanyMcKesson / The US Oncology Networkno product linkededit file
- CompanyMedableno product linkededit file
- CompanyMedidata (Dassault Systèmes)no product linkededit file
- CompanyMediLink Therapeuticsno product linkededit file
- CompanyMedpaceno product linkededit file
- CompanyMersana Therapeuticsno product linkededit file
- CompanyMevion Medical Systemsno product linkededit file
- CompanyMGI Techno product linkededit file
- CompanyMicrosoft (Health & Life Sciences)no product linkededit file
- CompanyMicrosoft (Research and Health AI)no product linkededit file
- CompanyMiltenyi Biotecno product linkededit file
- CompanyMIM Software (GE HealthCare)no product linkededit file
- CompanyMonte Rosa Therapeuticsno product linkededit file
- CompanyMORE Healthno product linkededit file
- CompanyMorphoSys (Novartis)no product linkededit file
- CompanyMVision AIno product linkededit file
- CompanyNavexiono product linkededit file
- CompanyNeoGenomicsno product linkededit file
- CompanyNkartano product linkededit file
- CompanyNorthStar Medical Radioisotopesno product linkededit file
- CompanyNouscomno product linkededit file
- CompanyNurix Therapeuticsno product linkededit file
- CompanyNVIDIAno product linkededit file
- CompanyOmnicellno product linkededit file
- CompanyOneOncologyno product linkededit file
- CompanyOracle Health (Cerner) & Oracle Life Sciencesno product linkededit file
- CompanyOrna Therapeutics (Eli Lilly)no product linkededit file
- CompanyOwkinno product linkededit file
- CompanyOXB (Oxford Biomedica)no product linkededit file
- CompanyOxford Nanopore Technologiesno product linkededit file
- CompanyPacBiono product linkededit file
- CompanyPaige AIno product linkededit file
- CompanyParexelno product linkededit file
- CompanyPathAIno product linkededit file
- CompanyPatient Data Vault (data-vault.health)no product linkededit file
- CompanyPersonalis (Tempus)no product linkededit file
- CompanyPerspective Therapeuticsno product linkededit file
- CompanyPETNET Solutions (Siemens Healthineers)no product linkededit file
- CompanyPhilipsno product linkededit file
- CompanyPiramal Pharma Solutionsno product linkededit file
- CompanyProfluentno product linkededit file
- CompanyProsciano product linkededit file
- CompanyQIAGENno product linkededit file
- CompanyQuest Diagnosticsno product linkededit file
- CompanyRaySearch Laboratoriesno product linkededit file
- CompanyRecursion Pharmaceuticalsno product linkededit file
- CompanyRefleXion Medicalno product linkededit file
- CompanySakura Finetekno product linkededit file
- CompanySamsung Biologicsno product linkededit file
- CompanySana Biotechnologyno product linkededit file
- CompanySarah Cannon Research Instituteno product linkededit file
- CompanyScience 37 (eMed)no product linkededit file
- CompanySectrano product linkededit file
- CompanySEngine Precision Medicineno product linkededit file
- CompanySerovano product linkededit file
- CompanySHINE Technologiesno product linkededit file
- CompanySiemens Healthineersno product linkededit file
- CompanySirtex Medicalno product linkededit file
- CompanySOFIE Biosciencesno product linkededit file
- CompanySOPHiA GENETICSno product linkededit file
- CompanyStandard BioTools (SomaLogic)no product linkededit file
- CompanyStreckno product linkededit file
- CompanySun Nuclear (Mirion)no product linkededit file
- CompanySynaffix (Lonza)no product linkededit file
- CompanyTempus AIno product linkededit file
- CompanyTerraPower Isotopesno product linkededit file
- CompanyTerumo Blood and Cell Technologiesno product linkededit file
- CompanyTheraPanaceano product linkededit file
- CompanyThermo Fisher Scientificno product linkededit file
- CompanyTouchlightno product linkededit file
- CompanyTrasisno product linkededit file
- CompanyTriNetXno product linkededit file
- CompanyTScan Therapeuticsno product linkededit file
- CompanyTubulis (Gilead)no product linkededit file
- CompanyUltima Genomicsno product linkededit file
- CompanyUmoja Biopharmano product linkededit file
- CompanyUnited Imagingno product linkededit file
- CompanyValius Sciencesno product linkededit file
- CompanyVarian (Siemens Healthineers)no product linkededit file
- CompanyVeeva Systemsno product linkededit file
- CompanyVelsera (Seven Bridges and Pierian)no product linkededit file
- CompanyVevo Therapeuticsno product linkededit file
- CompanyVizgenno product linkededit file
- CompanyWuXi XDCno product linkededit file
- CompanyXaira Therapeuticsno product linkededit file
- CompanyXencorno product linkededit file
- CompanyXilisno product linkededit file
Objects with no external source
1601Add a Wikipedia link, a registry record, or a primary source in `links`.
- TermTumour proportion score (TPS)no external link or Wikipedia entryedit file
- TermEGFR exon 19 deletion & L858Rno external link or Wikipedia entryedit file
- TermEGFR exon 20 insertionno external link or Wikipedia entryedit file
- TermEGFR C797Sno external link or Wikipedia entryedit file
- TermMET amplification (bypass resistance)no external link or Wikipedia entryedit file
- TermHistologic transformationno external link or Wikipedia entryedit file
- TermOligoprogressionno external link or Wikipedia entryedit file
- PairingAmivantamab + lazertinib (first-line EGFR NSCLC)no external link or Wikipedia entryedit file
- PairingPD-1 blockade + chemotherapy in PD-L1-low NSCLCno external link or Wikipedia entryedit file
- PairingSequence: targeted therapy before immunotherapy in driver-positive NSCLCno external link or Wikipedia entryedit file
- TermBiochemical recurrence (BCR)no external link or Wikipedia entryedit file
- TermPSA50 / PSA90 responseno external link or Wikipedia entryedit file
- ProductPasritamigno external link or Wikipedia entryedit file
- ProductFlotufolastat F-18no external link or Wikipedia entryedit file
- ProductDecipher Prostateno external link or Wikipedia entryedit file
- IdeaPSMA-PET-guided metastasis-directed therapy as a curative strategy in oligorecurrent prostate cancerno external link or Wikipedia entryedit file
- IdeaAlpha-emitting PSMA therapy at first metastatic diagnosisno external link or Wikipedia entryedit file
- ProductElironrasibno external link or Wikipedia entryedit file
- ProductMRTX1133no external link or Wikipedia entryedit file
- TechnologyPDAC organoid pharmacotypingno external link or Wikipedia entryedit file
- IdeaRAS(ON) inhibitors to convert unresectable pancreatic cancer to resectableno external link or Wikipedia entryedit file
- IdeaBlood-based pancreatic cancer detection in new-onset diabetesno external link or Wikipedia entryedit file
- PairingG12D-selective + pan-RAS(ON) inhibitor (zoldonrasib + daraxonrasib)no external link or Wikipedia entryedit file
- ProductRindopepimutno external link or Wikipedia entryedit file
- TechnologyFocused-ultrasound blood-brain barrier openingno external link or Wikipedia entryedit file
- TechnologyCAR-T for glioma (IL13Rα2, GD2, EGFRvIII, multi-target)no external link or Wikipedia entryedit file
- IdeaNeoadjuvant immunotherapy with surgical window for glioblastomano external link or Wikipedia entryedit file
- IdeaFocused-ultrasound BBB opening to deliver ADCs and radioligands to gliomano external link or Wikipedia entryedit file
- ProductCamizestrantno external link or Wikipedia entryedit file
- ProductImlunestrantno external link or Wikipedia entryedit file
- ProductGiredestrantno external link or Wikipedia entryedit file
- ProductAtirmociclibno external link or Wikipedia entryedit file
- TermOral SERDno external link or Wikipedia entryedit file
- TermEndocrine resistanceno external link or Wikipedia entryedit file
- TermOvarian function suppression (OFS)no external link or Wikipedia entryedit file
- TermLate recurrenceno external link or Wikipedia entryedit file
- PairingOral SERD + CDK4/6 inhibitor after ESR1 emergenceno external link or Wikipedia entryedit file
- PairingPI3K/AKT-pathway inhibitor + endocrine therapy (± CDK4/6)no external link or Wikipedia entryedit file
- PairingGene-expression assay → chemotherapy omissionno external link or Wikipedia entryedit file
- IdeaMolecular-progression switching beyond ESR1no external link or Wikipedia entryedit file
- IdeaCDK4-selective inhibitors as the new first-line backboneno external link or Wikipedia entryedit file
- IdeaIntercepting late recurrence with ctDNA surveillance and oral SERDsno external link or Wikipedia entryedit file
- ProductPyrotinibno external link or Wikipedia entryedit file
- ProductTrastuzumab rezetecanno external link or Wikipedia entryedit file
- ProductTrastuzumab brengitecanno external link or Wikipedia entryedit file
- ProductARX788no external link or Wikipedia entryedit file
- TermDual HER2 blockadeno external link or Wikipedia entryedit file
- TermHER2-positive brain metastasesno external link or Wikipedia entryedit file
- TermTrastuzumab cardiotoxicityno external link or Wikipedia entryedit file
- PairingTucatinib + trastuzumab + capecitabine for brain metastasesno external link or Wikipedia entryedit file
- PairingEarly FDG-PET response → chemotherapy omission (HER2+)no external link or Wikipedia entryedit file
- IdeaCan T-DXd alone cure early HER2-positive disease?no external link or Wikipedia entryedit file
- IdeaSystemic-first management of HER2-positive brain metastasesno external link or Wikipedia entryedit file
- IdeaSequencing HER2 ADCs by payload after T-DXdno external link or Wikipedia entryedit file
- ProductCamrelizumab + rivoceranibno external link or Wikipedia entryedit file
- PairingTACE + immunotherapy/anti-VEGFno external link or Wikipedia entryedit file
- PairingCaution: bevacizumab-based regimens with untreated varicesno external link or Wikipedia entryedit file
- IdeaImmunotherapy downstaging to transplant with a safe washoutno external link or Wikipedia entryedit file
- IdeaBlood-based HCC surveillance to replace six-monthly ultrasoundno external link or Wikipedia entryedit file
- TermFGFR2 fusions and rearrangementsno external link or Wikipedia entryedit file
- ProductTinengotinibno external link or Wikipedia entryedit file
- TrialBILCAPno external link or Wikipedia entryedit file
- PairingGemcitabine-cisplatin + PD-(L)1 blockade in biliary cancerno external link or Wikipedia entryedit file
- IdeactDNA-guided switching among FGFR inhibitorsno external link or Wikipedia entryedit file
- Product177Lu-edotreotideno external link or Wikipedia entryedit file
- ProductCapecitabine + temozolomide (CAPTEM)no external link or Wikipedia entryedit file
- PairingSSTR PET → PRRTno external link or Wikipedia entryedit file
- PairingBeta PRRT → alpha PRRTno external link or Wikipedia entryedit file
- IdeaDosimetry-personalised PRRT instead of four fixed cyclesno external link or Wikipedia entryedit file
- IdeaSSTR antagonist radioligands to increase tumour doseno external link or Wikipedia entryedit file
- TechnologyDermoscopy, total-body photography & AI skin analysisno external link or Wikipedia entryedit file
- TermUlceration (melanoma)no external link or Wikipedia entryedit file
- TermMajor pathological response (MPR)no external link or Wikipedia entryedit file
- TermHLA-A*02:01 restrictionno external link or Wikipedia entryedit file
- PairingImmunotherapy first, then BRAF/MEK (BRAF-mutant melanoma)no external link or Wikipedia entryedit file
- PairingNeoadjuvant immunotherapy → response-adapted adjuvantno external link or Wikipedia entryedit file
- PairingCaution: LAG-3 blockade outside active diseaseno external link or Wikipedia entryedit file
- IdeactDNA-guided adjuvant therapy in stage II-III melanomano external link or Wikipedia entryedit file
- IdeaTCR therapeutics for non-HLA-A*02 patientsno external link or Wikipedia entryedit file
- TechnologyCirculating tumour HPV DNA (ctHPV-DNA)no external link or Wikipedia entryedit file
- TermLGR5no external link or Wikipedia entryedit file
- PairingImmunotherapy before surgery rather than with chemoradiation (HNSCC)no external link or Wikipedia entryedit file
- PairingEGFR-directed bispecific + PD-1 blockadeno external link or Wikipedia entryedit file
- PairingCaution: de-escalating radiation on HPV status aloneno external link or Wikipedia entryedit file
- IdeactHPV-DNA-adapted de-escalation of chemoradiationno external link or Wikipedia entryedit file
- IdeaPhotoimmunotherapy as an in situ vaccine with PD-1 blockadeno external link or Wikipedia entryedit file
- TechnologyThyroid nodule FNA, Bethesda cytology & molecular classifiersno external link or Wikipedia entryedit file
- TechnologyActive surveillance of papillary microcarcinomano external link or Wikipedia entryedit file
- TermRadioiodine-refractory (RAI-R) thyroid cancerno external link or Wikipedia entryedit file
- TermLow-risk differentiated thyroid cancer (ATA risk)no external link or Wikipedia entryedit file
- TermBethesda category (thyroid cytology)no external link or Wikipedia entryedit file
- TermTSH suppressionno external link or Wikipedia entryedit file
- TermTERT promoter mutationno external link or Wikipedia entryedit file
- PairingBRAF/MEK inhibition → surgery in anaplastic thyroid cancerno external link or Wikipedia entryedit file
- PairingMAPK inhibitor redifferentiation → radioiodineno external link or Wikipedia entryedit file
- IdeaUltrasound restraint and surveillance to reverse thyroid cancer overdiagnosisno external link or Wikipedia entryedit file
- IdeaBRAF/MEK plus PD-1 blockade as standard for BRAF-mutant anaplastic thyroid cancerno external link or Wikipedia entryedit file
- TermSidedness (left vs right colon)no external link or Wikipedia entryedit file
- TermConsensus molecular subtypes (CMS1-4)no external link or Wikipedia entryedit file
- TermClinical complete response (cCR)no external link or Wikipedia entryedit file
- PairingAnti-EGFR antibody + chemotherapy in left-sided RAS/BRAF wild-type mCRCno external link or Wikipedia entryedit file
- PairingNeoadjuvant checkpoint inhibitor → surgery (or no surgery) in dMMR colorectal cancerno external link or Wikipedia entryedit file
- IdeactDNA-guided adjuvant therapy as the default in stage II-III colon cancerno external link or Wikipedia entryedit file
- IdeaMaking microsatellite-stable colorectal cancer immunotherapy-responsiveno external link or Wikipedia entryedit file
- TermPeritoneal metastasisno external link or Wikipedia entryedit file
- PairingHER2 sequence in gastric cancer: zanidatamab/trastuzumab + chemo ± PD-1 → T-DXdno external link or Wikipedia entryedit file
- PairingCLDN18.2 antibody first line → CLDN18.2 ADC or CAR-T on progressionno external link or Wikipedia entryedit file
- IdeaBiomarker-directed first-line quadruplets in gastric cancerno external link or Wikipedia entryedit file
- IdeaPeritoneal-directed therapy for gastric cancerno external link or Wikipedia entryedit file
- TermSquamous cell carcinoma vs adenocarcinoma of the oesophagusno external link or Wikipedia entryedit file
- PairingCROSS chemoradiation → surgery → adjuvant nivolumab if residual diseaseno external link or Wikipedia entryedit file
- IdeaOrgan preservation as the default after complete response in oesophageal cancerno external link or Wikipedia entryedit file
- IdeaNon-endoscopic screening for Barrett's oesophagus and early adenocarcinomano external link or Wikipedia entryedit file
- ProductSerplulimabno external link or Wikipedia entryedit file
- TermLimited-stage vs extensive-stage (SCLC)no external link or Wikipedia entryedit file
- PairingChemo-immunotherapy induction → maintenance intensification (SCLC)no external link or Wikipedia entryedit file
- PairingSequencing DLL3 engager and B7-H3 ADC in relapsed SCLCno external link or Wikipedia entryedit file
- IdeaSubtype-directed therapy for SCLC (ASCL1 / NEUROD1 / POU2F3 / inflamed)no external link or Wikipedia entryedit file
- IdeaMRI surveillance replaces prophylactic cranial irradiation in SCLCno external link or Wikipedia entryedit file
- TermEpithelioid vs sarcomatoid (biphasic) mesotheliomano external link or Wikipedia entryedit file
- PairingHistology → first-line choice in mesotheliomano external link or Wikipedia entryedit file
- IdeaPRMT5/MAT2A synthetic lethality for MTAP-deleted mesotheliomano external link or Wikipedia entryedit file
- IdeaRegionally delivered mesothelin CAR-T with PD-1 blockadeno external link or Wikipedia entryedit file
- ProductGemcitabine intravesical system (TAR-200)no external link or Wikipedia entryedit file
- ProductCretostimogene grenadenorepvecno external link or Wikipedia entryedit file
- ProductNogapendekin alfa inbakiceptno external link or Wikipedia entryedit file
- ProductZelenectide pevedotinno external link or Wikipedia entryedit file
- TermNon-muscle-invasive vs muscle-invasive bladder cancer (NMIBC / MIBC)no external link or Wikipedia entryedit file
- TermBCG-unresponsiveno external link or Wikipedia entryedit file
- TermFGFR3 alterations (bladder cancer)no external link or Wikipedia entryedit file
- PairingEnfortumab vedotin + pembrolizumab across the bladder cancer continuumno external link or Wikipedia entryedit file
- PairingDurvalumab + BCG in BCG-naive high-risk NMIBCno external link or Wikipedia entryedit file
- IdeaBladder preservation for MIBC after perioperative EV + pembrolizumab complete responseno external link or Wikipedia entryedit file
- IdeaUrine tumour DNA to replace surveillance cystoscopy in NMIBCno external link or Wikipedia entryedit file
- TechnologyCAIX PET (89Zr-girentuximab)no external link or Wikipedia entryedit file
- TermIMDC risk groups (favourable / intermediate / poor)no external link or Wikipedia entryedit file
- TermSarcomatoid differentiation (RCC)no external link or Wikipedia entryedit file
- PairingCaution: PD-1 rechallenge after progression on immunotherapy (RCC)no external link or Wikipedia entryedit file
- PairingIMDC risk → first-line regimen choice (RCC)no external link or Wikipedia entryedit file
- IdeaBiomarker-selected adjuvant therapy in RCC (ctDNA, CAIX PET, gene signatures)no external link or Wikipedia entryedit file
- IdeaCAIX theranostics: 89Zr-girentuximab PET and 177Lu/225Ac-girentuximab therapyno external link or Wikipedia entryedit file
- ProductAvutometinib + defactinibno external link or Wikipedia entryedit file
- ProductRinatabart sesutecanno external link or Wikipedia entryedit file
- TermLow-grade serous ovarian cancer (LGSOC)no external link or Wikipedia entryedit file
- TermHigh-grade serous ovarian carcinoma (HGSOC)no external link or Wikipedia entryedit file
- PairingPARP inhibitor + bevacizumab maintenance (HRD-positive)no external link or Wikipedia entryedit file
- PairingHIPEC at interval cytoreductive surgeryno external link or Wikipedia entryedit file
- PairingCaution: checkpoint inhibitors in first-line ovarian cancerno external link or Wikipedia entryedit file
- IdeaSequence folate-receptor ADCs by payload classno external link or Wikipedia entryedit file
- IdeactDNA-guided duration of PARP maintenanceno external link or Wikipedia entryedit file
- TechnologyFertility-sparing hormonal treatment of early endometrial cancerno external link or Wikipedia entryedit file
- PairingChemotherapy + PD-1/PD-L1 blockade, first-line advanced endometrial cancerno external link or Wikipedia entryedit file
- PairingLenvatinib + pembrolizumab (pMMR endometrial cancer after platinum)no external link or Wikipedia entryedit file
- IdeaMolecular-class-directed adjuvant therapy in endometrial cancerno external link or Wikipedia entryedit file
- IdeaHER2 ADCs as standard for HER2-positive serous endometrial cancerno external link or Wikipedia entryedit file
- ProductCadonilimabno external link or Wikipedia entryedit file
- TechnologyThermal ablation and cryotherapy for cervical precancerno external link or Wikipedia entryedit file
- PairingInduction chemotherapy → chemoradiation (locally advanced cervical cancer)no external link or Wikipedia entryedit file
- PairingPD-1 blockade + chemoradiation (locally advanced cervical cancer)no external link or Wikipedia entryedit file
- PairingCaution: minimally invasive radical hysterectomy for early cervical cancerno external link or Wikipedia entryedit file
- IdeaSingle-dose HPV vaccination plus HPV self-sampling to reach WHO elimination in low-income countriesno external link or Wikipedia entryedit file
- IdeaHPV circulating tumour DNA to guide cervical cancer therapyno external link or Wikipedia entryedit file
- TermFLT3-ITD allelic rationo external link or Wikipedia entryedit file
- Termdel(17p) / TP53 aberration in CLLno external link or Wikipedia entryedit file
- TermMRD-negative complete remissionno external link or Wikipedia entryedit file
- TermPh-positive ALLno external link or Wikipedia entryedit file
- ProductZiftomenibno external link or Wikipedia entryedit file
- PairingVenetoclax + hypomethylating agentno external link or Wikipedia entryedit file
- PairingFLT3 inhibitor + intensive chemotherapyno external link or Wikipedia entryedit file
- PairingMenin inhibitor + venetoclax + azacitidineno external link or Wikipedia entryedit file
- IdeaMRD-guided transplant decisions in intermediate-risk AMLno external link or Wikipedia entryedit file
- IdeaShorter venetoclax courses in unfit AMLno external link or Wikipedia entryedit file
- ProductObecabtagene autoleucelno external link or Wikipedia entryedit file
- PairingBCR::ABL1 TKI + blinatumomab (chemotherapy-free Ph+ ALL)no external link or Wikipedia entryedit file
- PairingBlinatumomab added to frontline chemotherapyno external link or Wikipedia entryedit file
- PairingCaution: inotuzumab before transplant (veno-occlusive disease)no external link or Wikipedia entryedit file
- IdeaTransplant-free Ph-positive ALL for MRD-negative adultsno external link or Wikipedia entryedit file
- IdeaMenin inhibitors for infant KMT2A-rearranged ALLno external link or Wikipedia entryedit file
- ProductSonrotoclaxno external link or Wikipedia entryedit file
- ProductNemtabrutinibno external link or Wikipedia entryedit file
- PairingBTK inhibitor + venetoclax, fixed durationno external link or Wikipedia entryedit file
- PairingVenetoclax + obinutuzumab (12 months)no external link or Wikipedia entryedit file
- PairingCaution: chemoimmunotherapy in del(17p)/TP53 CLLno external link or Wikipedia entryedit file
- PairingCaution: ibrutinib in patients with cardiac riskno external link or Wikipedia entryedit file
- IdeaMRD-guided treatment duration in CLLno external link or Wikipedia entryedit file
- IdeaBTK degraders to pre-empt resistance in frontline CLLno external link or Wikipedia entryedit file
- TechnologyctDNA monitoring in lymphoma (PhasED-seq, clonoSEQ)no external link or Wikipedia entryedit file
- TermCell of origin (GCB vs ABC)no external link or Wikipedia entryedit file
- TermDouble-hit / high-grade B-cell lymphomano external link or Wikipedia entryedit file
- ProductOdronextamabno external link or Wikipedia entryedit file
- ProductGolcadomideno external link or Wikipedia entryedit file
- PairingCD20 bispecific + CD79b ADC (mosunetuzumab + polatuzumab)no external link or Wikipedia entryedit file
- PairingEarly relapse: CAR-T before transplantno external link or Wikipedia entryedit file
- IdeactDNA-guided escalation and de-escalation in frontline DLBCLno external link or Wikipedia entryedit file
- IdeaHead-to-head bispecific vs CAR-T in second-line LBCLno external link or Wikipedia entryedit file
- TermHigh-risk cytogenetics (myeloma)no external link or Wikipedia entryedit file
- TermMRD negativity (myeloma, 10⁻⁵ / 10⁻⁶)no external link or Wikipedia entryedit file
- ProductAnitocabtagene autoleucelno external link or Wikipedia entryedit file
- ProductLinvoseltamabno external link or Wikipedia entryedit file
- ProductIberdomideno external link or Wikipedia entryedit file
- ProductMezigdomideno external link or Wikipedia entryedit file
- PairingCD38 antibody added to PI-IMiD-dex (quadruplet induction)no external link or Wikipedia entryedit file
- PairingBCMA-directed therapy → GPRC5D-directed therapyno external link or Wikipedia entryedit file
- PairingCaution: T-cell redirectors and infectionsno external link or Wikipedia entryedit file
- IdeaMRD-guided treatment-free intervals in myelomano external link or Wikipedia entryedit file
- IdeaOne CAR-T infusion instead of autologous transplantno external link or Wikipedia entryedit file
- TechnologyPET-adapted (response-adapted) therapyno external link or Wikipedia entryedit file
- TermDeauville five-point scaleno external link or Wikipedia entryedit file
- PairingPD-1 blockade + AVD chemotherapyno external link or Wikipedia entryedit file
- PairingCaution: bleomycin lung toxicity, especially with brentuximab or G-CSFno external link or Wikipedia entryedit file
- IdeaChemotherapy-free Hodgkin lymphoma: brentuximab + PD-1 in early stageno external link or Wikipedia entryedit file
- IdeaCD30 CAR-T for multiply relapsed Hodgkin lymphomano external link or Wikipedia entryedit file
- TermFNCLCC grade (soft-tissue sarcoma)no external link or Wikipedia entryedit file
- TermHistotype-tailored therapyno external link or Wikipedia entryedit file
- ProductVimseltinibno external link or Wikipedia entryedit file
- ProductLetetresgene autoleucelno external link or Wikipedia entryedit file
- PairingctDNA KIT genotyping → TKI selection in GISTno external link or Wikipedia entryedit file
- PairingCaution: cumulative anthracycline dose and the heartno external link or Wikipedia entryedit file
- IdeaExtending sarcoma TCR-T beyond HLA-A*02no external link or Wikipedia entryedit file
- IdeaIntermittent or stop-and-restart nirogacestat in desmoid tumoursno external link or Wikipedia entryedit file
- TechnologyTandem autologous transplantno external link or Wikipedia entryedit file
- PairingAnti-GD2 antibody + irinotecan-temozolomide (chemoimmunotherapy)no external link or Wikipedia entryedit file
- PairingCaution: IL-2 added to anti-GD2 therapyno external link or Wikipedia entryedit file
- IdeaGD2 CAR-T as consolidation in high-risk neuroblastomano external link or Wikipedia entryedit file
- Idea18F-MFBG PET replacing 123I-MIBG scintigraphyno external link or Wikipedia entryedit file
- FrontImagingno external link or Wikipedia entryedit file
- FrontDiagnostics & Biomarkersno external link or Wikipedia entryedit file
- FrontEarly Detection & Screeningno external link or Wikipedia entryedit file
- FrontSurgery & Interventionalno external link or Wikipedia entryedit file
- FrontRadiation Therapyno external link or Wikipedia entryedit file
- FrontChemotherapyno external link or Wikipedia entryedit file
- FrontTargeted Therapyno external link or Wikipedia entryedit file
- FrontAntibody-Drug Conjugatesno external link or Wikipedia entryedit file
- FrontImmunotherapyno external link or Wikipedia entryedit file
- FrontCell Therapyno external link or Wikipedia entryedit file
- FrontRadiopharmaceuticals & Theranosticsno external link or Wikipedia entryedit file
- FrontHormonal Therapyno external link or Wikipedia entryedit file
- FrontEpigenetic & Transcriptional Therapyno external link or Wikipedia entryedit file
- FrontSupportive Care & Survivorshipno external link or Wikipedia entryedit file
- FrontAI & Computationno external link or Wikipedia entryedit file
- FrontDrug Discovery Platformsno external link or Wikipedia entryedit file
- FrontPrevention & Riskno external link or Wikipedia entryedit file
- FrontDevices & Physical Therapiesno external link or Wikipedia entryedit file
- TechnologyTROP2 PETno external link or Wikipedia entryedit file
- TechnologyHER2 PETno external link or Wikipedia entryedit file
- TechnologyPARP PETno external link or Wikipedia entryedit file
- TechnologyWhole-body MRIno external link or Wikipedia entryedit file
- TechnologyHRD & BRCA testingno external link or Wikipedia entryedit file
- TechnologyBispecific ADCno external link or Wikipedia entryedit file
- TechnologyDual-payload ADCno external link or Wikipedia entryedit file
- TechnologyDegrader-antibody conjugate (DAC)no external link or Wikipedia entryedit file
- TechnologyImmune-stimulating antibody conjugate (ISAC)no external link or Wikipedia entryedit file
- TechnologyMasked / conditionally active ADCno external link or Wikipedia entryedit file
- TechnologyOff-the-shelf cancer vaccinesno external link or Wikipedia entryedit file
- TechnologyIn vivo CAR-Tno external link or Wikipedia entryedit file
- TechnologyTCR-T cell therapyno external link or Wikipedia entryedit file
- TechnologyCAR-NK & CAR-macrophageno external link or Wikipedia entryedit file
- TechnologyAllogeneic (off-the-shelf) cell therapyno external link or Wikipedia entryedit file
- TechnologyArmoured, logic-gated & next-gen CARsno external link or Wikipedia entryedit file
- TechnologyExercise & lifestyle oncologyno external link or Wikipedia entryedit file
- TechnologyGeriatric assessmentno external link or Wikipedia entryedit file
- TechnologyPathology & radiology foundation modelsno external link or Wikipedia entryedit file
- TechnologyAI trial matching & clinical decision supportno external link or Wikipedia entryedit file
- ProductTelisotuzumab vedotinno external link or Wikipedia entryedit file
- ProductPatritumab deruxtecanno external link or Wikipedia entryedit file
- ProductIfinatamab deruxtecanno external link or Wikipedia entryedit file
- ProductRaludotatug deruxtecanno external link or Wikipedia entryedit file
- ProductTilatamig samrotecanno external link or Wikipedia entryedit file
- ProductAK146D1no external link or Wikipedia entryedit file
- ProductDisitamab vedotinno external link or Wikipedia entryedit file
- ProductZilovertamab vedotinno external link or Wikipedia entryedit file
- ProductSonesitatug vedotinno external link or Wikipedia entryedit file
- ProductPuxitatug samrotecanno external link or Wikipedia entryedit file
- ProductIvonescimabno external link or Wikipedia entryedit file
- ProductSatricabtagene autoleucelno external link or Wikipedia entryedit file
- ProductActinium-225 DOTATATEno external link or Wikipedia entryedit file
- ProductActinium-225 PSMA agentsno external link or Wikipedia entryedit file
- ProductFAP-2286 (177Lu / 68Ga)no external link or Wikipedia entryedit file
- ProductZongertinibno external link or Wikipedia entryedit file
- ProductZidesamtinibno external link or Wikipedia entryedit file
- ProductGedatolisibno external link or Wikipedia entryedit file
- ProductVepdegestrantno external link or Wikipedia entryedit file
- ProductRelacorilantno external link or Wikipedia entryedit file
- ProductAutogene cevumeranno external link or Wikipedia entryedit file
- ProductVusolimogene oderparepvecno external link or Wikipedia entryedit file
- ProductShieldno external link or Wikipedia entryedit file
- ProductSignaterano external link or Wikipedia entryedit file
- ProductFoundationOne CDx / Liquid CDxno external link or Wikipedia entryedit file
- ProductArteraAI Prostateno external link or Wikipedia entryedit file
- ProductArteraAI Breastno external link or Wikipedia entryedit file
- TermDrug-to-antibody ratio (DAR)no external link or Wikipedia entryedit file
- TermBystander effect (ADC)no external link or Wikipedia entryedit file
- TermEvent-free / disease-free survival (EFS, DFS, iDFS, RFS)no external link or Wikipedia entryedit file
- TermResidual cancer burden (RCB)no external link or Wikipedia entryedit file
- TermStage shiftno external link or Wikipedia entryedit file
- TermHER2-low and HER2-ultralowno external link or Wikipedia entryedit file
- TermCombined positive score (CPS)no external link or Wikipedia entryedit file
- TermVariant allele frequency (VAF)no external link or Wikipedia entryedit file
- TermPAM50 / intrinsic subtypesno external link or Wikipedia entryedit file
- TermICANS (neurotoxicity)no external link or Wikipedia entryedit file
- TermFc engineering / effector functionno external link or Wikipedia entryedit file
- TermLines of therapyno external link or Wikipedia entryedit file
- TermBreakthrough Therapy / Priority Review / Priority Voucherno external link or Wikipedia entryedit file
- TermCompanion diagnosticno external link or Wikipedia entryedit file
- TermAlpha vs beta emittersno external link or Wikipedia entryedit file
- TermDosimetryno external link or Wikipedia entryedit file
- TermHot vs cold tumoursno external link or Wikipedia entryedit file
- TermADC sequencingno external link or Wikipedia entryedit file
- PairingADC + checkpoint inhibitorno external link or Wikipedia entryedit file
- PairingCDK4/6 inhibitor + endocrine therapyno external link or Wikipedia entryedit file
- PairingBRAF inhibitor + MEK inhibitorno external link or Wikipedia entryedit file
- PairingKRAS G12C inhibitor + anti-EGFR antibody (colorectal)no external link or Wikipedia entryedit file
- PairingPD-1 blockade + VEGF inhibitionno external link or Wikipedia entryedit file
- PairingPARP inhibitor + AR pathway inhibitor (prostate)no external link or Wikipedia entryedit file
- PairingPersonalised neoantigen vaccine + PD-1 blockadeno external link or Wikipedia entryedit file
- PairingRadiotherapy + immunotherapyno external link or Wikipedia entryedit file
- PairingOncolytic virus + PD-1 blockadeno external link or Wikipedia entryedit file
- PairingPlatinum chemotherapy in HRD tumoursno external link or Wikipedia entryedit file
- PairingPSMA PET → PSMA radioligand therapyno external link or Wikipedia entryedit file
- PairingTROP2 PET → TROP2 ADC selectionno external link or Wikipedia entryedit file
- PairingctDNA MRD → adjuvant therapy decisionno external link or Wikipedia entryedit file
- PairingHER2-low scoring → T-DXdno external link or Wikipedia entryedit file
- PairingGermline BRCA test → adjuvant PARP inhibitorno external link or Wikipedia entryedit file
- PairingAI pathology → androgen deprivation durationno external link or Wikipedia entryedit file
- PairingEGFR TKI → ADC on progressionno external link or Wikipedia entryedit file
- PairingPD-1 failure → TIL therapyno external link or Wikipedia entryedit file
- PairingBeta radioligand → alpha radioligandno external link or Wikipedia entryedit file
- PairingCaution: TOP1 ADC immediately after TOP1 ADCno external link or Wikipedia entryedit file
- PairingCaution: TIGIT + PD-(L)1 blockadeno external link or Wikipedia entryedit file
- PairingCaution: DXd ADC + agents with pneumonitis riskno external link or Wikipedia entryedit file
- RoadmapADC roadmap: from Mylotarg to bispecific and dual-payload ADCsno external link or Wikipedia entryedit file
- RoadmapTROP2 ADC roadmap: sacituzumab govitecan → Dato-DXd → sac-TMT → bispecifics and PETno external link or Wikipedia entryedit file
- RoadmapTNBC roadmap: from 'nothing to target' to ADC + immunotherapy first lineno external link or Wikipedia entryedit file
- RoadmapRadiopharmaceutical roadmap: iodine → lutetium → actiniumno external link or Wikipedia entryedit file
- RoadmapCell therapy roadmap: CD19 CAR-T → solid tumours → in vivo CARno external link or Wikipedia entryedit file
- RoadmapMolecular imaging roadmap: FDG → PSMA → FAP → antigen and immune PETno external link or Wikipedia entryedit file
- RoadmapEarly detection roadmap: organ screening → blood tests for many cancersno external link or Wikipedia entryedit file
- RoadmapImmunotherapy roadmap: Coley's toxins → checkpoint inhibitors → engineered immunityno external link or Wikipedia entryedit file
- RoadmapKRAS roadmap: undruggable → G12C → pan-RASno external link or Wikipedia entryedit file
- IdeaTROP2 PET to choose and sequence TROP2 ADCsno external link or Wikipedia entryedit file
- IdeaPayload-class switching as the rule for ADC sequencingno external link or Wikipedia entryedit file
- IdeaADC for residual disease after KEYNOTE-522no external link or Wikipedia entryedit file
- IdeactDNA-triggered escalation in early TNBCno external link or Wikipedia entryedit file
- IdeaEfflux-agnostic therapy for mesenchymal TNBCno external link or Wikipedia entryedit file
- IdeaFAP theranostics as a pan-cancer stromal strategyno external link or Wikipedia entryedit file
- IdeaIn vivo CAR-T against solid-tumour antigensno external link or Wikipedia entryedit file
- IdeaNeoadjuvant ADC + IO replacing anthracycline chemotherapy in TNBCno external link or Wikipedia entryedit file
- IdeaTIL-based omission of chemotherapy in stage I TNBCno external link or Wikipedia entryedit file
- IdeaAI quantification of HER2-low and HER2-ultralowno external link or Wikipedia entryedit file
- IdeaAlpha radioligands after ADC failureno external link or Wikipedia entryedit file
- IdeaOff-the-shelf KRAS vaccines after pancreatic cancer surgeryno external link or Wikipedia entryedit file
- IdeaFAPI PET as the workup for MCED positivesno external link or Wikipedia entryedit file
- IdeaTotal-body PET for personalised radioligand dosingno external link or Wikipedia entryedit file
- IdeaPatient-derived organoids to pick ADC payloadsno external link or Wikipedia entryedit file
- IdeaDual-payload ADCs in first line to prevent resistanceno external link or Wikipedia entryedit file
- IdeaCD8 PET to stop or switch immunotherapy earlyno external link or Wikipedia entryedit file
- IdeaStructured exercise prescribed like a drug in all curative-intent cancer careno external link or Wikipedia entryedit file
- IdeaPatient-level multimodal foundation models for treatment selectionno external link or Wikipedia entryedit file
- IdeaCancer interception vaccines for high-risk carriersno external link or Wikipedia entryedit file
- PersonFabrice Barlesino external link or Wikipedia entryedit file
- PersonFabrice Andréno external link or Wikipedia entryedit file
- PersonJean-Charles Soriano external link or Wikipedia entryedit file
- PersonBenjamin Besseno external link or Wikipedia entryedit file
- PersonAurélien Marabelleno external link or Wikipedia entryedit file
- PersonKarim Fizazino external link or Wikipedia entryedit file
- PersonLaurence Zitvogelno external link or Wikipedia entryedit file
- PersonNicholas Turnerno external link or Wikipedia entryedit file
- PersonJohann de Bonono external link or Wikipedia entryedit file
- PersonAndrew Tuttno external link or Wikipedia entryedit file
- PersonNicholas Jamesno external link or Wikipedia entryedit file
- PersonDavid Cunninghamno external link or Wikipedia entryedit file
- PersonJames Larkinno external link or Wikipedia entryedit file
- PersonUwe Oelfkeno external link or Wikipedia entryedit file
- PersonKristian Helinno external link or Wikipedia entryedit file
- PersonPaul Workmanno external link or Wikipedia entryedit file
- PersonChristopher Lordno external link or Wikipedia entryedit file
- PersonKevin Harringtonno external link or Wikipedia entryedit file
- PersonMel Greavesno external link or Wikipedia entryedit file
- PersonCharles Swantonno external link or Wikipedia entryedit file
- PersonPaul Nurseno external link or Wikipedia entryedit file
- PersonCaetano Reis e Sousano external link or Wikipedia entryedit file
- PersonErik Sahaino external link or Wikipedia entryedit file
- PersonMichelle Mitchellno external link or Wikipedia entryedit file
- PersonIain Foulkesno external link or Wikipedia entryedit file
- PersonRuth Plummerno external link or Wikipedia entryedit file
- PersonCaroline Diveno external link or Wikipedia entryedit file
- PersonFiona Blackhallno external link or Wikipedia entryedit file
- PersonAndrew Wardleyno external link or Wikipedia entryedit file
- PersonAnanya Choudhuryno external link or Wikipedia entryedit file
- PersonUwe Haberkornno external link or Wikipedia entryedit file
- PersonFrederik Gieselno external link or Wikipedia entryedit file
- PersonClemens Kratochwilno external link or Wikipedia entryedit file
- PersonStefan Fröhlingno external link or Wikipedia entryedit file
- PersonJürgen Debusno external link or Wikipedia entryedit file
- PersonAndreas von Deimlingno external link or Wikipedia entryedit file
- PersonMichael Baumannno external link or Wikipedia entryedit file
- PersonStefan Pfisterno external link or Wikipedia entryedit file
- PersonHermann Brennerno external link or Wikipedia entryedit file
- PersonAndreas Trumppno external link or Wikipedia entryedit file
- PersonSteven Le Gouillno external link or Wikipedia entryedit file
- PersonFrançois-Clément Bidardno external link or Wikipedia entryedit file
- PersonSergio Roman-Romanno external link or Wikipedia entryedit file
- PersonOlivier Delattreno external link or Wikipedia entryedit file
- PersonEliane Piaggiono external link or Wikipedia entryedit file
- PersonGiuseppe Curiglianono external link or Wikipedia entryedit file
- PersonPaolo Veronesino external link or Wikipedia entryedit file
- PersonRoberto Orecchiano external link or Wikipedia entryedit file
- PersonPier Giuseppe Peliccino external link or Wikipedia entryedit file
- PersonAlessandro Gronchino external link or Wikipedia entryedit file
- PersonFilippo de Braudno external link or Wikipedia entryedit file
- PersonMarco Guzzono external link or Wikipedia entryedit file
- PersonJosep Tabernerono external link or Wikipedia entryedit file
- PersonJavier Cortésno external link or Wikipedia entryedit file
- PersonElena Garraldano external link or Wikipedia entryedit file
- PersonEnriqueta Felipno external link or Wikipedia entryedit file
- PersonElena Élezno external link or Wikipedia entryedit file
- PersonJoaquín Arribasno external link or Wikipedia entryedit file
- PersonUlrich Keilholzno external link or Wikipedia entryedit file
- PersonLars Bullingerno external link or Wikipedia entryedit file
- PersonAngelika Eggertno external link or Wikipedia entryedit file
- PersonChristof von Kalleno external link or Wikipedia entryedit file
- PersonMarkus Graefenno external link or Wikipedia entryedit file
- PersonCarsten Bokemeyerno external link or Wikipedia entryedit file
- PersonKlaus Pantelno external link or Wikipedia entryedit file
- PersonVolker Heinemannno external link or Wikipedia entryedit file
- PersonPeter Bartensteinno external link or Wikipedia entryedit file
- PersonMichael von Bergweltno external link or Wikipedia entryedit file
- PersonClaus Belkano external link or Wikipedia entryedit file
- PersonMichael Hallekno external link or Wikipedia entryedit file
- PersonJürgen Wolfno external link or Wikipedia entryedit file
- PersonReinhard Büttnerno external link or Wikipedia entryedit file
- PersonRoman Thomasno external link or Wikipedia entryedit file
- PersonGiovanni Scambiano external link or Wikipedia entryedit file
- PersonAnna Fagottino external link or Wikipedia entryedit file
- PersonGiampaolo Tortorano external link or Wikipedia entryedit file
- PersonVincenzo Valentinino external link or Wikipedia entryedit file
- PersonJonas Berghno external link or Wikipedia entryedit file
- PersonPer Hallno external link or Wikipedia entryedit file
- PersonRolf Kiesslingno external link or Wikipedia entryedit file
- PersonHans-Gustaf Ljunggrenno external link or Wikipedia entryedit file
- PersonChristian Blankno external link or Wikipedia entryedit file
- PersonMyriam Chalabino external link or Wikipedia entryedit file
- PersonJohn Haanenno external link or Wikipedia entryedit file
- PersonEmile Voestno external link or Wikipedia entryedit file
- PersonTon Schumacherno external link or Wikipedia entryedit file
- PersonRené Bernardsno external link or Wikipedia entryedit file
- PersonSabine Linnno external link or Wikipedia entryedit file
- PersonJaime Feliuno external link or Wikipedia entryedit file
- PersonEnrique Espinosano external link or Wikipedia entryedit file
- PersonBeatriz Castelono external link or Wikipedia entryedit file
- PersonMiguel Martínno external link or Wikipedia entryedit file
- PersonSara López-Tarruellano external link or Wikipedia entryedit file
- PersonPilar Garridono external link or Wikipedia entryedit file
- PersonDenis Lacombeno external link or Wikipedia entryedit file
- PersonAlexander Eggermontno external link or Wikipedia entryedit file
- PersonMartine Piccartno external link or Wikipedia entryedit file
- PersonMichael Wellerno external link or Wikipedia entryedit file
- PersonRoger Stuppno external link or Wikipedia entryedit file
- PersonNathan Chernyno external link or Wikipedia entryedit file
- PersonAndrés Cervantesno external link or Wikipedia entryedit file
- PersonSolange Petersno external link or Wikipedia entryedit file
- PersonDavid Cameronno external link or Wikipedia entryedit file
- PersonEvandro de Azambujano external link or Wikipedia entryedit file
- PersonSibylle Loiblno external link or Wikipedia entryedit file
- PersonGunter von Minckwitzno external link or Wikipedia entryedit file
- PersonCarsten Denkertno external link or Wikipedia entryedit file
- PersonJean-Yves Blayno external link or Wikipedia entryedit file
- PersonThomas Bachelotno external link or Wikipedia entryedit file
- PersonChristophe Le Tourneauno external link or Wikipedia entryedit file
- PersonAnthony Gonçalvesno external link or Wikipedia entryedit file
- PersonMyung-Ju Ahnno external link or Wikipedia entryedit file
- PersonYeon Hee Parkno external link or Wikipedia entryedit file
- PersonJeeyun Leeno external link or Wikipedia entryedit file
- PersonWon Ki Kangno external link or Wikipedia entryedit file
- PersonHo Yeong Limno external link or Wikipedia entryedit file
- PersonWoong-Yang Parkno external link or Wikipedia entryedit file
- PersonSung-Bae Kimno external link or Wikipedia entryedit file
- PersonYoon-Koo Kangno external link or Wikipedia entryedit file
- PersonMin-Hee Ryuno external link or Wikipedia entryedit file
- PersonTae Won Kimno external link or Wikipedia entryedit file
- PersonJae Lyun Leeno external link or Wikipedia entryedit file
- PersonDae Ho Leeno external link or Wikipedia entryedit file
- PersonSung-Gyu Leeno external link or Wikipedia entryedit file
- PersonYung-Jue Bangno external link or Wikipedia entryedit file
- PersonSeock-Ah Imno external link or Wikipedia entryedit file
- PersonDo-Youn Ohno external link or Wikipedia entryedit file
- PersonTae-You Kimno external link or Wikipedia entryedit file
- PersonDong-Wan Kimno external link or Wikipedia entryedit file
- PersonSe-Hoon Leeno external link or Wikipedia entryedit file
- PersonByoung Chul Chono external link or Wikipedia entryedit file
- PersonSun Young Rhano external link or Wikipedia entryedit file
- PersonHye Ryun Kimno external link or Wikipedia entryedit file
- PersonSang Joon Shinno external link or Wikipedia entryedit file
- PersonJoohyuk Sohnno external link or Wikipedia entryedit file
- PersonHitoshi Nakagamano external link or Wikipedia entryedit file
- PersonYuichiro Oheno external link or Wikipedia entryedit file
- PersonNoboru Yamamotono external link or Wikipedia entryedit file
- PersonKan Yonemorino external link or Wikipedia entryedit file
- PersonTakashi Kohnono external link or Wikipedia entryedit file
- PersonKoichi Gotono external link or Wikipedia entryedit file
- PersonTakayuki Yoshinono external link or Wikipedia entryedit file
- PersonKohei Shitarano external link or Wikipedia entryedit file
- PersonToshihiko Doino external link or Wikipedia entryedit file
- PersonTakeshi Sanono external link or Wikipedia entryedit file
- PersonShunji Takahashino external link or Wikipedia entryedit file
- PersonShinji Ohnono external link or Wikipedia entryedit file
- PersonTakayuki Uenono external link or Wikipedia entryedit file
- PersonHaruhiko Fukudano external link or Wikipedia entryedit file
- PersonYuko Kitagawano external link or Wikipedia entryedit file
- PersonMichael Hofmanno external link or Wikipedia entryedit file
- PersonGrant McArthurno external link or Wikipedia entryedit file
- PersonSherene Loino external link or Wikipedia entryedit file
- PersonBenjamin Solomonno external link or Wikipedia entryedit file
- PersonShahneen Sandhuno external link or Wikipedia entryedit file
- PersonSarah-Jane Dawsonno external link or Wikipedia entryedit file
- PersonJoseph Trapanino external link or Wikipedia entryedit file
- PersonRafael Kaliksno external link or Wikipedia entryedit file
- PersonPaulo Hoffno external link or Wikipedia entryedit file
- PersonArtur Katzno external link or Wikipedia entryedit file
- PersonCarlos Barriosno external link or Wikipedia entryedit file
- PersonJun Mano external link or Wikipedia entryedit file
- PersonRui-Hua Xuno external link or Wikipedia entryedit file
- PersonLi Zhangno external link or Wikipedia entryedit file
- PersonWenfeng Fangno external link or Wikipedia entryedit file
- PersonMu-Sheng Zengno external link or Wikipedia entryedit file
- PersonFeng Wangno external link or Wikipedia entryedit file
- PersonZhi-Ming Shaono external link or Wikipedia entryedit file
- PersonYi-Zhou Jiangno external link or Wikipedia entryedit file
- PersonXichun Huno external link or Wikipedia entryedit file
- PersonShaoli Songno external link or Wikipedia entryedit file
- PersonDingwei Yeno external link or Wikipedia entryedit file
- PersonJin Lino external link or Wikipedia entryedit file
- PersonYuquan Weino external link or Wikipedia entryedit file
- PersonYou Luno external link or Wikipedia entryedit file
- PersonWeimin Lino external link or Wikipedia entryedit file
- PersonJie Heno external link or Wikipedia entryedit file
- PersonYuankai Shino external link or Wikipedia entryedit file
- PersonBinghe Xuno external link or Wikipedia entryedit file
- PersonJie Wangno external link or Wikipedia entryedit file
- PersonFei Mano external link or Wikipedia entryedit file
- PersonJing Huangno external link or Wikipedia entryedit file
- PersonCaicun Zhouno external link or Wikipedia entryedit file
- PersonLin Shenno external link or Wikipedia entryedit file
- PersonChangsong Qino external link or Wikipedia entryedit file
- PersonYi-Long Wuno external link or Wikipedia entryedit file
- PersonShun Luno external link or Wikipedia entryedit file
- PersonSudeep Guptano external link or Wikipedia entryedit file
- PersonRajendra Badweno external link or Wikipedia entryedit file
- PersonVijay Patilno external link or Wikipedia entryedit file
- PersonKumar Prabhashno external link or Wikipedia entryedit file
- PersonVanita Noronhano external link or Wikipedia entryedit file
- PersonPankaj Chaturvedino external link or Wikipedia entryedit file
- PersonSurendra Shastrino external link or Wikipedia entryedit file
- PersonJanet Danceyno external link or Wikipedia entryedit file
- PersonDongsheng Tuno external link or Wikipedia entryedit file
- PersonWendy Parulekarno external link or Wikipedia entryedit file
- PersonElisabete Weiderpassno external link or Wikipedia entryedit file
- PersonFreddie Brayno external link or Wikipedia entryedit file
- PersonPartha Basuno external link or Wikipedia entryedit file
- PersonIan Creeno external link or Wikipedia entryedit file
- PersonAndré Ilbawino external link or Wikipedia entryedit file
- PersonSelwyn M. Vickersno external link or Wikipedia entryedit file
- PersonAndrea Cercekno external link or Wikipedia entryedit file
- PersonLuis A. Diaz Jr.no external link or Wikipedia entryedit file
- PersonCharles L. Sawyersno external link or Wikipedia entryedit file
- PersonHoward I. Scherno external link or Wikipedia entryedit file
- PersonMichael J. Morrisno external link or Wikipedia entryedit file
- PersonBob T. Lino external link or Wikipedia entryedit file
- PersonAlexander Drilonno external link or Wikipedia entryedit file
- PersonHelena A. Yuno external link or Wikipedia entryedit file
- PersonYelena Y. Janjigianno external link or Wikipedia entryedit file
- PersonEileen M. O'Reillyno external link or Wikipedia entryedit file
- PersonRoss L. Levineno external link or Wikipedia entryedit file
- PersonJae H. Parkno external link or Wikipedia entryedit file
- PersonSaad Z. Usmanino external link or Wikipedia entryedit file
- PersonDavid B. Solitno external link or Wikipedia entryedit file
- PersonBenjamin L. Ebertno external link or Wikipedia entryedit file
- PersonSara M. Tolaneyno external link or Wikipedia entryedit file
- PersonNancy U. Linno external link or Wikipedia entryedit file
- PersonPasi A. Jänneno external link or Wikipedia entryedit file
- PersonKenneth C. Andersonno external link or Wikipedia entryedit file
- PersonPaul G. Richardsonno external link or Wikipedia entryedit file
- PersonUrsula A. Matulonisno external link or Wikipedia entryedit file
- PersonToni K. Choueirino external link or Wikipedia entryedit file
- PersonF. Stephen Hodino external link or Wikipedia entryedit file
- PersonWilliam G. Kaelin Jr.no external link or Wikipedia entryedit file
- PersonEliezer M. Van Allenno external link or Wikipedia entryedit file
- PersonJudy E. Garberno external link or Wikipedia entryedit file
- PersonAnn H. Partridgeno external link or Wikipedia entryedit file
- PersonDaniel A. Haberno external link or Wikipedia entryedit file
- PersonKeith T. Flahertyno external link or Wikipedia entryedit file
- PersonLecia V. Sequistno external link or Wikipedia entryedit file
- PersonJustin F. Gainorno external link or Wikipedia entryedit file
- PersonRyan B. Corcoranno external link or Wikipedia entryedit file
- PersonRyan J. Sullivanno external link or Wikipedia entryedit file
- PersonTheodore S. Hongno external link or Wikipedia entryedit file
- PersonLeif W. Ellisenno external link or Wikipedia entryedit file
- PersonWilliam G. Nelsonno external link or Wikipedia entryedit file
- PersonBert Vogelsteinno external link or Wikipedia entryedit file
- PersonKenneth W. Kinzlerno external link or Wikipedia entryedit file
- PersonDrew M. Pardollno external link or Wikipedia entryedit file
- PersonSuzanne L. Topalianno external link or Wikipedia entryedit file
- PersonJulie R. Brahmerno external link or Wikipedia entryedit file
- PersonDung T. Leno external link or Wikipedia entryedit file
- PersonElizabeth M. Jaffeeno external link or Wikipedia entryedit file
- PersonPatrick M. Fordeno external link or Wikipedia entryedit file
- PersonStephen B. Baylinno external link or Wikipedia entryedit file
- PersonKellie N. Smithno external link or Wikipedia entryedit file
- PersonRobert H. Vonderheideno external link or Wikipedia entryedit file
- PersonCarl H. Juneno external link or Wikipedia entryedit file
- PersonBruce L. Levineno external link or Wikipedia entryedit file
- PersonDrew Weissmanno external link or Wikipedia entryedit file
- PersonSusan M. Domchekno external link or Wikipedia entryedit file
- PersonAngela DeMicheleno external link or Wikipedia entryedit file
- PersonCharu Aggarwalno external link or Wikipedia entryedit file
- PersonRobert H. Machno external link or Wikipedia entryedit file
- PersonDavid L. Porterno external link or Wikipedia entryedit file
- PersonAnthony Letaino external link or Wikipedia entryedit file
- PersonDouglas R. Lowyno external link or Wikipedia entryedit file
- PersonSteven A. Rosenbergno external link or Wikipedia entryedit file
- PersonLouis M. Staudtno external link or Wikipedia entryedit file
- PersonJames L. Gulleyno external link or Wikipedia entryedit file
- PersonBrigitte C. Widemannno external link or Wikipedia entryedit file
- PersonNirali N. Shahno external link or Wikipedia entryedit file
- PersonRaffit Hassanno external link or Wikipedia entryedit file
- PersonRamon E. Parsonsno external link or Wikipedia entryedit file
- PersonMiriam Meradno external link or Wikipedia entryedit file
- PersonSundar Jagannathno external link or Wikipedia entryedit file
- PersonJoshua Brodyno external link or Wikipedia entryedit file
- PersonMatthew D. Galskyno external link or Wikipedia entryedit file
- PersonNina Bhardwajno external link or Wikipedia entryedit file
- PersonThomas U. Marronno external link or Wikipedia entryedit file
- PersonCandace S. Johnsonno external link or Wikipedia entryedit file
- PersonRenier J. Brentjensno external link or Wikipedia entryedit file
- PersonIgor Puzanovno external link or Wikipedia entryedit file
- PersonRobert A. Fenstermakerno external link or Wikipedia entryedit file
- PersonEunice S. Wangno external link or Wikipedia entryedit file
- PersonPawel Kalinskino external link or Wikipedia entryedit file
- PersonTodd R. Golubno external link or Wikipedia entryedit file
- PersonGad Getzno external link or Wikipedia entryedit file
- PersonMatthew Meyersonno external link or Wikipedia entryedit file
- PersonFrancisca Vazquezno external link or Wikipedia entryedit file
- PersonAndrew J. Aguirreno external link or Wikipedia entryedit file
- PersonFeng Zhangno external link or Wikipedia entryedit file
- PersonBradley E. Bernsteinno external link or Wikipedia entryedit file
- PersonBruce W. Stillmanno external link or Wikipedia entryedit file
- PersonDavid A. Tuvesonno external link or Wikipedia entryedit file
- PersonChristopher R. Vakocno external link or Wikipedia entryedit file
- PersonAdrian R. Krainerno external link or Wikipedia entryedit file
- PersonTobias Janowitzno external link or Wikipedia entryedit file
- PersonSemir Beyazno external link or Wikipedia entryedit file
- PersonTimothy J. Eberleinno external link or Wikipedia entryedit file
- PersonTimothy J. Leyno external link or Wikipedia entryedit file
- PersonLi Dingno external link or Wikipedia entryedit file
- PersonMalachi Griffithno external link or Wikipedia entryedit file
- PersonObi L. Griffithno external link or Wikipedia entryedit file
- PersonJohn F. DiPersiono external link or Wikipedia entryedit file
- PersonRamaswamy Govindanno external link or Wikipedia entryedit file
- PersonRobert D. Schreiberno external link or Wikipedia entryedit file
- PersonEric R. Fearonno external link or Wikipedia entryedit file
- PersonArul M. Chinnaiyanno external link or Wikipedia entryedit file
- PersonShaomeng Wangno external link or Wikipedia entryedit file
- PersonMax S. Wichano external link or Wikipedia entryedit file
- PersonWeiping Zouno external link or Wikipedia entryedit file
- PersonTheodore S. Lawrenceno external link or Wikipedia entryedit file
- PersonCostas A. Lyssiotisno external link or Wikipedia entryedit file
- PersonVincent K. Tuohyno external link or Wikipedia entryedit file
- PersonTimothy A. Channo external link or Wikipedia entryedit file
- PersonJame Abrahamno external link or Wikipedia entryedit file
- PersonJustin D. Lathiano external link or Wikipedia entryedit file
- PersonJaroslaw P. Maciejewskino external link or Wikipedia entryedit file
- PersonShilpa Guptano external link or Wikipedia entryedit file
- PersonNathan A. Pennellno external link or Wikipedia entryedit file
- PersonPatrick Hwuno external link or Wikipedia entryedit file
- PersonAmod A. Sarnaikno external link or Wikipedia entryedit file
- PersonFrederick L. Lockeno external link or Wikipedia entryedit file
- PersonRobert A. Gatenbyno external link or Wikipedia entryedit file
- PersonEric B. Haurano external link or Wikipedia entryedit file
- PersonHatem Solimanno external link or Wikipedia entryedit file
- PersonChristine H. Chungno external link or Wikipedia entryedit file
- PersonShari Pilon-Thomasno external link or Wikipedia entryedit file
- PersonA. Keith Stewartno external link or Wikipedia entryedit file
- PersonJohn E. Dickno external link or Wikipedia entryedit file
- PersonLillian L. Siuno external link or Wikipedia entryedit file
- PersonTak W. Makno external link or Wikipedia entryedit file
- PersonPamela S. Ohashino external link or Wikipedia entryedit file
- PersonAaron D. Schimmerno external link or Wikipedia entryedit file
- PersonNatasha B. Leighlno external link or Wikipedia entryedit file
- PersonAmit M. Ozano external link or Wikipedia entryedit file
- PersonTrevor J. Pughno external link or Wikipedia entryedit file
- PersonPeter W. T. Pistersno external link or Wikipedia entryedit file
- PersonGiulio Draettano external link or Wikipedia entryedit file
- PersonJames P. Allisonno external link or Wikipedia entryedit file
- PersonPadmanee Sharmano external link or Wikipedia entryedit file
- PersonChristopher R. Flowersno external link or Wikipedia entryedit file
- PersonDebu Tripathyno external link or Wikipedia entryedit file
- PersonJohn V. Heymachno external link or Wikipedia entryedit file
- PersonHagop M. Kantarjianno external link or Wikipedia entryedit file
- PersonFunda Meric-Bernstamno external link or Wikipedia entryedit file
- PersonAnirban Maitrano external link or Wikipedia entryedit file
- PersonJennifer K. Littonno external link or Wikipedia entryedit file
- PersonAlbert C. Koongno external link or Wikipedia entryedit file
- PersonMariana Chavez-MacGregorno external link or Wikipedia entryedit file
- PersonCheryl L. Willmanno external link or Wikipedia entryedit file
- PersonEvanthia Galanisno external link or Wikipedia entryedit file
- PersonS. Vincent Rajkumarno external link or Wikipedia entryedit file
- PersonShaji K. Kumarno external link or Wikipedia entryedit file
- PersonMatthew P. Goetzno external link or Wikipedia entryedit file
- PersonTanios Bekaii-Saabno external link or Wikipedia entryedit file
- PersonAlan Ashworthno external link or Wikipedia entryedit file
- PersonEric J. Smallno external link or Wikipedia entryedit file
- PersonRahul Aggarwalno external link or Wikipedia entryedit file
- PersonAlan P. Venookno external link or Wikipedia entryedit file
- PersonLaura J. Essermanno external link or Wikipedia entryedit file
- PersonThomas A. Hopeno external link or Wikipedia entryedit file
- PersonKevan M. Shokatno external link or Wikipedia entryedit file
- PersonFrank McCormickno external link or Wikipedia entryedit file
- PersonEmily K. Bergslandno external link or Wikipedia entryedit file
- PersonKatherine K. Matthayno external link or Wikipedia entryedit file
- PersonSteven E. Artandino external link or Wikipedia entryedit file
- PersonCrystal L. Mackallno external link or Wikipedia entryedit file
- PersonIrving L. Weissmanno external link or Wikipedia entryedit file
- PersonRonald Levyno external link or Wikipedia entryedit file
- PersonHeather A. Wakeleeno external link or Wikipedia entryedit file
- PersonAsh A. Alizadehno external link or Wikipedia entryedit file
- PersonMaximilian Diehnno external link or Wikipedia entryedit file
- PersonMichael A. Teitellno external link or Wikipedia entryedit file
- PersonAntoni Ribasno external link or Wikipedia entryedit file
- PersonDennis J. Slamonno external link or Wikipedia entryedit file
- PersonJohannes Czerninno external link or Wikipedia entryedit file
- PersonJeremie Calaisno external link or Wikipedia entryedit file
- PersonOwen N. Witteno external link or Wikipedia entryedit file
- PersonAmar U. Kishanno external link or Wikipedia entryedit file
- PersonRobert W. Stoneno external link or Wikipedia entryedit file
- PersonSteven T. Rosenno external link or Wikipedia entryedit file
- PersonMichael A. Caligiurino external link or Wikipedia entryedit file
- PersonChristine E. Brownno external link or Wikipedia entryedit file
- PersonBehnam Badieno external link or Wikipedia entryedit file
- PersonHope S. Rugono external link or Wikipedia entryedit file
- PersonAlex F. Herrerano external link or Wikipedia entryedit file
- PersonVirginia Sunno external link or Wikipedia entryedit file
- PersonStephen J. Formanno external link or Wikipedia entryedit file
- PersonThomas J. Lynch Jr.no external link or Wikipedia entryedit file
- PersonStanley R. Riddellno external link or Wikipedia entryedit file
- PersonSara A. Hurvitzno external link or Wikipedia entryedit file
- PersonMichael LeBlancno external link or Wikipedia entryedit file
- PersonPhilip D. Greenbergno external link or Wikipedia entryedit file
- PersonDenise A. Gallowayno external link or Wikipedia entryedit file
- PersonHans-Peter Kiemno external link or Wikipedia entryedit file
- PersonGary H. Lymanno external link or Wikipedia entryedit file
- PersonDawn L. Hershmanno external link or Wikipedia entryedit file
- PersonPrimo N. Lara Jr.no external link or Wikipedia entryedit file
- PersonCharles D. Blankeno external link or Wikipedia entryedit file
- PersonNeeraj Agarwalno external link or Wikipedia entryedit file
- PersonKathy S. Albainno external link or Wikipedia entryedit file
- PersonPriyanka Sharmano external link or Wikipedia entryedit file
- PersonAnne C. Chiangno external link or Wikipedia entryedit file
- PersonHagen F. Kenneckeno external link or Wikipedia entryedit file
- PersonCharles E. Geyer Jr.no external link or Wikipedia entryedit file
- PersonLori J. Pierceno external link or Wikipedia entryedit file
- PersonDeborah Watkins Brunerno external link or Wikipedia entryedit file
- PersonPeter J. O'Dwyerno external link or Wikipedia entryedit file
- PersonMitchell D. Schnallno external link or Wikipedia entryedit file
- PersonMark R. Litzowno external link or Wikipedia entryedit file
- PersonDouglas S. Hawkinsno external link or Wikipedia entryedit file
- PersonRachel E. Rauno external link or Wikipedia entryedit file
- PersonSusan L. Cohnno external link or Wikipedia entryedit file
- PersonJulie R. Parkno external link or Wikipedia entryedit file
- PersonAlice L. Yuno external link or Wikipedia entryedit file
- PersonClifford A. Hudisno external link or Wikipedia entryedit file
- PersonRobin T. Zonno external link or Wikipedia entryedit file
- PersonLynn M. Schuchterno external link or Wikipedia entryedit file
- PersonEverett E. Vokesno external link or Wikipedia entryedit file
- PersonMargaret Fotino external link or Wikipedia entryedit file
- PersonBarbara Bradfieldno external link or Wikipedia entryedit file
- PersonBud Romineno external link or Wikipedia entryedit file
- PersonSharon Belvinno external link or Wikipedia entryedit file
- PersonRobert Sandlerno external link or Wikipedia entryedit file
- PersonFran Viscono external link or Wikipedia entryedit file
- IdeaA clone report from blood at every treatment cycleno external link or Wikipedia entryedit file
- IdeaLabel every targetable mutation as truncal or branch on the reportno external link or Wikipedia entryedit file
- IdeaBiopsy the one lesion that is growing while the others shrinkno external link or Wikipedia entryedit file
- IdeaBarcode patient-derived tumours to watch which clones win under each drugno external link or Wikipedia entryedit file
- IdeaA standard evolvability score for every tumourno external link or Wikipedia entryedit file
- IdeactDNA-guided dose holidays for lung cancer targeted therapyno external link or Wikipedia entryedit file
- IdeaSwitch drugs at maximum response, not at relapseno external link or Wikipedia entryedit file
- IdeaAn open atlas of collateral sensitivity for every approved targeted drugno external link or Wikipedia entryedit file
- IdeaDesign drug pairs where resisting one makes you vulnerable to the otherno external link or Wikipedia entryedit file
- IdeaMap which tumour clones sit next to which immune cells before choosing therapyno external link or Wikipedia entryedit file
- IdeaTrack clones in blood with methylation patterns instead of mutationsno external link or Wikipedia entryedit file
- IdeaMake clonal clearance, not tumour shrinkage, a trial endpointno external link or Wikipedia entryedit file
- IdeaForecast the next resistance mutation like the weatherno external link or Wikipedia entryedit file
- IdeaLook for the resistant sub-population before the first doseno external link or Wikipedia entryedit file
- IdeaDetect tumours changing cell type from RNA in the bloodno external link or Wikipedia entryedit file
- IdeaEvolutionary tumour boards with a modeller in the roomno external link or Wikipedia entryedit file
- IdeaSlow the tumour's mutation engine with APOBEC inhibitors during targeted therapyno external link or Wikipedia entryedit file
- IdeaTurn chromosomal chaos into a weakness with KIF18A inhibitorsno external link or Wikipedia entryedit file
- IdeaMatch each blood-detected clone to the lesion it comes from on the scanno external link or Wikipedia entryedit file
- IdeaRe-test the metastasis, not the old primary, before every change of treatmentno external link or Wikipedia entryedit file
- IdeaVaccines aimed only at mutations shared by every tumour cellno external link or Wikipedia entryedit file
- IdeaMolecular glues that break the MYC-MAX partnershipno external link or Wikipedia entryedit file
- IdeamRNA-delivered MYC decoy proteins instead of MYC inhibitorsno external link or Wikipedia entryedit file
- IdeaExtend p53 reactivation beyond the Y220C mutationno external link or Wikipedia entryedit file
- IdeaDegrade the damaged p53 protein rather than trying to repair itno external link or Wikipedia entryedit file
- IdeaCovalent chemistry for the RAS mutations that still have no drugno external link or Wikipedia entryedit file
- IdeaAn open map of which cancer proteins any drug can stick tono external link or Wikipedia entryedit file
- IdeaScreen glue-like compounds against every cancer cell line and publish itno external link or Wikipedia entryedit file
- IdeaDegraders for the fusion proteins that drive childhood sarcomasno external link or Wikipedia entryedit file
- IdeaBreak up the liquid droplets where oncogenic transcription happensno external link or Wikipedia entryedit file
- IdeaFind E3 ligases that only tumours have, and build degraders around themno external link or Wikipedia entryedit file
- IdeaUse antibodies to deliver protein-destroying drugs into the right cellsno external link or Wikipedia entryedit file
- IdeaDrag cancer's surface and secreted proteins to the cell's recycling binno external link or Wikipedia entryedit file
- IdeaSmall molecules that cut the RNA message of an undruggable oncogeneno external link or Wikipedia entryedit file
- IdeaSwitch off an undruggable oncogene permanently with epigenetic editingno external link or Wikipedia entryedit file
- IdeaAttack the backup copy when a tumour has lost the original geneno external link or Wikipedia entryedit file
- IdeaTurn a brake back on: drugs that reactivate the PP2A phosphataseno external link or Wikipedia entryedit file
- IdeaWRN inhibitors: a second synthetic-lethal win for mismatch-repair cancersno external link or Wikipedia entryedit file
- IdeaMacrocyclic peptides to cover protein surfaces that pills cannotno external link or Wikipedia entryedit file
- IdeaDestroy the truncated androgen receptor that hormone drugs cannot touchno external link or Wikipedia entryedit file
- IdeaAI-designed proteins that grip the floppy parts of cancer driversno external link or Wikipedia entryedit file
- IdeaAntibodies that see mutant KRAS and p53 fragments displayed on the cell surfaceno external link or Wikipedia entryedit file
- IdeaInstruct tumour cells to make antibodies against their own oncoproteinno external link or Wikipedia entryedit file
- IdeaStarve MYC-driven tumours by blocking protein production machineryno external link or Wikipedia entryedit file
- IdeaA guaranteed purchase prize for the first drug against a named hard targetno external link or Wikipedia entryedit file
- IdeaHumanised mice with an immune system matched to the tumour donorno external link or Wikipedia entryedit file
- IdeaRun the mouse or organoid trial at the same time as the human trialno external link or Wikipedia entryedit file
- IdeaGrow tumour organoids together with the patient's own immune cellsno external link or Wikipedia entryedit file
- IdeaTumour-on-a-chip with blood flow to test whether big drugs actually get inno external link or Wikipedia entryedit file
- IdeaIn silico trials to choose the dose before the first patientno external link or Wikipedia entryedit file
- IdeaMulti-centre randomised animal trials before committing to a human trialno external link or Wikipedia entryedit file
- IdeaScore every model system on how well it predicted real trial resultsno external link or Wikipedia entryedit file
- IdeaA home for the animal and organoid experiments that failedno external link or Wikipedia entryedit file
- IdeaTest drugs on freshly cut slices of the patient's own tumourno external link or Wikipedia entryedit file
- IdeaBuild laboratory models of the organs cancer spreads tono external link or Wikipedia entryedit file
- IdeaTest cancer drugs in old and unhealthy animals, not just young fit onesno external link or Wikipedia entryedit file
- IdeaZebrafish avatars for a drug answer within a weekno external link or Wikipedia entryedit file
- IdeaLinked human organ chips to predict side effects before people are dosedno external link or Wikipedia entryedit file
- IdeaAn open organoid bank for cancers too rare to have modelsno external link or Wikipedia entryedit file
- IdeaHold organoid drug tests to the same standard as a diagnostic testno external link or Wikipedia entryedit file
- IdeaUse patient organoids to check a cell therapy will work before infusing itno external link or Wikipedia entryedit file
- IdeaMake bespoke mouse cancer models in weeks with in vivo gene editingno external link or Wikipedia entryedit file
- IdeaGrow models from tumour cells in the blood when a biopsy is impossibleno external link or Wikipedia entryedit file
- IdeaEvery resistance mechanism found in a patient must be rebuilt in the laboratoryno external link or Wikipedia entryedit file
- IdeaKeep a freshly removed tumour alive on a pump and test drugs in itno external link or Wikipedia entryedit file
- IdeaA virtual cancer cell that predicts what a drug will do before you test itno external link or Wikipedia entryedit file
- IdeaFund a biopsy at progression, every time, as standard careno external link or Wikipedia entryedit file
- IdeaOne open atlas of how tumours escape every drugno external link or Wikipedia entryedit file
- IdeaAdd the second drug on day one when the escape route is predictableno external link or Wikipedia entryedit file
- IdeaRandomise the next line of treatment before the first one failsno external link or Wikipedia entryedit file
- IdeaRe-map the tumour's surface proteins before choosing the next antibody drugno external link or Wikipedia entryedit file
- IdeaTwo-target antibody drugs to close the antigen escape routeno external link or Wikipedia entryedit file
- IdeaPlan the second CAR-T target before the first one is lostno external link or Wikipedia entryedit file
- IdeaPause a failed drug so the tumour becomes sensitive to it againno external link or Wikipedia entryedit file
- IdeaKill the sleeping survivor cells with iron-dependent cell deathno external link or Wikipedia entryedit file
- IdeaBlock the chemical switch that lets cells hide from treatmentno external link or Wikipedia entryedit file
- IdeaTurn off the error-prone repair that manufactures resistance mutationsno external link or Wikipedia entryedit file
- IdeaCut off the emergency programme cancer cells use to survive treatmentno external link or Wikipedia entryedit file
- IdeaClear the zombie cells left behind by chemotherapy and radiotherapyno external link or Wikipedia entryedit file
- IdeaStarve the survivors: target the energy pathway drug-tolerant cells switch tono external link or Wikipedia entryedit file
- IdeaAdd a drug when the blood test turns, without stopping the one that worksno external link or Wikipedia entryedit file
- IdeaRotate between drugs on a fixed schedule instead of waiting for failureno external link or Wikipedia entryedit file
- IdeaVaccinate against the resistance mutation before it takes overno external link or Wikipedia entryedit file
- IdeaA standing platform trial that assigns treatment by how the tumour escapedno external link or Wikipedia entryedit file
- IdeaUse SLFN11 status to decide which antibody-drug payload to give nextno external link or Wikipedia entryedit file
- IdeaBlock the survival signals the tumour's neighbours provideno external link or Wikipedia entryedit file
- IdeaTreat resistance like an infectious disease and run national surveillanceno external link or Wikipedia entryedit file
- IdeaMake post-progression sampling a condition of accelerated approvalno external link or Wikipedia entryedit file
- IdeaFind the parts of a tumour the drug never reachesno external link or Wikipedia entryedit file
- IdeaTime immunotherapy to the moment targeted drugs make tumours visibleno external link or Wikipedia entryedit file
- IdeaCirculating tumour cell clearance as the phase 2 gate for anti-metastatic drugsno external link or Wikipedia entryedit file
- IdeaBreak the neutrophil DNA nets that catch tumour cells after surgeryno external link or Wikipedia entryedit file
- IdeaCheap perioperative beta-blocker plus anti-inflammatory to blunt surgical stressno external link or Wikipedia entryedit file
- IdeaA blood test for the pre-metastatic nicheno external link or Wikipedia entryedit file
- IdeaInhaled immune therapy to make the lung hostile to arriving tumour cellsno external link or Wikipedia entryedit file
- IdeaReprogramme the liver's own immune cells to refuse metastasesno external link or Wikipedia entryedit file
- IdeaFlush dormant cells out of bone marrow, then kill themno external link or Wikipedia entryedit file
- IdeaStrip the platelet coat off travelling tumour cells in ctDNA-positive patientsno external link or Wikipedia entryedit file
- IdeaMake in vivo metastasis screens a required step in drug discoveryno external link or Wikipedia entryedit file
- IdeaGrow blood-borne tumour cells to test drugs on the cells that actually spreadno external link or Wikipedia entryedit file
- IdeaTreat the draining lymph node before removing itno external link or Wikipedia entryedit file
- IdeaAn organotropism atlas that predicts where a cancer will spreadno external link or Wikipedia entryedit file
- IdeaSoften the tissue that new metastases need in order to growno external link or Wikipedia entryedit file
- IdeaPrevention trials aimed only at brain metastasisno external link or Wikipedia entryedit file
- IdeaA test to tell true oligometastatic disease from hidden widespread spreadno external link or Wikipedia entryedit file
- IdeaA drug screen that only rewards killing sleeping cancer cellsno external link or Wikipedia entryedit file
- IdeaBlock the recycling that keeps dormant cells aliveno external link or Wikipedia entryedit file
- IdeaKeep dormant cells asleep instead of trying to kill themno external link or Wikipedia entryedit file
- IdeaBlunt the inflammation that wakes sleeping cancer cellsno external link or Wikipedia entryedit file
- IdeaA national platform trial that every ctDNA-positive patient can joinno external link or Wikipedia entryedit file
- IdeaReference materials and open proficiency testing for residual disease testsno external link or Wikipedia entryedit file
- IdeaPersonalised vaccines given only when the blood test turns positiveno external link or Wikipedia entryedit file
- IdeaOff-the-shelf natural killer cells to sweep up residual diseaseno external link or Wikipedia entryedit file
- IdeaPush residual disease detection a hundredfold deeper with whole-genome methodsno external link or Wikipedia entryedit file
- IdeaA bone marrow niche on a chip to study human dormancyno external link or Wikipedia entryedit file
- IdeaWhen the blood test is positive, hunt for the lesion with sensitive imagingno external link or Wikipedia entryedit file
- IdeaTake the blood test, and give the drug, at the right time of dayno external link or Wikipedia entryedit file
- IdeaUse residual disease tests to decide who needs ten years of hormone therapyno external link or Wikipedia entryedit file
- IdeaPay for residual disease tests only inside a trial or registryno external link or Wikipedia entryedit file
- IdeaA dedicated clinic for people whose blood test says the cancer is backno external link or Wikipedia entryedit file
- IdeaBank yearly blood from cancer survivors so future tests can be validatedno external link or Wikipedia entryedit file
- IdeaReprogramme suppressive macrophages instead of trying to delete themno external link or Wikipedia entryedit file
- IdeaTurn one tumour into a vaccine to treat all the othersno external link or Wikipedia entryedit file
- IdeaOncolytic viruses that make interleukin-12 only inside the tumourno external link or Wikipedia entryedit file
- IdeaEngineered bacteria that live in tumours and manufacture drugs thereno external link or Wikipedia entryedit file
- IdeaAnchor a TGF-beta trap in the tumour stroma so it cannot act everywhereno external link or Wikipedia entryedit file
- IdeaDe-acidify the tumour so T cells can work in itno external link or Wikipedia entryedit file
- IdeaPick the radiation dose that switches the immune alarm on, not offno external link or Wikipedia entryedit file
- IdeaGrow immune command posts inside tumoursno external link or Wikipedia entryedit file
- IdeaClear the suppressive neutrophils out of pancreatic tumours firstno external link or Wikipedia entryedit file
- IdeaMatch therapy to the type of scar-forming cell in the tumourno external link or Wikipedia entryedit file
- IdeaImplant a tiny device that tests twenty drugs inside the patient's own tumourno external link or Wikipedia entryedit file
- IdeaUse imaging to find the window when tumour blood vessels are working properlyno external link or Wikipedia entryedit file
- IdeaBlock the complement signal that recruits tumour-protecting cellsno external link or Wikipedia entryedit file
- IdeaTreat the body cavity, not the bloodstream, for surface spreadno external link or Wikipedia entryedit file
- IdeaBispecific antibodies that engage macrophages instead of T cellsno external link or Wikipedia entryedit file
- IdeaUse a hypoxia scan to pick patients for adenosine-pathway drugsno external link or Wikipedia entryedit file
- IdeaMechanically pulverise one tumour with ultrasound to wake the immune systemno external link or Wikipedia entryedit file
- IdeaTrain the bone marrow to make better anti-tumour immune cellsno external link or Wikipedia entryedit file
- IdeaDeliver CAR-T cells straight into the fluid around the brainno external link or Wikipedia entryedit file
- IdeaRobot-placed catheters and live imaging for drug infusion into brain tumoursno external link or Wikipedia entryedit file
- IdeaUse the brain's own transport door to carry antibody drugs acrossno external link or Wikipedia entryedit file
- IdeaA skull ultrasound implant that opens the barrier at every cycleno external link or Wikipedia entryedit file
- IdeaRead the spinal fluid to track brain tumours without opening the skullno external link or Wikipedia entryedit file
- IdeaRequire every oncology candidate to publish how much reaches the brainno external link or Wikipedia entryedit file
- IdeaDeliver drugs and cells to the brain through the noseno external link or Wikipedia entryedit file
- IdeaBuild a human model of the barrier that guards the brain fluidno external link or Wikipedia entryedit file
- IdeaOpen the barrier so engineered immune cells can enter the brainno external link or Wikipedia entryedit file
- IdeaDesign protein degraders small enough to get into the brainno external link or Wikipedia entryedit file
- IdeaFour weeks of training and nutrition before major cancer surgery, as standardno external link or Wikipedia entryedit file
- IdeaPay for supervised exercise the way we pay for drugsno external link or Wikipedia entryedit file
- IdeaGet the one approved appetite drug licensed beyond a single countryno external link or Wikipedia entryedit file
- IdeaRead muscle loss automatically from scans patients already haveno external link or Wikipedia entryedit file
- IdeaDose chemotherapy by muscle mass, not body surface areano external link or Wikipedia entryedit file
- IdeaA cheap old tablet to restore appetiteno external link or Wikipedia entryedit file
- IdeaTreat wasting like sepsis: a trigger, a bundle, an auditno external link or Wikipedia entryedit file
- IdeaTest protein and resistance training during immunotherapyno external link or Wikipedia entryedit file
- IdeaCatch wasting early with a smart scale and a step counterno external link or Wikipedia entryedit file
- IdeaOne standing umbrella trial for all rare cancers in a countryno external link or Wikipedia entryedit file
- IdeaDevelop drugs in children first when the target is a children's targetno external link or Wikipedia entryedit file
- IdeaA same-week expert second opinion for every rare cancer diagnosisno external link or Wikipedia entryedit file
- IdeaTest drugs on the patient's own cancer cells when there is no trial to joinno external link or Wikipedia entryedit file
- IdeaRandomise inside the registry that already follows every patientno external link or Wikipedia entryedit file
- IdeaLet patients themselves donate their records and samples for ultra-rare cancersno external link or Wikipedia entryedit file
- IdeaGroup trials by broken mechanism, not by organ or single mutationno external link or Wikipedia entryedit file
- IdeaA shared compound library that rare cancer researchers can actually useno external link or Wikipedia entryedit file
- IdeaAgree in advance how to borrow evidence between similar rare cancersno external link or Wikipedia entryedit file
- IdeaAn open model bank for the rare tumours nobody has models forno external link or Wikipedia entryedit file
- IdeaWatch the immune system's response in the blood three weeks inno external link or Wikipedia entryedit file
- IdeaTake faecal transplant plus immunotherapy to a definitive trialno external link or Wikipedia entryedit file
- IdeaProtect the gut flora of patients about to start immunotherapyno external link or Wikipedia entryedit file
- IdeaTurn the map of immune cells inside a tumour into a standardised testno external link or Wikipedia entryedit file
- IdeaUse a blood test at six weeks to decide whether to keep goingno external link or Wikipedia entryedit file
- IdeaPool every immunotherapy trial's biomarker data into one commonsno external link or Wikipedia entryedit file
- IdeaSelect patients for cell therapy by whether their tumour holds reactive T cellsno external link or Wikipedia entryedit file
- IdeaCheck whether a tumour can still show itself to the immune systemno external link or Wikipedia entryedit file
- IdeaUnmask hidden antigens with a short epigenetic course before immunotherapyno external link or Wikipedia entryedit file
- IdeaUse pre-surgery immunotherapy windows as the field's biomarker engineno external link or Wikipedia entryedit file
- IdeaTreat immunotherapy side-effects without wiping out the responseno external link or Wikipedia entryedit file
- IdeaTest a high-fibre diet as an immunotherapy adjunctno external link or Wikipedia entryedit file
- IdeaRegistry-based randomised MCED trial: a million people, no study visitsno external link or Wikipedia entryedit file
- IdeaPre-agreed update rules so an MCED test is not obsolete when its trial reads outno external link or Wikipedia entryedit file
- IdeaA 28-day national pathway for people with a positive multi-cancer blood testno external link or Wikipedia entryedit file
- IdeaMandatory interval-cancer audit for every blood-based screening testno external link or Wikipedia entryedit file
- IdeaLung screening eligibility by risk score, not pack-years, including high-risk never-smokersno external link or Wikipedia entryedit file
- IdeaAI clears the normal lung screening scans so radiologists read only the suspicious onesno external link or Wikipedia entryedit file
- IdeaRoll out AI-supported mammography nationally as a stepped-wedge trialno external link or Wikipedia entryedit file
- IdeaEvery routine CT scan checked by AI for early cancer signs, with a tracked follow-up pathwayno external link or Wikipedia entryedit file
- IdeaAI that spots pancreatic cancer on scans taken a year before diagnosisno external link or Wikipedia entryedit file
- IdeaNew diabetes after 50 plus weight loss triggers a pancreatic cancer checkno external link or Wikipedia entryedit file
- IdeaA breath test to rule out cancer in people with vague symptomsno external link or Wikipedia entryedit file
- IdeaA urine DNA test to decide who with blood in the urine needs a camera testno external link or Wikipedia entryedit file
- IdeaSmart scales and health records flag unexplained weight loss for a cancer checkno external link or Wikipedia entryedit file
- IdeaGlucose monitor data as an early pancreatic cancer signalno external link or Wikipedia entryedit file
- IdeaCancer risk scores running automatically in GP records to prompt urgent referralno external link or Wikipedia entryedit file
- IdeaMulti-cancer blood test as the first step for patients with non-specific symptomsno external link or Wikipedia entryedit file
- IdeaUse the trend in routine blood counts, not a single threshold, to spot cancerno external link or Wikipedia entryedit file
- IdeaPersonalised stool-test cut-offs by age, sex and prior resultsno external link or Wikipedia entryedit file
- IdeaOffer the blood test for bowel cancer only to people who refuse stool tests or colonoscopyno external link or Wikipedia entryedit file
- IdeaA swallowable sponge test for reflux patients, offered in pharmaciesno external link or Wikipedia entryedit file
- IdeaStomach cancer serology screening for high-risk migrant communities in low-incidence countriesno external link or Wikipedia entryedit file
- IdeaReplace six-monthly ultrasound with a blood test for liver cancer in cirrhosisno external link or Wikipedia entryedit file
- IdeaCommunity health workers with smartphone AI screen for mouth cancer in South Asiano external link or Wikipedia entryedit file
- IdeaA ten-dollar blood test for the five cancers that kill most people in poorer countriesno external link or Wikipedia entryedit file
- IdeaCheap DNA fragment-pattern blood test as a first sieve before expensive cancer testsno external link or Wikipedia entryedit file
- IdeaA live national dashboard of stage at diagnosis as the scorecard for early detectionno external link or Wikipedia entryedit file
- IdeaA cancer blood test for older people arriving at A&E with unexplained symptomsno external link or Wikipedia entryedit file
- IdeaTake lung screening scanners to supermarket car parks in the poorest areasno external link or Wikipedia entryedit file
- IdeaBlood EBV DNA screening for nasopharyngeal cancer across southern China and Southeast Asiano external link or Wikipedia entryedit file
- IdeaMake a two-minute mouth cancer check part of every dental visitno external link or Wikipedia entryedit file
- IdeaA single 'cancer check at 60' appointment bundling all screening testsno external link or Wikipedia entryedit file
- IdeaStop biopsying small thyroid nodules and never screen the thyroidno external link or Wikipedia entryedit file
- IdeaActive surveillance as the default for tiny papillary thyroid cancersno external link or Wikipedia entryedit file
- IdeaAfter the COMET trial: surveillance pathways and a new name for low-risk DCISno external link or Wikipedia entryedit file
- IdeaAn international body to rename indolent lesions so 'cancer' means somethingno external link or Wikipedia entryedit file
- IdeaTest whether calling Gleason 6 'not cancer' changes what men chooseno external link or Wikipedia entryedit file
- IdeaProstate active surveillance without scheduled biopsies: MRI and blood tests decideno external link or Wikipedia entryedit file
- IdeaWatch small kidney tumours rather than remove them, with a national registryno external link or Wikipedia entryedit file
- IdeaAI malignancy scores to end repeat scans and biopsies for benign lung nodulesno external link or Wikipedia entryedit file
- IdeaA watch-and-wait registry for blood precursor conditions found by chanceno external link or Wikipedia entryedit file
- IdeaEvery screening programme must publish its overdiagnosis rate each yearno external link or Wikipedia entryedit file
- IdeaStop screening by life expectancy, not birthday, with a tool in the recordno external link or Wikipedia entryedit file
- IdeaA mandatory decision aid before any multi-cancer blood testno external link or Wikipedia entryedit file
- IdeaStop routine endoscopies for non-dysplastic Barrett's oesophagusno external link or Wikipedia entryedit file
- IdeaJudge skin cancer AI by the thick melanomas it prevents, not the thin ones it findsno external link or Wikipedia entryedit file
- IdeaA ten-year cohort of incidental findings to calibrate follow-up guidelinesno external link or Wikipedia entryedit file
- IdeaStop watching stable low-risk pancreatic cysts after five yearsno external link or Wikipedia entryedit file
- IdeaAI second reads to stop borderline lesions being upgraded to cancerno external link or Wikipedia entryedit file
- IdeaHormone tablets instead of surgery for small breast cancers in the frail over-80sno external link or Wikipedia entryedit file
- IdeaMake skipping radiotherapy the default for very low-risk breast cancerno external link or Wikipedia entryedit file
- IdeaModern autopsy studies to measure how much silent cancer people carryno external link or Wikipedia entryedit file
- IdeaOffer HPV vaccination to women when they come for cervical screening or treatmentno external link or Wikipedia entryedit file
- IdeaPost every woman an HPV self-test kit instead of asking her to book a smearno external link or Wikipedia entryedit file
- IdeaA therapeutic vaccine to clear cervical precancer without surgeryno external link or Wikipedia entryedit file
- IdeaCure hepatitis C in prisons and drug services, and enrol the cured in liver cancer surveillanceno external link or Wikipedia entryedit file
- IdeaFamily-based H. pylori test-and-treat to prevent stomach cancerno external link or Wikipedia entryedit file
- IdeaAntibiotic-resistance testing from a stool sample before treating H. pylorino external link or Wikipedia entryedit file
- IdeaA vaccine against H. pylori for children in high-risk regionsno external link or Wikipedia entryedit file
- IdeaEvery lung screening visit includes stop-smoking medicine, opt-outno external link or Wikipedia entryedit file
- IdeaPut cytisine, a cheap plant-based quit-smoking pill, on every essential medicines listno external link or Wikipedia entryedit file
- IdeaCancer warnings on alcohol labels, evaluated as a natural experimentno external link or Wikipedia entryedit file
- IdeaMinimum alcohol pricing evaluated with cancer endpointsno external link or Wikipedia entryedit file
- IdeaA trial of GLP-1 weight-loss drugs with cancer as the primary outcomeno external link or Wikipedia entryedit file
- IdeaGLP-1 drugs to reverse endometrial precancer in women with obesityno external link or Wikipedia entryedit file
- IdeaOne master trial for cancer prevention drugs across many precancersno external link or Wikipedia entryedit file
- IdeaLow-dose tamoxifen for high-risk women, prescribed by pharmacists and nursesno external link or Wikipedia entryedit file
- IdeaRemove the fallopian tubes during any pelvic surgery once childbearing is finishedno external link or Wikipedia entryedit file
- IdeaBan commercial sunbedsno external link or Wikipedia entryedit file
- IdeaMandatory radon testing when homes are sold, with subsidised mitigationno external link or Wikipedia entryedit file
- IdeaEvaluate clean-air policies using lung cancer in never-smokersno external link or Wikipedia entryedit file
- IdeaSend screening invitations with a pre-booked time, not a request to callno external link or Wikipedia entryedit file
- IdeaCommunity pharmacies as one-stop cancer prevention hubsno external link or Wikipedia entryedit file
- IdeaPay insurers and health systems for cancers prevented and caught earlyno external link or Wikipedia entryedit file
- IdeaRegulators accept shrinking of precancer as the endpoint for prevention drug approvalno external link or Wikipedia entryedit file
- IdeaCatch-up HPV vaccination for men to prevent throat cancerno external link or Wikipedia entryedit file
- IdeaAn Epstein-Barr virus vaccine to prevent nasopharyngeal cancer and lymphomasno external link or Wikipedia entryedit file
- IdeaLet clinics contact relatives directly when a cancer gene is foundno external link or Wikipedia entryedit file
- IdeaUse a polygenic risk score to set when screening startsno external link or Wikipedia entryedit file
- IdeaBuild polygenic scores that work in every ancestry before deploying anyno external link or Wikipedia entryedit file
- IdeaA randomised trial of a shared-antigen vaccine to prevent Lynch syndrome cancersno external link or Wikipedia entryedit file
- IdeaA bone drug to prevent breast cancer in BRCA1 carriersno external link or Wikipedia entryedit file
- IdeaGet every Lynch syndrome carrier onto the right dose of aspirinno external link or Wikipedia entryedit file
- IdeaAutomatic germline testing for every cancer type where it changes careno external link or Wikipedia entryedit file
- IdeaGo back to families of women who died of ovarian cancer and offer BRCA testingno external link or Wikipedia entryedit file
- IdeaTest every possible mutation in every cancer gene so no result is 'uncertain'no external link or Wikipedia entryedit file
- IdeaWhole-body MRI plus blood DNA surveillance for people with Li-Fraumeni syndromeno external link or Wikipedia entryedit file
- IdeaA chatbot for pre-test genetic counselling so counsellors see only who needs themno external link or Wikipedia entryedit file
- IdeaFamily history collected by app and matched to testing criteria automaticallyno external link or Wikipedia entryedit file
- IdeaBan life and disability insurers from using genetic resultsno external link or Wikipedia entryedit file
- IdeaA mandatory trial line in every tumour board recommendationno external link or Wikipedia entryedit file
- IdeaEvery tumour sequencing report lists open, nearby, matched trials pulled liveno external link or Wikipedia entryedit file
- IdeaRemote consent and tele-screening so the first trial visit is a video callno external link or Wikipedia entryedit file
- IdeaLay trial navigators funded per centre, evaluated in a randomised trialno external link or Wikipedia entryedit file
- IdeaTrial-in-a-box: a preconfigured protocol kit any hospital can open for a rare cancerno external link or Wikipedia entryedit file
- IdeaPre-consented cohorts that can be randomised to future trials (TwiCs)no external link or Wikipedia entryedit file
- IdeaPublish why patients were screened out of each trialno external link or Wikipedia entryedit file
- IdeaA live 'seats available' feed for trial slots, like airline inventoryno external link or Wikipedia entryedit file
- IdeaThe pathology lab triggers a trial referral the day a rare cancer is diagnosedno external link or Wikipedia entryedit file
- IdeaEvening and weekend trial clinics for working-age patientsno external link or Wikipedia entryedit file
- IdeaEvery payer covers routine care costs for trial participants, in every countryno external link or Wikipedia entryedit file
- IdeaPay oncologists for the time it takes to enrol a patientno external link or Wikipedia entryedit file
- IdeaGuidelines list the open trials at every decision point, updated monthlyno external link or Wikipedia entryedit file
- IdeaMobile research units bring trial visits to rural townsno external link or Wikipedia entryedit file
- IdeaDrop mandatory fresh biopsies where blood or archival tissue would dono external link or Wikipedia entryedit file
- IdeaSeamless phase 2/3 with pre-registered go rules as the default for new agentsno external link or Wikipedia entryedit file
- IdeaPre-specified crossover-adjusted survival in every trial that allows crossoverno external link or Wikipedia entryedit file
- IdeaRandomised trials of stopping immunotherapy after one year versus continuingno external link or Wikipedia entryedit file
- IdeaUse tumour DNA in blood to decide when to pause treatment in metastatic cancerno external link or Wikipedia entryedit file
- IdeaCompeting sponsors share one control arm in the same indicationno external link or Wikipedia entryedit file
- IdeaBayesian shrinkage for subgroup claims to stop false 'works in this group' storiesno external link or Wikipedia entryedit file
- IdeaAI-assisted central imaging reads to cut endpoint cost and variabilityno external link or Wikipedia entryedit file
- IdeaAggregated single-patient crossover trials for symptom and supportive treatmentsno external link or Wikipedia entryedit file
- IdeaStop failing trials earlier with pre-registered aggressive futility rulesno external link or Wikipedia entryedit file
- IdeaA short pre-surgery drug window as the default early test of new agentsno external link or Wikipedia entryedit file
- IdeaRequire a randomised phase 2 before any phase 3no external link or Wikipedia entryedit file
- IdeaSMART designs to test treatment strategies, not just single drugsno external link or Wikipedia entryedit file
- IdeaEmulate the trial in real-world data first to decide which trials to runno external link or Wikipedia entryedit file
- IdeaA standard for tumour-agnostic approvals: minimum histologies and hierarchical modellingno external link or Wikipedia entryedit file
- IdeaValidate real-world progression endpoints so pragmatic trials can use themno external link or Wikipedia entryedit file
- IdeaSet trial enrolment targets from who actually gets the disease, and publish progress liveno external link or Wikipedia entryedit file
- IdeaFix the neutrophil count rule that excludes many people of African ancestryno external link or Wikipedia entryedit file
- IdeaParallel real-world cohorts for sicker patients alongside every pivotal trialno external link or Wikipedia entryedit file
- IdeaPivotal trials include sites in Africa, South Asia and Latin America, sponsor-fundedno external link or Wikipedia entryedit file
- IdeaCommunity health workers and trusted local organisations paid to recruit for trialsno external link or Wikipedia entryedit file
- IdeaA public equity index for trial sites and sponsors, tied to fundingno external link or Wikipedia entryedit file
- IdeaStop over-excluding people who could become pregnant; study pregnancy exposureno external link or Wikipedia entryedit file
- IdeaAnalyse and dose by sex: women get more toxicity from many cancer drugs at the same doseno external link or Wikipedia entryedit file
- IdeaRemove blanket exclusions for mental illness and dementia; support consent insteadno external link or Wikipedia entryedit file
- IdeaFund investigators from under-represented communities and community sites to lead trialsno external link or Wikipedia entryedit file
- IdeaPaid community advisory boards with power to change protocol burdenno external link or Wikipedia entryedit file
- IdeaPost-marketing safety monitoring stratified by ancestry and sex, with label updatesno external link or Wikipedia entryedit file
- IdeaDedicated cohorts for patients with performance status 2 in first-line trialsno external link or Wikipedia entryedit file
- IdeaA public map of trial deserts to steer where new sites openno external link or Wikipedia entryedit file
- IdeaTest flat versus weight-based dosing of antibodies, and use dose banding to cut wasteno external link or Wikipedia entryedit file
- IdeaExtended-interval immunotherapy: give checkpoint inhibitors every 8-12 weeks once stableno external link or Wikipedia entryedit file
- IdeaMeasure blood levels of oral targeted drugs and adjust doses to a target rangeno external link or Wikipedia entryedit file
- IdeaStart low and step up: individualised titration of oral cancer drugs, randomisedno external link or Wikipedia entryedit file
- IdeaDose-finding in older and frail patients, not extrapolation from fit onesno external link or Wikipedia entryedit file
- IdeaRetire the 3+3: model-based dose finding that counts late and chronic side effectsno external link or Wikipedia entryedit file
- IdeaDose and schedule optimisation trials specific to antibody-drug conjugatesno external link or Wikipedia entryedit file
- IdeaUse food effects to cut the dose and cost of oral drugs that absorb better with mealsno external link or Wikipedia entryedit file
- IdeaFactorial dose finding for drug combinations instead of full dose of everythingno external link or Wikipedia entryedit file
- IdeaKidney and liver impairment dosing studies completed before approval, not years afterno external link or Wikipedia entryedit file
- IdeaConfirm ultra-low-dose immunotherapy so it can be afforded where most patients liveno external link or Wikipedia entryedit file
- IdeaReduce the dose once the cancer responds: response-adapted de-escalation trialsno external link or Wikipedia entryedit file
- IdeaSequential multiple-assignment randomised trials to find the best order of ADCsno external link or Wikipedia entryedit file
- IdeaGrow each trial patient's tumour as organoids to decide which platform arm opens nextno external link or Wikipedia entryedit file
- IdeaRegistry-embedded randomisation of treatment order in routine careno external link or Wikipedia entryedit file
- IdeaTest alternating drug schedules against giving both drugs at onceno external link or Wikipedia entryedit file
- IdeaEmulate combination trials from real-world data to triage which ones to runno external link or Wikipedia entryedit file
- IdeaKill combination arms early using circulating tumour DNA, before waiting for scansno external link or Wikipedia entryedit file
- IdeaCombination baskets defined by resistance mechanism rather than by cancer typeno external link or Wikipedia entryedit file
- IdeaA non-profit phase 1b combination unit that any drug owner can useno external link or Wikipedia entryedit file
- IdeaA patent pool for combination method-of-use claimsno external link or Wikipedia entryedit file
- IdeaA registry of every treatment sequence patients actually receive, with outcomesno external link or Wikipedia entryedit file
- IdeaLet the trial learn: response-adaptive allocation across many combination armsno external link or Wikipedia entryedit file
- IdeaEvery approved cancer drug ships with a public combination-readiness data packno external link or Wikipedia entryedit file
- IdeaPayers cover off-label combinations only inside registry-randomised trialsno external link or Wikipedia entryedit file
- IdeaAn open forecasting tournament on which combination trials will succeedno external link or Wikipedia entryedit file
- IdeaWatch routine care for drug combinations that quietly make cancer treatment worseno external link or Wikipedia entryedit file
- IdeaNo accelerated approval for a combination without proof each part contributesno external link or Wikipedia entryedit file
- IdeaTwo-week pre-operative windows to compare combination biology head to headno external link or Wikipedia entryedit file
- IdeaA registry for preclinical experiments that did not workno external link or Wikipedia entryedit file
- IdeaA funder-backed, indexed journal of negative and inconclusive cancer resultsno external link or Wikipedia entryedit file
- IdeaNo new trial approval until the sponsor has reported its old onesno external link or Wikipedia entryedit file
- IdeaPublic post-mortem reports when a cancer drug programme is stoppedno external link or Wikipedia entryedit file
- IdeaListed companies must disclose top-line data, not just 'did not meet endpoint'no external link or Wikipedia entryedit file
- IdeaRescue the biological samples from failed trials for biomarker researchno external link or Wikipedia entryedit file
- IdeaSmall grants that pay scientists to write up abandoned projectsno external link or Wikipedia entryedit file
- IdeaGrant progress reports must list what did not workno external link or Wikipedia entryedit file
- IdeaGive negative trials plenary slots at the big cancer conferencesno external link or Wikipedia entryedit file
- IdeaA machine-readable taxonomy of why cancer drugs failno external link or Wikipedia entryedit file
- IdeaScore every preclinical model by how often it predicted the clinical resultno external link or Wikipedia entryedit file
- IdeaRecord what happens when doctors use cancer drugs off-labelno external link or Wikipedia entryedit file
- IdeaA public registry of cancer treatments that were later shown not to workno external link or Wikipedia entryedit file
- IdeaOne digital PD-L1 scale that maps across all the competing assaysno external link or Wikipedia entryedit file
- IdeaTest the drug in biomarker-negative patients too, so the biomarker can be validatedno external link or Wikipedia entryedit file
- IdeaRegulators recognise each other's companion diagnostic approvalsno external link or Wikipedia entryedit file
- IdeaPublish the disagreement between trial doctors and independent reviewers for every trialno external link or Wikipedia entryedit file
- IdeaLabel every biomarker claim with an evidence phase, like drugsno external link or Wikipedia entryedit file
- IdeaA functional test for homologous recombination deficiency validated across laboratoriesno external link or Wikipedia entryedit file
- IdeaRecord how long tissue waited before fixation in every pathology reportno external link or Wikipedia entryedit file
- IdeaLock the biomarker cut-off before phase 3, and publish itno external link or Wikipedia entryedit file
- IdeaA formal regulatory route for validating a biomarker on archived trial samplesno external link or Wikipedia entryedit file
- IdeaStandards for spatial and multiplex tissue biomarkers before they reach the clinicno external link or Wikipedia entryedit file
- IdeaPre-register biomarker validation studies the way trials are registeredno external link or Wikipedia entryedit file
- IdeaPay for new biomarker tests only while evidence of clinical utility is being collectedno external link or Wikipedia entryedit file
- IdeaVersion control and locked reference sets for AI algorithms used as companion diagnosticsno external link or Wikipedia entryedit file
- IdeaDrug labels must state which biomarker assays were validated and how they compareno external link or Wikipedia entryedit file
- IdeaRandomised trials to test whether biomarker-negative patients really do not benefitno external link or Wikipedia entryedit file
- IdeaMonitor biomarker positivity rates across labs in real time to catch assay driftno external link or Wikipedia entryedit file
- IdeaIndependent replication of the key experiment before first-in-human academic trialsno external link or Wikipedia entryedit file
- IdeaBounties for documented failed replications of high-impact findingsno external link or Wikipedia entryedit file
- IdeaEvery drug screen includes standard reference compounds whose performance is publishedno external link or Wikipedia entryedit file
- IdeaTime-stamped electronic lab notebooks submitted with the paperno external link or Wikipedia entryedit file
- IdeaRandom audits of published, funded research, like tax auditsno external link or Wikipedia entryedit file
- IdeaJournals check that data links actually work, and flag papers whose data vanishno external link or Wikipedia entryedit file
- IdeaPaid independent statistical review for preclinical papers that inform trialsno external link or Wikipedia entryedit file
- IdeaA registry of external validation datasets for cancer AI models, with mandatory reportingno external link or Wikipedia entryedit file
- IdeaTop journals require an independent lab to reproduce key findings before publicationno external link or Wikipedia entryedit file
- IdeaBarcode every reagent lot so batch effects can be traced across experiments and labsno external link or Wikipedia entryedit file
- IdeaEvery cancer biology PhD begins with a funded replication of a published findingno external link or Wikipedia entryedit file
- IdeaConditional approvals that lapse automatically if the confirmatory trial is lateno external link or Wikipedia entryedit file
- IdeaSponsors deposit the confirmatory trial budget in escrow at accelerated approvalno external link or Wikipedia entryedit file
- IdeaMutual recognition of GMP inspections for cell, gene and radiopharmaceutical plantsno external link or Wikipedia entryedit file
- IdeaOne clinical trial application accepted by regulators in every major regionno external link or Wikipedia entryedit file
- IdeaA reliance pathway for companion diagnostics so the test arrives with the drugno external link or Wikipedia entryedit file
- IdeaOne global paediatric cancer development plan instead of separate FDA and EMA plansno external link or Wikipedia entryedit file
- IdeaAdopt tumour-agnostic cancer drug labels across regions by reliance, not re-reviewno external link or Wikipedia entryedit file
- IdeaA public index of how the same cancer drug's label differs between countriesno external link or Wikipedia entryedit file
- IdeaLive tracker of the lag from first approval to real availability in every countryno external link or Wikipedia entryedit file
- IdeaOpen-source dossier-building software for academic sponsors and generic makersno external link or Wikipedia entryedit file
- IdeaA shared AI review assistant that maps one dossier to every regulator's questionsno external link or Wikipedia entryedit file
- IdeaOne international registry, not one per country, for conditional approvalsno external link or Wikipedia entryedit file
- IdeaAutomatic reciprocity of orphan and rare-paediatric designations between regulatorsno external link or Wikipedia entryedit file
- IdeaPublish every complete response letter and negative opinion across all regulatorsno external link or Wikipedia entryedit file
- IdeaIn vivo CAR-T as a vial on the shelf: a cost and access trial in lymphomano external link or Wikipedia entryedit file
- IdeaTwo-day CAR-T manufacture paired with rapid release tests that regulators acceptno external link or Wikipedia entryedit file
- IdeaQualify one iPSC master cell bank once for many off-the-shelf cell productsno external link or Wikipedia entryedit file
- IdeaAn open interoperability standard for closed automated cell-processing machinesno external link or Wikipedia entryedit file
- IdeaPublic reference standards and potency assays for CAR-T so every lab measures alikeno external link or Wikipedia entryedit file
- IdeaMandatory public reporting of vein-to-vein time and failure rate per CAR-T productno external link or Wikipedia entryedit file
- IdeaRegional cyclotron hubs for actinium-225 with an agreed actinium-227 impurity limitno external link or Wikipedia entryedit file
- IdeaBuild Western ytterbium-176 enrichment so lutetium-177 has more than one supplierno external link or Wikipedia entryedit file
- IdeaFund alpha emitters beyond actinium-225: lead-212, terbium-149 and astatine-211no external link or Wikipedia entryedit file
- IdeaRegional radiopharmacy hubs and harmonised transport rules for short-lived isotopesno external link or Wikipedia entryedit file
- IdeaContinuous-flow synthesis of ultra-potent ADC payloads to ease the capacity squeezeno external link or Wikipedia entryedit file
- IdeaNon-profit, open-licence lentiviral vectors and producer cell lines for CAR-Tno external link or Wikipedia entryedit file
- IdeaNon-viral CAR-T (transposon or CRISPR knock-in) as the default manufacturing routeno external link or Wikipedia entryedit file
- IdeaA neutral slot exchange so unused CAR-T manufacturing slots go to the next patientno external link or Wikipedia entryedit file
- IdeaHarmonise Europe's hospital exemption for academic cell therapies, with one registryno external link or Wikipedia entryedit file
- IdeaPublic-sector CAR-T manufacturing in India, Brazil and South Africa under $50,000no external link or Wikipedia entryedit file
- IdeaDigital batch records and AI process control to halve cell therapy batch failuresno external link or Wikipedia entryedit file
- IdeaCollect and freeze T cells at diagnosis for high-risk patients, before chemotherapyno external link or Wikipedia entryedit file
- IdeaPublic cell-therapy foundries at cancer centres for academics and start-upsno external link or Wikipedia entryedit file
- IdeaComparability by design: a digital twin and sentinel panel for cell process changesno external link or Wikipedia entryedit file
- IdeaA global medical isotope supply observatory with forecasts and shortage alertsno external link or Wikipedia entryedit file
- IdeaSubscription pricing for checkpoint inhibitors: fixed national fee, unlimited useno external link or Wikipedia entryedit file
- IdeaPay a different price for the same cancer drug depending on the indicationno external link or Wikipedia entryedit file
- IdeaAn advance market commitment for PD-1 biosimilars for lower-income countriesno external link or Wikipedia entryedit file
- IdeaCap public prices for new cancer drugs to tiers of the ESMO and ASCO value scalesno external link or Wikipedia entryedit file
- IdeaRestore weight-based dosing and vial sharing for immunotherapy in the labelno external link or Wikipedia entryedit file
- IdeaPublicly funded trials of lower and less frequent doses of expensive cancer drugsno external link or Wikipedia entryedit file
- IdeaScreen every cancer patient for financial toxicity as a vital sign, with navigationno external link or Wikipedia entryedit file
- IdeaAn international registry of real (net) cancer drug prices paid by public payersno external link or Wikipedia entryedit file
- IdeaDisclose R&D and manufacturing costs of publicly funded cancer drugs to get coverageno external link or Wikipedia entryedit file
- IdeaProvisional prices for surrogate-endpoint approvals, reset when survival data arriveno external link or Wikipedia entryedit file
- IdeaBuy out the patent on a curative cancer drug and sell it at generic pricesno external link or Wikipedia entryedit file
- IdeaLimit secondary patents and pay-for-delay so cancer generics arrive on timeno external link or Wikipedia entryedit file
- IdeaPublic payers cover academic CAR-T at cost as a benchmark for commercial pricesno external link or Wikipedia entryedit file
- IdeaA joint price negotiation bloc for middle-income countries, modelled on Beneluxano external link or Wikipedia entryedit file
- IdeaGrant extra exclusivity only in exchange for binding low prices in poorer countriesno external link or Wikipedia entryedit file
- IdeaBiosimilar-first defaults and payment parity in every cancer day unitno external link or Wikipedia entryedit file
- IdeaPay for one-time curative therapies as an annuity that stops at relapseno external link or Wikipedia entryedit file
- IdeaSocial impact bonds that fund biosimilar switching, repaid from payer savingsno external link or Wikipedia entryedit file
- IdeaAutomatic price cuts when a cancer drug's approved indications and volumes expandno external link or Wikipedia entryedit file
- IdeaA $50 million prize for the first off-patent drug proven to extend cancer survivalno external link or Wikipedia entryedit file
- IdeaA social impact bond: investors fund a repurposing trial, payers repay from savingsno external link or Wikipedia entryedit file
- IdeaPerioperative beta-blocker plus COX-2 inhibitor to reduce metastasis after surgeryno external link or Wikipedia entryedit file
- IdeaA pragmatic trial of statins to prevent liver cancer in people with cirrhosisno external link or Wikipedia entryedit file
- IdeaRequire genetic and target-trial evidence before funding any repurposing phase 3no external link or Wikipedia entryedit file
- IdeaAn automated pipeline emulating trials of every common drug against every cancerno external link or Wikipedia entryedit file
- IdeaThree years of indication-specific exclusivity for proving a new cancer use of an old drugno external link or Wikipedia entryedit file
- IdeaA delinked market-entry reward paid by payers when a repurposed generic wins approvalno external link or Wikipedia entryedit file
- IdeaA DRUP-style protocol for off-label generic targeted drugs in rare tumoursno external link or Wikipedia entryedit file
- IdeaRandomise a cheap antihistamine alongside immunotherapyno external link or Wikipedia entryedit file
- IdeaA biomarker-directed trial of vitamin D after surgery for digestive tract cancersno external link or Wikipedia entryedit file
- IdeaLosartan to loosen the stroma of pancreatic cancer before chemotherapy: a phase 3no external link or Wikipedia entryedit file
- IdeaA guideline fast track for repurposed drugs with phase 3 evidence but no manufacturerno external link or Wikipedia entryedit file
- IdeaPayers pre-commit to cover off-label generics when a definitive trial is positiveno external link or Wikipedia entryedit file
- IdeaA non-profit company to hold marketing authorisations for repurposed cancer drugsno external link or Wikipedia entryedit file
- IdeaValidate low-cost metronomic oral regimens in phase 3 and carry them into guidelinesno external link or Wikipedia entryedit file
- IdeaA strategic reserve of essential generic cancer drugs to end recurring shortagesno external link or Wikipedia entryedit file
- IdeaAdd a cheap-drug factorial arm to every cooperative-group adjuvant cancer trialno external link or Wikipedia entryedit file
- IdeaConfirm low-dose olanzapine for appetite and weight in advanced cancer worldwideno external link or Wikipedia entryedit file
- IdeaPre-registered, publicly scored AI ranking of repurposing candidates for cancerno external link or Wikipedia entryedit file
- IdeaRound-the-clock remote treatment-planning hubs for clinics without physicistsno external link or Wikipedia entryedit file
- IdeaModernised cobalt-60 machines as a deliberate bridge where linacs cannot be kept runningno external link or Wikipedia entryedit file
- IdeaAI-first reading for high-volume common cancer diagnoses, pathologist for the exceptionsno external link or Wikipedia entryedit file
- IdeaNurse-led chemotherapy day units with a doctor on a screenno external link or Wikipedia entryedit file
- IdeaWHO prequalification plus pooled demand to push biosimilar prices below 10% of the originatorno external link or Wikipedia entryedit file
- IdeaA live stock-out map for essential chemotherapy drugsno external link or Wikipedia entryedit file
- IdeaMobile diagnostic units that biopsy, scan and treat on the same visitno external link or Wikipedia entryedit file
- IdeaA platform trial of very-low-cost metronomic chemotherapy in LMIC common cancersno external link or Wikipedia entryedit file
- IdeaA dedicated global financing window for cancer, modelled on the Global Fundno external link or Wikipedia entryedit file
- IdeaLow-cost cobalt-60 brachytherapy for cervical cancer in every regional centreno external link or Wikipedia entryedit file
- IdeaCash for transport and food to stop families abandoning curative treatmentno external link or Wikipedia entryedit file
- IdeaCredentialed diaspora oncologists staffing remote tumour boards for home-country hospitalsno external link or Wikipedia entryedit file
- IdeaSolar microgrids so radiotherapy, pathology and drug fridges never lose powerno external link or Wikipedia entryedit file
- IdeaAn 18-month oncology track for clinical officers and physician associatesno external link or Wikipedia entryedit file
- IdeaOncology pharmacists as protocol prescribers for supportive care and dose adjustmentsno external link or Wikipedia entryedit file
- IdeaOne medical physicist covering many radiotherapy machines through remote quality assuranceno external link or Wikipedia entryedit file
- IdeaRetention packages so trained oncology staff stay: bonds, top-ups, working equipmentno external link or Wikipedia entryedit file
- IdeaRegional training hubs that produce oncologists, physicists and radiographers in-regionno external link or Wikipedia entryedit file
- IdeaAmbient AI note-taking to give oncologists back a day a weekno external link or Wikipedia entryedit file
- IdeaAdvanced-practice radiation therapists doing contouring and on-treatment reviewsno external link or Wikipedia entryedit file
- IdeaNurse-led follow-up clinics for survivors, freeing oncologists for active treatmentno external link or Wikipedia entryedit file
- IdeaPathologist assistants plus AI triage to multiply pathologist capacityno external link or Wikipedia entryedit file
- IdeaAn open global model of cancer workforce supply and demand by countryno external link or Wikipedia entryedit file
- IdeaFast-track relicensing for refugee, migrant and returning oncology professionalsno external link or Wikipedia entryedit file
- IdeaOncology teams order germline tests; tele-genetic counsellors handle the resultsno external link or Wikipedia entryedit file
- IdeaCommunity health workers trained in cancer triage, navigation and home palliative careno external link or Wikipedia entryedit file
- IdeaStructured mentorship so district general surgeons perform common cancer operations safelyno external link or Wikipedia entryedit file
- IdeaOne-stop breast clinics: imaging, biopsy and a preliminary answer in a single visitno external link or Wikipedia entryedit file
- IdeaA paid patient navigator for every new cancer diagnosis, reimbursed as a serviceno external link or Wikipedia entryedit file
- IdeaPathologists order genomic profiling automatically at diagnosis of advanced cancerno external link or Wikipedia entryedit file
- IdeaLive guideline-concordance dashboards for every tumour board, generated from the recordno external link or Wikipedia entryedit file
- IdeaMandatory national virtual tumour boards for rare and complex cancersno external link or Wikipedia entryedit file
- IdeaA machine-readable treatment summary handed to every patient and readable by any hospitalno external link or Wikipedia entryedit file
- IdeaFormal shared-care agreements between oncology and family doctors, with same-day e-consultno external link or Wikipedia entryedit file
- IdeaAudit whether tumour board recommendations were actually carried outno external link or Wikipedia entryedit file
- IdeaAcute oncology assessment units so sick cancer patients bypass the emergency departmentno external link or Wikipedia entryedit file
- IdeaRecord and publish the symptom-to-diagnosis interval for every cancer, by hospitalno external link or Wikipedia entryedit file
- IdeaStanding reflex biomarker panels per tumour type, run without an oncologist's orderno external link or Wikipedia entryedit file
- IdeaRapid diagnostic centres for people with vague but worrying symptomsno external link or Wikipedia entryedit file
- IdeaDecision aids built into the record for every preference-sensitive cancer choiceno external link or Wikipedia entryedit file
- IdeaScreen every patient for financial hardship at diagnosis and connect them to helpno external link or Wikipedia entryedit file
- IdeaAn asynchronous expert second opinion for every new advanced-cancer diagnosisno external link or Wikipedia entryedit file
- IdeaBundled episode payments for cancer care with bonuses for guideline concordanceno external link or Wikipedia entryedit file
- IdeaA standard handoff with medication reconciliation at every cancer care transitionno external link or Wikipedia entryedit file
- IdeaSimulate each hospital's cancer pathway as a queue to find and remove the waitsno external link or Wikipedia entryedit file
- IdeaA risk-stratified cardio-oncology pathway for everyone receiving heart-toxic cancer therapyno external link or Wikipedia entryedit file
- IdeaDefault fertility preservation referral for every patient under 40 before treatmentno external link or Wikipedia entryedit file
- IdeaA national late-effects registry linking treatment exposures to outcomes decades laterno external link or Wikipedia entryedit file
- IdeaRisk-stratified follow-up: low-risk survivors to primary care with fast re-entryno external link or Wikipedia entryedit file
- IdeaTailored screening for second cancers in survivors with known high-risk exposuresno external link or Wikipedia entryedit file
- IdeaVocational rehabilitation integrated into cancer care so survivors can return to workno external link or Wikipedia entryedit file
- IdeaTrials of structured cognitive rehabilitation for cancer-related cognitive impairmentno external link or Wikipedia entryedit file
- IdeaCardiometabolic screening and treatment for survivors on long-term hormone therapyno external link or Wikipedia entryedit file
- IdeaA survivorship passport app for adolescent and young adult survivorsno external link or Wikipedia entryedit file
- IdeaA survivor biobank to find who will develop late effects before they dono external link or Wikipedia entryedit file
- IdeaProspective arm-volume surveillance to catch and reverse lymphoedema earlyno external link or Wikipedia entryedit file
- IdeaLocally prepared oral morphine solution, licensed for nurse prescribingno external link or Wikipedia entryedit file
- IdeaVolunteer-led neighbourhood palliative networks, the Kerala model, adapted elsewhereno external link or Wikipedia entryedit file
- IdeaVideo palliative care as an equivalent default option for patients far from a teamno external link or Wikipedia entryedit file
- IdeaEarmark a fixed share of every national cancer budget for palliative careno external link or Wikipedia entryedit file
- IdeaMeasure and publish pain control rates in every cancer centreno external link or Wikipedia entryedit file
- IdeaTrain every oncology team in serious-illness conversations and prompt them in the recordno external link or Wikipedia entryedit file
- IdeaSingle-fraction radiotherapy as the default for painful bone metastasesno external link or Wikipedia entryedit file
- IdeaA paediatric palliative care team in every childhood cancer unitno external link or Wikipedia entryedit file
- IdeaHome end-of-life care kits and trained family carers where no hospice existsno external link or Wikipedia entryedit file
- IdeaTrials of low-cost opioid alternatives where morphine supply is unreliableno external link or Wikipedia entryedit file
- IdeaMake sponsors justify every trial exclusion of older and multimorbid patientsno external link or Wikipedia entryedit file
- IdeaPragmatic trials in patients over 75 with function, not just survival, as the primary endpointno external link or Wikipedia entryedit file
- IdeaHome administration of selected chemotherapy and immunotherapy for older and frail patientsno external link or Wikipedia entryedit file
- IdeaHospital-at-home for oncology: treating low-risk febrile neutropenia and dehydration at homeno external link or Wikipedia entryedit file
- IdeaUpfront reduced-dose regimens tested head-to-head in frail older patientsno external link or Wikipedia entryedit file
- IdeaAn automatic electronic frailty index inside the oncology recordno external link or Wikipedia entryedit file
- IdeaGeriatrician co-management for older patients having cancer surgeryno external link or Wikipedia entryedit file
- IdeaRequire post-approval evidence in patients over 75 and update labels accordinglyno external link or Wikipedia entryedit file
- IdeaCaregiver training and respite as a covered service in cancer care for older patientsno external link or Wikipedia entryedit file
- IdeaPharmacist interaction check before every oral cancer-drug prescriptionno external link or Wikipedia entryedit file
- IdeaReport time toxicity, the days spent in healthcare, as a standard outcome for older patientsno external link or Wikipedia entryedit file
- IdeaMultimodal prehabilitation for older patients before major cancer surgeryno external link or Wikipedia entryedit file
- IdeaA defined pathway for patients with both dementia and cancerno external link or Wikipedia entryedit file
- IdeaDynamic consent with usage receiptsno external link or Wikipedia entryedit file
- IdeaBroad research consent as a routine step of the cancer pathwayno external link or Wikipedia entryedit file
- IdeaDigitise the nation's pathology slides and link them to outcomesno external link or Wikipedia entryedit file
- IdeaOpen, benchmarked algorithms for lines of therapy and progression from routine datano external link or Wikipedia entryedit file
- IdeaPoint-of-care randomisation built into the oncology recordno external link or Wikipedia entryedit file
- IdeaPublic procurement clauses banning data export fees and lock-inno external link or Wikipedia entryedit file
- IdeaPrivacy-preserving linkage tokens for every cancer data holderno external link or Wikipedia entryedit file
- IdeaLink single-cell and spatial tumour atlases to clinical outcomesno external link or Wikipedia entryedit file
- IdeaA national repository of radiotherapy dose plans linked to outcomesno external link or Wikipedia entryedit file
- IdeaA consented commons of surgical video linked to pathology and outcomesno external link or Wikipedia entryedit file
- IdeaPublic data-quality scorecards for every cancer centreno external link or Wikipedia entryedit file
- IdeaStructured, coded radiology reports for cancer response instead of free textno external link or Wikipedia entryedit file
- IdeaAn open library pairing completed cancer trials with real-world emulationsno external link or Wikipedia entryedit file
- IdeaEvery patient on an accelerated-approval drug enrolled in a registry until confirmationno external link or Wikipedia entryedit file
- IdeaValidate real-world progression against central imaging reviewno external link or Wikipedia entryedit file
- IdeaRegistry-based randomised trials for oncology comparative effectivenessno external link or Wikipedia entryedit file
- IdeaMandatory real-world reporting for patients excluded from pivotal trialsno external link or Wikipedia entryedit file
- IdeaLinked prescribing and outcome data to find drug interactions with cancer therapyno external link or Wikipedia entryedit file
- IdeaOne outcome record for every donated or discounted cancer drug packno external link or Wikipedia entryedit file
- IdeaFollow every trial participant for 30 years through registry linkageno external link or Wikipedia entryedit file
- IdeaWearable activity data as a validated real-world endpointno external link or Wikipedia entryedit file
- IdeaStandards for external control arms built from federated real-world datano external link or Wikipedia entryedit file
- IdeaAn international consortium pooling the outcome of every treated child with cancerno external link or Wikipedia entryedit file
- IdeaA real-world sequencing analysis within a year of every new approvalno external link or Wikipedia entryedit file
- IdeaReassess cancer drug prices at three years using real-world outcomesno external link or Wikipedia entryedit file
- IdeaDeposit trial results as structured data, not just PDFsno external link or Wikipedia entryedit file
- IdeaDecision support that cites the exact trial and guideline line it relies onno external link or Wikipedia entryedit file
- IdeaA tumour board assistant that cites its evidence and tracks outcomesno external link or Wikipedia entryedit file
- IdeaReal-time guideline-concordance feedback for every cancer centreno external link or Wikipedia entryedit file
- IdeaMicro-learning pushed to community oncologists within 30 days of a practice changeno external link or Wikipedia entryedit file
- IdeaA plain-language explainer for every guideline recommendation, in every major languageno external link or Wikipedia entryedit file
- IdeaA public tracker of how long each country takes to adopt new evidenceno external link or Wikipedia entryedit file
- IdeaOpen licences for publicly funded cancer guidelinesno external link or Wikipedia entryedit file
- IdeaA monthly-updated benchmark for AI answers to oncology questions with citation accuracyno external link or Wikipedia entryedit file
- IdeaExpert-verified translation of guideline updates into 20 languages within 30 daysno external link or Wikipedia entryedit file
- IdeaToxicity-management decision support for nurses and pharmacistsno external link or Wikipedia entryedit file
- IdeaA digital second-opinion network answering community oncologists within 72 hoursno external link or Wikipedia entryedit file
- IdeaSubscribable alerts when the standard of care changes for a patient's situationno external link or Wikipedia entryedit file
- IdeaEnd the abstract-to-paper gap: require full results with any conference presentationno external link or Wikipedia entryedit file
- IdeaRandomised trials of how to spread proven cancer treatments, not just what worksno external link or Wikipedia entryedit file
- IdeaUpdate hospital order sets within 30 days of a guideline changeno external link or Wikipedia entryedit file
- IdeaA public API serving the current standard of care for any cancer, stage and biomarkerno external link or Wikipedia entryedit file
- IdeaMandatory post-market performance reporting for cancer AIno external link or Wikipedia entryedit file
- IdeaA standard for monitoring AI performance drift with pause thresholdsno external link or Wikipedia entryedit file
- IdeaA neutral public evaluator for cancer AI, on the model of NISTno external link or Wikipedia entryedit file
- IdeaA liability framework for clinical AI: safe harbour for clinicians, liability for makersno external link or Wikipedia entryedit file
- IdeaPay for cancer AI only when it has outcome evidence, then pay properlyno external link or Wikipedia entryedit file
- IdeaA mandatory silent (shadow) trial before any cancer AI goes liveno external link or Wikipedia entryedit file
- IdeaMandatory subgroup performance reporting for cancer AIno external link or Wikipedia entryedit file
- IdeaA pre-competitive consortium to train a shared multimodal cancer foundation modelno external link or Wikipedia entryedit file
- IdeaPublicly funded cancer AI must release open weights and model cardsno external link or Wikipedia entryedit file
- IdeaDigital twins for treatment selection, validated by predicting before observingno external link or Wikipedia entryedit file
- IdeaIn silico trials to prioritise combinations, scored against later real trialsno external link or Wikipedia entryedit file
- IdeaA standard evaluation pathway for AI-assisted pathology, from reader study to deploymentno external link or Wikipedia entryedit file
- IdeaRequire stage-shift or interval-cancer endpoints for AI in cancer screeningno external link or Wikipedia entryedit file
- IdeaExternal validation at five or more sites in two countries before clearanceno external link or Wikipedia entryedit file
- IdeaPatients told which AI is used in their care, in plain languageno external link or Wikipedia entryedit file
- IdeaRed-team programmes that attack cancer AI before patients dono external link or Wikipedia entryedit file
- IdeaEvery AI output logged in the record with input hash, version and clinician responseno external link or Wikipedia entryedit file
- IdeaRules for retiring cancer AI when performance drops or the standard of care movesno external link or Wikipedia entryedit file
- IdeaA randomised trial of AI scribes in oncology clinics measuring errors and timeno external link or Wikipedia entryedit file
- IdeaA randomised trial of AI-generated treatment recommendations versus tumour boardsno external link or Wikipedia entryedit file
- IdeaA fixed share of trial-group funding for getting proven care to patientsno external link or Wikipedia entryedit file
- IdeaBurden-matched funding for trials led in low- and middle-income countriesno external link or Wikipedia entryedit file
- IdeaA survivorship research endowment funded by a levy on curative therapy pricesno external link or Wikipedia entryedit file
- IdeaA statutory minimum share of public trial money for surgery and radiotherapyno external link or Wikipedia entryedit file
- IdeaJudge funding programme officers on burden alignment and trials completedno external link or Wikipedia entryedit file
- IdeaA dedicated programme for cachexia and treatment toxicity researchno external link or Wikipedia entryedit file
- IdeaA trials fund reserved for older and multimorbid patientsno external link or Wikipedia entryedit file
- IdeaTreat brain metastases as a disease with its own trials programmeno external link or Wikipedia entryedit file
- IdeaMilestone prizes for first-in-class mechanisms reaching human proof of conceptno external link or Wikipedia entryedit file
- IdeaPatent term extension scaled to proven survival gainno external link or Wikipedia entryedit file
- IdeaShorter exclusivity for later-in-class drugs without added benefitno external link or Wikipedia entryedit file
- IdeaOutcome-based annuity payments for potentially curative one-time therapiesno external link or Wikipedia entryedit file
- IdeaHospital-based CAR-T manufacturing at cost through a public networkno external link or Wikipedia entryedit file
- IdeaRequire head-to-head trials against the best in class for later entrantsno external link or Wikipedia entryedit file
- IdeaExtra exclusivity for sponsors who run treatment-duration and de-escalation trialsno external link or Wikipedia entryedit file
- IdeaAn abbreviated approval path for follow-on antibodies within a validated classno external link or Wikipedia entryedit file
- IdeaA repurposing label pathway with short exclusivity that non-profits can holdno external link or Wikipedia entryedit file
- IdeaSocial impact bonds for cancer prevention, repaid from avoided treatment costsno external link or Wikipedia entryedit file
- IdeaGovernment reinsurance for phase 2 failures of first-in-class cancer drugsno external link or Wikipedia entryedit file
- IdeaA phase 0 fund to test academic compounds in humans with microdoses and imagingno external link or Wikipedia entryedit file
- IdeaA national non-profit contract research organisation for academic oncology trialsno external link or Wikipedia entryedit file
- IdeaTwo-year translational fellowships that pay scientists to develop their own discoveryno external link or Wikipedia entryedit file
- IdeaHospital-exemption cell therapies at scale, backed by a shared registryno external link or Wikipedia entryedit file
- IdeaA university cyclotron network with shared regulatory files for new tracersno external link or Wikipedia entryedit file
- IdeaA translation fund for academic surgical devices and radiotherapy technologyno external link or Wikipedia entryedit file
- IdeaA fund for prospective validation of academic biomarkers and companion diagnosticsno external link or Wikipedia entryedit file
- IdeaHospital-funded protected time for clinician-scientists, repaid by trial revenueno external link or Wikipedia entryedit file
- IdeaA diversified royalty pool that finances academic phase 1 trials across fifty assetsno external link or Wikipedia entryedit file
- IdeaA global first-in-human network for academic cancer trials with single ethics reviewno external link or Wikipedia entryedit file
- IdeaA public indemnity pool so universities can sponsor first-in-human cancer trialsno external link or Wikipedia entryedit file
- IdeaAn antitrust safe harbour for cross-company combination trials and data poolingno external link or Wikipedia entryedit file
- IdeaFunder bonuses for releasing results and data within six months, negatives includedno external link or Wikipedia entryedit file
- IdeaAutomatic offer of shelved cancer assets to non-profits after two yearsno external link or Wikipedia entryedit file
- IdeaA federated learning consortium of cancer centres that jointly own the modelsno external link or Wikipedia entryedit file
- IdeaScoop protection and co-publication norms to reduce academic secrecyno external link or Wikipedia entryedit file
- IdeaAn independent evaluation unit for surgical robots and AI, paid on evidenceno external link or Wikipedia entryedit file
- IdeaPay per course of radiotherapy, not per session, so short courses are not penalisedno external link or Wikipedia entryedit file
- IdeaA video-based surgical quality registry linking assessed skill to cancer outcomesno external link or Wikipedia entryedit file
- IdeaA funded programme of organ-preservation trials to avoid radical surgeryno external link or Wikipedia entryedit file
- IdeaPayer-funded trials that omit surgery or radiotherapy in low-risk patientsno external link or Wikipedia entryedit file
- IdeaA pragmatic trial network for intraoperative margin tools, paid on margin reductionno external link or Wikipedia entryedit file
- IdeaA neutral platform trial for radiotherapy plus immunotherapy combinationsno external link or Wikipedia entryedit file
- IdeaCoverage-with-evidence registries for MR-guided and adaptive radiotherapyno external link or Wikipedia entryedit file
- IdeaValidate and reimburse AI contouring and planning to expand radiotherapy capacityno external link or Wikipedia entryedit file
- IdeaDevice-agnostic public trials of ablation technologies against surgeryno external link or Wikipedia entryedit file
- IdeaPrizes for unpatentable surgical and radiotherapy techniques proven in trialsno external link or Wikipedia entryedit file
- IdeaTwo-page plain-language consent with teach-back for every cancer trial and treatmentno external link or Wikipedia entryedit file
- IdeaEvery pathology and genomic report ships with a signed plain-language versionno external link or Wikipedia entryedit file
- IdeaCertified decision aids required for every preference-sensitive cancer decisionno external link or Wikipedia entryedit file
- IdeaScreen every patient for financial toxicity at diagnosis and refer like any other symptomno external link or Wikipedia entryedit file
- IdeaAlgorithm-triggered goals-of-care conversations before crisisno external link or Wikipedia entryedit file
- IdeaA funded expert second opinion for every new high-stakes or rare cancer diagnosisno external link or Wikipedia entryedit file
- IdeaRecorded, AI-summarised consultations given to patients by defaultno external link or Wikipedia entryedit file
- IdeaQuestion prompt lists sent to patients before every major consultationno external link or Wikipedia entryedit file
- IdeaPaid survivor peer-navigators as a recognised health workforce roleno external link or Wikipedia entryedit file
- IdeaReport time toxicity, the days a treatment consumes, in every trial and decision aidno external link or Wikipedia entryedit file
- IdeaQuantitative patient preference studies set the benefit-risk bar before phase 3no external link or Wikipedia entryedit file
- IdeaFormal caregiver assessment and training written into every treatment planno external link or Wikipedia entryedit file
- IdeaA health-literacy certification standard for oncology portals, letters and appsno external link or Wikipedia entryedit file
- IdeaPatients are told which trials they qualify for at every treatment decision, in writingno external link or Wikipedia entryedit file
- IdeaTolerability as a co-primary endpoint with its own label claimno external link or Wikipedia entryedit file
- IdeaA prevention programme for chemotherapy nerve damage: SARM1 inhibitors, cooling and compressionno external link or Wikipedia entryedit file
- IdeaBiomarker-guided cardioprotection for everyone on cardiotoxic cancer therapyno external link or Wikipedia entryedit file
- IdeaPayers price drugs on quality-adjusted benefit, so toxicity costs the manufacturerno external link or Wikipedia entryedit file
- IdeaA lifelong late-effects registry linked to every treatment for adult survivorsno external link or Wikipedia entryedit file
- IdeaMeasure and treat chemo brain with objective digital cognitive testingno external link or Wikipedia entryedit file
- IdeaPredict immune side-effects before they happen and pre-empt themno external link or Wikipedia entryedit file
- IdeaFertility preservation offered and funded by default before gonadotoxic treatmentno external link or Wikipedia entryedit file
- IdeaProtect hearing from cisplatin in adults as we now do in childrenno external link or Wikipedia entryedit file
- IdeaFund scalp cooling and hair-preserving measures for every alopecia-inducing regimenno external link or Wikipedia entryedit file
- IdeaOncology hospital-at-home with remote monitoring for toxicityno external link or Wikipedia entryedit file
- IdeaA permanent platform trial for supportive-care interventions inside cooperative groupsno external link or Wikipedia entryedit file
- IdeaPhotobiomodulation and a taste and swallowing programme for mouth and throat toxicityno external link or Wikipedia entryedit file
- IdeaSexual health assessed and treated as a standard toxicity domainno external link or Wikipedia entryedit file
- IdeaQuality-adjusted survival reported in every trial publication and labelno external link or Wikipedia entryedit file
- IdeaTrain and fund oncology clinicians as public content creatorsno external link or Wikipedia entryedit file
- IdeaInoculate newly diagnosed patients against common cancer scamsno external link or Wikipedia entryedit file
- IdeaA public registry of unproven cancer clinics and reported outcomesno external link or Wikipedia entryedit file
- IdeaAn open supplement-drug interaction checker built into oncology prescribingno external link or Wikipedia entryedit file
- IdeaBan and enforce against paid advertising of unproven cancer treatmentsno external link or Wikipedia entryedit file
- IdeaEvidence-based integrative oncology in every cancer centre to meet demand safelyno external link or Wikipedia entryedit file
- IdeaA public benchmark and audit of chatbot answers to cancer questionsno external link or Wikipedia entryedit file
- IdeaCommunity-tailored HPV vaccine confidence campaigns with school-based deliveryno external link or Wikipedia entryedit file
- IdeaAn independent hype index grading cancer press releases and news storiesno external link or Wikipedia entryedit file
- IdeaTrained moderators with evidence tools in online patient communitiesno external link or Wikipedia entryedit file
- IdeaLiving plain-language evidence summaries for every common cancer question in 20 languagesno external link or Wikipedia entryedit file
- IdeaA structured pathway for patients declining proven treatmentno external link or Wikipedia entryedit file
- IdeaA whole-population cancer interception programme: risk-stratify every adult, detect and intercept earlyno external link or Wikipedia entryedit file
- IdeaA frameshift neoantigen vaccine for Lynch syndrome carriers as the first preventive cancer vaccine approvalno external link or Wikipedia entryedit file
- IdeaIn vivo CAR-T manufactured and priced like a generic biologicno external link or Wikipedia entryedit file
- IdeaAutonomous closed-loop adaptive therapy driven by blood tests and evolutionary modelsno external link or Wikipedia entryedit file
- IdeaEngineered immune surveillance: long-lived programmed immune cells that patrol for early cancerno external link or Wikipedia entryedit file
- IdeaA national residual-disease weather service: serial blood tests for every curatively treated patient, pooledno external link or Wikipedia entryedit file
- IdeaEradicate dormant cancer cells: a programme to wake and kill or lock asleep disseminated cellsno external link or Wikipedia entryedit file
- IdeaWhole-patient digital twins validated in prospective randomised trialsno external link or Wikipedia entryedit file
- IdeaA global ledger of negative results and failed compounds with mandatory depositionno external link or Wikipedia entryedit file
- IdeaA public fund and label pathway to trial generic drugs against cancerno external link or Wikipedia entryedit file
- IdeaA standard platform to get drugs into the brain: focused ultrasound plus shuttle-engineered therapeuticsno external link or Wikipedia entryedit file
- IdeaOne global rare cancer network with n-of-1 and Bayesian trial frameworksno external link or Wikipedia entryedit file
- IdeaMake every cold tumour hot: a coordinated programme to reprogramme immune-excluded tumoursno external link or Wikipedia entryedit file
- IdeaTreat cachexia as a disease: GDF-15 blockade plus anabolic and nutrition bundlesno external link or Wikipedia entryedit file
- IdeaModel-informed individual dosing with drug-level monitoring for every oral cancer drugno external link or Wikipedia entryedit file
- IdeaAutomated combination discovery: patient-sample screens feeding Bayesian platform trialsno external link or Wikipedia entryedit file
- IdeaMolecular indolence classifiers bundled with every screening programmeno external link or Wikipedia entryedit file
- IdeaA public biomarker validation utility with pre-diagnostic biobanks and blinded testingno external link or Wikipedia entryedit file
- IdeaMetastasis prevention as a formal indication with its own trials and regulatory pathwayno external link or Wikipedia entryedit file
- IdeaRisk-stratified lifelong care for tens of millions of survivors, automated and shared with primary careno external link or Wikipedia entryedit file
- IdeaPalliative care from diagnosis for every advanced cancer, including opioid access, worldwideno external link or Wikipedia entryedit file
- IdeaGeriatric assessment by default for every older patient, and trials that admit themno external link or Wikipedia entryedit file
- IdeaSelf-driving laboratories that run the cancer biology hypothesis loop autonomouslyno external link or Wikipedia entryedit file
- IdeaDouble oncology capacity in low-resource settings with task-shifting and AI decision supportno external link or Wikipedia entryedit file
- IdeaA global federated real-world evidence network at regulatory gradeno external link or Wikipedia entryedit file
- IdeaPay-for-cure contracts: instalment payments for curative therapies contingent on durable remissionno external link or Wikipedia entryedit file
- IdeaOpen-source drug discovery to clinical proof of concept for neglected cancersno external link or Wikipedia entryedit file
- IdeaA public-benefit phase 1 factory that takes academic discoveries into first-in-human trialsno external link or Wikipedia entryedit file
- IdeaPersonalised cancer vaccines at commodity cost through fully automated manufacturingno external link or Wikipedia entryedit file
- IdeaReal-time margin assessment and image-guided surgery as the global standardno external link or Wikipedia entryedit file
- IdeaCompact FLASH and proton systems at the price of a conventional linacno external link or Wikipedia entryedit file
- IdeaPopulation germline screening for hereditary cancer genes with cascade testingno external link or Wikipedia entryedit file
- IdeaLiving, machine-readable guidelines pushed to the point of care in every countryno external link or Wikipedia entryedit file
- IdeaContinuous prospective validation for every oncology AI tool after deploymentno external link or Wikipedia entryedit file
- IdeaReciprocal recognition of tumour-agnostic and rare-indication approvals across regulatorsno external link or Wikipedia entryedit file
- IdeaAn independent replication institute that re-tests key preclinical cancer findings before trialsno external link or Wikipedia entryedit file
- IdeaWhat decides which disseminated cells ever colonise?no external link or Wikipedia entryedit file
- IdeaWhat actually holds T cells at the tumour border?no external link or Wikipedia entryedit file
- IdeaCan MYC be drugged directly, and will patients tolerate it?no external link or Wikipedia entryedit file
- IdeaIs aneuploidy itself a druggable vulnerability?no external link or Wikipedia entryedit file
- IdeaWhat makes a neoantigen actually immunogenic?no external link or Wikipedia entryedit file
- IdeaKeep them asleep: dormancy maintenance as adjuvant therapyno external link or Wikipedia entryedit file
- IdeaMap metabolic dependencies in the patient, not the dishno external link or Wikipedia entryedit file
- IdeaOne-two punch: clear senescent cells after chemotherapyno external link or Wikipedia entryedit file
- IdeaMicrobiome transplant as a routine immunotherapy adjunctno external link or Wikipedia entryedit file
- IdeaCut the nerve supply to tumours with old drugsno external link or Wikipedia entryedit file
- IdeaTreat cachexia before it startsno external link or Wikipedia entryedit file
- IdeaWhich patients' blood clones will become leukaemia after treatment?no external link or Wikipedia entryedit file
- IdeaIntercept cancer at the field stageno external link or Wikipedia entryedit file
- IdeaKill drug-tolerant persisters through ferroptosisno external link or Wikipedia entryedit file
- IdeaShared splice-derived neoantigens as off-the-shelf vaccine targetsno external link or Wikipedia entryedit file
- IdeaGive immunotherapy in the morningno external link or Wikipedia entryedit file
- IdeaAttack extrachromosomal DNA, the engine of oncogene amplificationno external link or Wikipedia entryedit file
- RoadmapRadical oncology: what could change the war by 2035no external link or Wikipedia entryedit file
- RoadmapPaths to cures: interception, eradication, controlno external link or Wikipedia entryedit file
- TechnologyClosed automated cell-therapy manufacturingno external link or Wikipedia entryedit file
- TechnologyPoint-of-care and decentralised cell manufacturingno external link or Wikipedia entryedit file
- TechnologyViral vector manufacturing (lentiviral, retroviral, AAV)no external link or Wikipedia entryedit file
- TechnologyPlasmid DNA and mRNA raw-material manufacturingno external link or Wikipedia entryedit file
- TechnologyADC bioconjugation manufacturing (CDMOs)no external link or Wikipedia entryedit file
- TechnologyRadiopharmacy and cyclotron networksno external link or Wikipedia entryedit file
- TechnologyTherapeutic isotope supply chain (Mo-99, Lu-177, Ac-225)no external link or Wikipedia entryedit file
- TechnologyLong-read sequencing (PacBio, Oxford Nanopore)no external link or Wikipedia entryedit file
- TechnologyNew short-read sequencing platformsno external link or Wikipedia entryedit file
- TechnologySpatial biology instrumentsno external link or Wikipedia entryedit file
- TechnologyWhole-slide scanners and image managementno external link or Wikipedia entryedit file
- TechnologyRadiotherapy treatment planning and QA softwareno external link or Wikipedia entryedit file
- TechnologyAI auto-contouring and adaptive planningno external link or Wikipedia entryedit file
- TechnologyOncology EHR and real-world data platformsno external link or Wikipedia entryedit file
- TechnologyClinical trial software (EDC, eCOA, CTMS, RTSM)no external link or Wikipedia entryedit file
- TechnologyDecentralised and hybrid clinical trialsno external link or Wikipedia entryedit file
- TechnologyCommunity oncology and site networksno external link or Wikipedia entryedit file
- TechnologyContract research organisations (CROs)no external link or Wikipedia entryedit file
- TechnologyImaging core labs and central reviewno external link or Wikipedia entryedit file
- TechnologyBiobanking and tissue procurementno external link or Wikipedia entryedit file
- TechnologyReference laboratories and companion-diagnostic testingno external link or Wikipedia entryedit file
- TechnologyPET tracer manufacturing and distributionno external link or Wikipedia entryedit file
- TechnologyNuclear medicine and total-body PET hardwareno external link or Wikipedia entryedit file
- TechnologyElectronic patient-reported outcomes and remote monitoringno external link or Wikipedia entryedit file
- TechnologyOncology pharmacy automation and compounding robotsno external link or Wikipedia entryedit file
- TechnologyAI compute and model platforms for oncologyno external link or Wikipedia entryedit file
- TechnologySterile fill-finish and lyophilisationno external link or Wikipedia entryedit file
- TechnologyGeneric oncology drug supply and shortage mitigationno external link or Wikipedia entryedit file
- TechnologyOncology EHR modules and treatment pathwaysno external link or Wikipedia entryedit file
- TechnologyPayload-linker synthesis (high-potency API)no external link or Wikipedia entryedit file
- TechnologyApheresis and starting-material collectionno external link or Wikipedia entryedit file
- TechnologyCryopreservation and cell-therapy cold chainno external link or Wikipedia entryedit file
- TechnologyCell-therapy orchestration and chain-of-identity softwareno external link or Wikipedia entryedit file
- TechnologyCell-therapy release and potency testingno external link or Wikipedia entryedit file
- TechnologyAllogeneic donor and iPSC master cell banksno external link or Wikipedia entryedit file
- TechnologyAntibody manufacturing (CHO bioprocessing)no external link or Wikipedia entryedit file
- TechnologyMedical cyclotrons, hot cells, and synthesis modulesno external link or Wikipedia entryedit file
- TechnologyRadionuclide generators and cold kitsno external link or Wikipedia entryedit file
- TechnologyClinical NGS bioinformatics and variant interpretationno external link or Wikipedia entryedit file
- TechnologyGenomics cloud and secure research environmentsno external link or Wikipedia entryedit file
- TechnologyCancer variant knowledgebases and molecular tumour boardsno external link or Wikipedia entryedit file
- TechnologyCancer registries and population surveillanceno external link or Wikipedia entryedit file
- TechnologyProteomics instruments and affinity platformsno external link or Wikipedia entryedit file
- TechnologyStructural biology infrastructure (cryo-EM, synchrotrons, AlphaFold)no external link or Wikipedia entryedit file
- TechnologyHigh-throughput screening and DNA-encoded librariesno external link or Wikipedia entryedit file
- TechnologyPre-analytics: blood-collection tubes and tissue fixationno external link or Wikipedia entryedit file
- TechnologyHistology automation and IHC autostainersno external link or Wikipedia entryedit file
- TechnologyInfusion pumps, ports, and ambulatory chemotherapy devicesno external link or Wikipedia entryedit file
- TechnologyFederated learning and privacy-preserving AIno external link or Wikipedia entryedit file
- TechnologyTelemedicine, teleoncology, and telepathologyno external link or Wikipedia entryedit file
- TermBlinded independent central review (BICR)no external link or Wikipedia entryedit file
- TermCDMO (contract development and manufacturing organisation)no external link or Wikipedia entryedit file
- TermBIOSECURE Actno external link or Wikipedia entryedit file
- IdeaA dose-finding trial for exercise after cancerno external link or Wikipedia entryedit file
- IdeaGLP-1 receptor agonists as adjuvant weight-loss therapy in HR-positive breast cancerno external link or Wikipedia entryedit file
- IdeaOne definitive ketogenic diet trial in glioblastoma, then stopno external link or Wikipedia entryedit file
- IdeaCapture diet, fibre and antibiotic exposure in every immunotherapy pivotal trialno external link or Wikipedia entryedit file
- IdeaEvaluate alcohol minimum unit pricing against cancer incidenceno external link or Wikipedia entryedit file
- IdeaControlled feeding trials to separate ultra-processing from caloriesno external link or Wikipedia entryedit file
- IdeaConfirm or refute the harm of antioxidant supplements during chemotherapyno external link or Wikipedia entryedit file
- IdeaLink bariatric and GLP-1 registries to cancer registries in every country that has bothno external link or Wikipedia entryedit file
- IdeaTreat insomnia in survivors and measure whether the cancer noticesno external link or Wikipedia entryedit file
- IdeaA dietitian in every gastrointestinal and head and neck tumour boardno external link or Wikipedia entryedit file
- IdeaAsk about diet at diagnosis, and prebunk the myths before the internet doesno external link or Wikipedia entryedit file
- TermDXdno external link or Wikipedia entryedit file
- TermT030 (belotecan derivative)no external link or Wikipedia entryedit file
- TermDM4no external link or Wikipedia entryedit file
- TermTopoisomerase-I inhibitor payloadsno external link or Wikipedia entryedit file
- TermTubulin inhibitor payloadsno external link or Wikipedia entryedit file
- TermDNA crosslinker payloads (PBD dimers)no external link or Wikipedia entryedit file
- TermDNA cleaver payloads (enediynes)no external link or Wikipedia entryedit file
- TermDNA alkylator payloadsno external link or Wikipedia entryedit file
- TermCL2Ano external link or Wikipedia entryedit file
- TermTetrapeptide GGFG (maleimide-GGFG-aminomethyl)no external link or Wikipedia entryedit file
- Termmc-Val-Cit-PABCno external link or Wikipedia entryedit file
- TermSMCC (thioether, non-cleavable)no external link or Wikipedia entryedit file
- TermSulfo-SPDB (disulfide)no external link or Wikipedia entryedit file
- TermAcid-labile hydrazone (AcBut)no external link or Wikipedia entryedit file
- TermVal-Ala dipeptideno external link or Wikipedia entryedit file
- TermMaleimidocaproyl (mc), non-cleavableno external link or Wikipedia entryedit file
- TermHydrophilic next-generation linkers (TMALIN, Dolaflexin, sulfonyl-pyrimidine, PEG-containing)no external link or Wikipedia entryedit file
- RoadmapVirtual cell roadmap: from bulk omics to a predictive model of a cancer cellno external link or Wikipedia entryedit file
- RoadmapAI in the oncology clinic: from narrow cleared tools to multimodal decision supportno external link or Wikipedia entryedit file
Weakly connected objects
257Two or fewer connections. Link to cancers, targets, products, trials, or terms so the object participates in the graph.
- CompanyMediLink Therapeutics2 connectionsedit file
- CompanyMORE Health2 connectionsedit file
- CollectionCOSMIC (Catalogue of Somatic Mutations in Cancer)2 connectionsedit file
- CollectionTherapeutic Target Database (TTD)0 connectionsedit file
- CollectionADCdb / ADC Review2 connectionsedit file
- Collectionawesome-cancer-variant-resources1 connectionedit file
- CollectionNewsweek/Statista World's Best Specialized Hospitals – Oncology0 connectionsedit file
- CollectionNature Index – Healthcare and Cancer institutions0 connectionsedit file
- CollectionSCImago Institutions Rankings – Oncology0 connectionsedit file
- PersonMel Greaves2 connectionsedit file
- PersonMichelle Mitchell2 connectionsedit file
- PersonIain Foulkes2 connectionsedit file
- PersonEliane Piaggio2 connectionsedit file
- PersonRoberto Orecchia2 connectionsedit file
- PersonFilippo de Braud1 connectionedit file
- PersonGiampaolo Tortora2 connectionsedit file
- PersonRolf Kiessling2 connectionsedit file
- PersonHans-Gustaf Ljunggren2 connectionsedit file
- PersonEnrique Espinosa2 connectionsedit file
- PersonBeatriz Castelo2 connectionsedit file
- PersonPilar Garrido2 connectionsedit file
- PersonDenis Lacombe2 connectionsedit file
- PersonHitoshi Nakagama2 connectionsedit file
- PersonRafael Kaliks2 connectionsedit file
- PersonArtur Katz2 connectionsedit file
- PersonFreddie Bray1 connectionedit file
- PersonCandace S. Johnson1 connectionedit file
- PersonBruce W. Stillman2 connectionsedit file
- PersonAdrian R. Krainer2 connectionsedit file
- PersonObi L. Griffith2 connectionsedit file
- PersonCostas A. Lyssiotis2 connectionsedit file
- PersonJustin D. Lathia2 connectionsedit file
- PersonJaroslaw P. Maciejewski2 connectionsedit file
- PersonChristine H. Chung2 connectionsedit file
- PersonJohn E. Dick2 connectionsedit file
- PersonAaron D. Schimmer2 connectionsedit file
- PersonSteven E. Artandi2 connectionsedit file
- PersonMichael A. Teitell2 connectionsedit file
- PersonRobert W. Stone1 connectionedit file
- PersonSteven T. Rosen2 connectionsedit file
- PersonRobin T. Zon1 connectionedit file
- PersonMargaret Foti1 connectionedit file
- PersonJim Valvano2 connectionsedit file
- IdeaProve the cell line is what you say it is, or the paper does not run2 connectionsedit file
- IdeaSmart scales and health records flag unexplained weight loss for a cancer check2 connectionsedit file
- IdeaTravel, lodging and meals reimbursed as a standard line in every trial budget2 connectionsedit file
- IdeaPay trial participants for their time, not only their expenses2 connectionsedit file
- IdeaEvery patient is asked once at diagnosis whether researchers may contact them2 connectionsedit file
- IdeaExposure-response modelling with a pre-set target exposure before any dose is chosen2 connectionsedit file
- IdeaTurn Project Orbis into a work-sharing review with one shared assessment report2 connectionsedit file
- Idea90-day reliance approval for cancer drugs cleared by two stringent regulators2 connectionsedit file
- IdeaOne structured global dossier: submit the cancer drug file once, to a shared cloud1 connectionedit file
- IdeaJoint FDA-EMA-MHRA-PMDA scientific advice by default before pivotal cancer trials2 connectionsedit file
- IdeaStream trial data to regulators as it accrues; review starts at last patient visit2 connectionsedit file
- IdeaEvery regulator publishes its full assessment report so others can rely on it2 connectionsedit file
- IdeaOne evidence plan agreed by regulator and payer before the pivotal trial2 connectionsedit file
- IdeaFund an oncology joint assessment unit inside the African Medicines Agency2 connectionsedit file
- IdeaOpen-source dossier-building software for academic sponsors and generic makers2 connectionsedit file
- IdeaA shared AI review assistant that maps one dossier to every regulator's questions2 connectionsedit file
- IdeaAutomatic reciprocity of orphan and rare-paediatric designations between regulators2 connectionsedit file
- IdeaScreen every cancer patient for financial toxicity as a vital sign, with navigation2 connectionsedit file
- IdeaAn international registry of real (net) cancer drug prices paid by public payers2 connectionsedit file
- IdeaBuy out the patent on a curative cancer drug and sell it at generic prices2 connectionsedit file
- IdeaA combination pricing rule so two-drug regimens are not priced as two monopolies2 connectionsedit file
- IdeaA joint price negotiation bloc for middle-income countries, modelled on Beneluxa2 connectionsedit file
- IdeaGrant extra exclusivity only in exchange for binding low prices in poorer countries2 connectionsedit file
- IdeaSocial impact bonds that fund biosimilar switching, repaid from payer savings2 connectionsedit file
- IdeaA public fund that pays for phase 3 trials of cheap, off-patent drugs against cancer2 connectionsedit file
- IdeaLet non-profits and academics add a cancer indication to an off-patent drug's label2 connectionsedit file
- IdeaA social impact bond: investors fund a repurposing trial, payers repay from savings2 connectionsedit file
- IdeaThree years of indication-specific exclusivity for proving a new cancer use of an old drug2 connectionsedit file
- IdeaA delinked market-entry reward paid by payers when a repurposed generic wins approval2 connectionsedit file
- IdeaFund regulator-ready evidence dossiers for the 20 best-supported off-patent drugs2 connectionsedit file
- IdeaPayers pre-commit to cover off-label generics when a definitive trial is positive2 connectionsedit file
- IdeaA non-profit company to hold marketing authorisations for repurposed cancer drugs2 connectionsedit file
- IdeaSolar microgrids so radiotherapy, pathology and drug fridges never lose power2 connectionsedit file
- IdeaRetention packages so trained oncology staff stay: bonds, top-ups, working equipment2 connectionsedit file
- IdeaFast-track relicensing for refugee, migrant and returning oncology professionals1 connectionedit file
- IdeaA legislated, publicly reported 28-day standard from urgent referral to diagnosis2 connectionsedit file
- IdeaFormal shared-care agreements between oncology and family doctors, with same-day e-consult2 connectionsedit file
- IdeaAudit whether tumour board recommendations were actually carried out2 connectionsedit file
- IdeaVocational rehabilitation integrated into cancer care so survivors can return to work2 connectionsedit file
- IdeaEarmark a fixed share of every national cancer budget for palliative care2 connectionsedit file
- IdeaA synthetic twin of every restricted cancer dataset for code development2 connectionsedit file
- IdeaPublic procurement clauses banning data export fees and lock-in2 connectionsedit file
- IdeaPrivacy-preserving linkage tokens for every cancer data holder2 connectionsedit file
- IdeaPatient navigation as a legal entitlement from the day of diagnosis2 connectionsedit file
- IdeaTwo-page plain-language consent with teach-back for every cancer trial and treatment2 connectionsedit file
- IdeaPatient panels approve trial burden and endpoints as a condition of funding2 connectionsedit file
- IdeaScreen every patient for financial toxicity at diagnosis and refer like any other symptom2 connectionsedit file
- IdeaRecorded, AI-summarised consultations given to patients by default2 connectionsedit file
- IdeaQuestion prompt lists sent to patients before every major consultation1 connectionedit file
- IdeaA mandatory patient-experience section in every cancer drug label and approval2 connectionsedit file
- IdeaPlain-language trial results returned to every participant within a year2 connectionsedit file
- IdeaQuantitative patient preference studies set the benefit-risk bar before phase 32 connectionsedit file
- IdeaFormal caregiver assessment and training written into every treatment plan2 connectionsedit file
- IdeaA health-literacy certification standard for oncology portals, letters and apps2 connectionsedit file
- IdeaPatient-reported side-effects (PRO-CTCAE) collected and published in every registrational trial2 connectionsedit file
- IdeaAn ARPA-style programme to develop supportive-care drugs nobody else will2 connectionsedit file
- IdeaPayers price drugs on quality-adjusted benefit, so toxicity costs the manufacturer2 connectionsedit file
- IdeaMeasure and treat chemo brain with objective digital cognitive testing2 connectionsedit file
- IdeaFund scalp cooling and hair-preserving measures for every alopecia-inducing regimen2 connectionsedit file
- IdeaOncology hospital-at-home with remote monitoring for toxicity2 connectionsedit file
- IdeaAn open commons of patient-reported outcome data from cancer trials2 connectionsedit file
- IdeaA verified information layer that labels and links cancer content across platforms2 connectionsedit file
- IdeaTrain and fund oncology clinicians as public content creators2 connectionsedit file
- IdeaA public registry of unproven cancer clinics and reported outcomes1 connectionedit file
- IdeaBan and enforce against paid advertising of unproven cancer treatments1 connectionedit file
- IdeaA public benchmark and audit of chatbot answers to cancer questions2 connectionsedit file
- IdeaAn independent hype index grading cancer press releases and news stories2 connectionsedit file
- IdeaTrained moderators with evidence tools in online patient communities2 connectionsedit file
- IdeaA structured pathway for patients declining proven treatment2 connectionsedit file
- CollectionNew England Journal of Medicine1 connectionedit file
- CollectionThe Lancet Oncology1 connectionedit file
- CollectionJournal of Clinical Oncology1 connectionedit file
- CollectionCancer Discovery1 connectionedit file
- CollectionNature Medicine1 connectionedit file
- CollectionNature Cancer1 connectionedit file
- CollectionCancer Cell1 connectionedit file
- CollectionAnnals of Oncology1 connectionedit file
- CollectionJAMA Oncology1 connectionedit file
- CollectionBlood2 connectionsedit file
- CollectionCancer Research1 connectionedit file
- CollectionClinical Cancer Research1 connectionedit file
- CollectionJNCI: Journal of the National Cancer Institute1 connectionedit file
- CollectionESMO Open1 connectionedit file
- Collectionnpj Precision Oncology0 connectionsedit file
- CollectionmedRxiv1 connectionedit file
- CollectionbioRxiv1 connectionedit file
- CollectionEMA news and CHMP meeting highlights1 connectionedit file
- CollectionNICE technology appraisals1 connectionedit file
- CollectionThe ASCO Post0 connectionsedit file
- CollectionOncLive0 connectionsedit file
- CollectionTargeted Oncology0 connectionsedit file
- CollectionCancerNetwork (ONCOLOGY)0 connectionsedit file
- CollectionThe Cancer Letter0 connectionsedit file
- CollectionEndpoints News0 connectionsedit file
- CollectionFierce Biotech0 connectionsedit file
- CollectionSTAT News0 connectionsedit file
- CollectionBioCentury0 connectionsedit file
- CollectionEvaluate Vantage0 connectionsedit file
- CollectionADC Review0 connectionsedit file
- CollectionUroToday0 connectionsedit file
- CollectionOncoDaily0 connectionsedit file
- CollectionHealio Hematology/Oncology0 connectionsedit file
- CollectionMedscape Oncology0 connectionsedit file
- CollectionBioPharma Dive0 connectionsedit file
- CollectionASCO Meeting Library1 connectionedit file
- CollectionESMO Congress1 connectionedit file
- CollectionAACR Annual Meeting1 connectionedit file
- CollectionASH Annual Meeting2 connectionsedit file
- CollectionSan Antonio Breast Cancer Symposium0 connectionsedit file
- CollectionASTRO Annual Meeting2 connectionsedit file
- CollectionSNMMI Annual Meeting2 connectionsedit file
- CollectionASCO Daily News0 connectionsedit file
- CollectionNature Briefing: Cancer1 connectionedit file
- CollectionAmerican Cancer Society (cancer.org, incl. former Cancer.Net)0 connectionsedit file
- CollectionCancer Research UK: About Cancer0 connectionsedit file
- CollectionMacmillan Cancer Support1 connectionedit file
- CollectionLiving Beyond Breast Cancer0 connectionsedit file
- CollectionBreast Cancer Research Foundation2 connectionsedit file
- CollectionPancreatic Cancer Action Network (PanCAN)1 connectionedit file
- CollectionTriple Negative Breast Cancer Foundation0 connectionsedit file
- CollectionSemantic Scholar0 connectionsedit file
- CollectionDimensions0 connectionsedit file
- TermProject Orbis0 connectionsedit file
- TermReal-Time Oncology Review (RTOR) and Assessment Aid2 connectionsedit file
- TermProject FrontRunner2 connectionsedit file
- Term340B Drug Pricing Program1 connectionedit file
- TermICER and health technology assessment0 connectionsedit file
- ProductPanobinostat2 connectionsedit file
- ProductSipuleucel-T2 connectionsedit file
- JournalNew England Journal of Medicine2 connectionsedit file
- JournalThe Lancet1 connectionedit file
- JournalJAMA1 connectionedit file
- JournalJAMA Internal Medicine0 connectionsedit file
- JournalBMJ1 connectionedit file
- JournalAnnals of Internal Medicine0 connectionsedit file
- JournalPLOS Medicine0 connectionsedit file
- JournalThe Lancet Global Health1 connectionedit file
- JournalThe Lancet Oncology2 connectionsedit file
- JournalJCO Precision Oncology2 connectionsedit file
- JournalJCO Oncology Practice2 connectionsedit file
- JournalESMO Open2 connectionsedit file
- JournalJAMA Oncology1 connectionedit file
- JournalJNCI: Journal of the National Cancer Institute2 connectionsedit file
- JournalCancer2 connectionsedit file
- JournalBritish Journal of Cancer1 connectionedit file
- JournalEuropean Journal of Cancer0 connectionsedit file
- JournalJournal of the National Comprehensive Cancer Network1 connectionedit file
- JournalJournal of Thoracic Oncology1 connectionedit file
- JournalGynecologic Oncology0 connectionsedit file
- JournalEuropean Urology1 connectionedit file
- JournalEuropean Urology Oncology0 connectionsedit file
- JournalNeuro-Oncology1 connectionedit file
- JournalRadiotherapy and Oncology1 connectionedit file
- JournalInternational Journal of Radiation Oncology, Biology, Physics1 connectionedit file
- JournalJournal of Nuclear Medicine2 connectionsedit file
- JournalRadiology0 connectionsedit file
- JournalPediatric Blood & Cancer0 connectionsedit file
- JournalBlood2 connectionsedit file
- JournalBlood Advances0 connectionsedit file
- JournalLeukemia0 connectionsedit file
- JournalThe Lancet Haematology0 connectionsedit file
- JournalHaematologica0 connectionsedit file
- JournalNature2 connectionsedit file
- JournalScience0 connectionsedit file
- JournalCell0 connectionsedit file
- JournalCancer Cell2 connectionsedit file
- JournalCell Stem Cell1 connectionedit file
- JournalNature Medicine1 connectionedit file
- JournalNature Cancer1 connectionedit file
- JournalNature Reviews Cancer0 connectionsedit file
- JournalNature Reviews Clinical Oncology0 connectionsedit file
- JournalNature Reviews Drug Discovery0 connectionsedit file
- JournalNature Genetics1 connectionedit file
- JournalNature Biotechnology0 connectionsedit file
- JournalNature Communications0 connectionsedit file
- JournalScience Translational Medicine0 connectionsedit file
- JournalCancer Research2 connectionsedit file
- JournalCancer Immunology Research1 connectionedit file
- JournalMolecular Cancer Therapeutics2 connectionsedit file
- JournalCancer Epidemiology, Biomarkers & Prevention1 connectionedit file
- JournalJournal for ImmunoTherapy of Cancer0 connectionsedit file
- JournalJournal of Clinical Investigation0 connectionsedit file
- JournalGenes & Development0 connectionsedit file
- JournalProceedings of the National Academy of Sciences0 connectionsedit file
- JournaleLife0 connectionsedit file
- JournalCancers0 connectionsedit file
- JournalClinical Pharmacology & Therapeutics0 connectionsedit file
- JournalThe Lancet Digital Health0 connectionsedit file
- JournalNEJM Evidence0 connectionsedit file
- JournalmedRxiv2 connectionsedit file
- JournalbioRxiv2 connectionsedit file
- InstitutionProvidence Health & Services2 connectionsedit file
- CompanyBioptimus2 connectionsedit file
- Companykaiko.ai2 connectionsedit file
- CompanyHistAI2 connectionsedit file
- CompanyLila Sciences2 connectionsedit file
- CompanyCradle1 connectionedit file
- CompanyProfluent1 connectionedit file
- CompanyLatent Labs1 connectionedit file
- CompanyGenesis Molecular AI (formerly Genesis Therapeutics)1 connectionedit file
- CompanyIambic Therapeutics2 connectionsedit file
- CollectionThe Cancer Imaging Archive (TCIA)2 connectionsedit file
- CollectionNCI Imaging Data Commons (IDC)2 connectionsedit file
- CollectionUK Biobank0 connectionsedit file
- CollectionAll of Us Research Program0 connectionsedit file
- CollectionPathology AI benchmarks (CAMELYON, PANDA, TCGA slide tasks)0 connectionsedit file
- CollectionArc Virtual Cell Atlas2 connectionsedit file
- TechnologyscFoundation (BioMap)2 connectionsedit file
- TechnologyCellFM1 connectionedit file
- TechnologyGenePT2 connectionsedit file
- TechnologyNucleotide Transformer (InstaDeep)1 connectionedit file
- TechnologyEnformer and Borzoi (DeepMind, Calico)2 connectionsedit file
- TechnologyAlphaGenome2 connectionsedit file
- TechnologyForesight (generative EHR model)2 connectionsedit file
Short summaries
557Under 160 characters. Expand with mechanism, evidence, and open questions.
- TrialALINA151-character summaryedit file
- TrialTeliMET NSCLC-01119-character summaryedit file
- CompanyBlue Earth Diagnostics (Bracco)144-character summaryedit file
- ProductApalutamide100-character summaryedit file
- ProductDarolutamide139-character summaryedit file
- ProductPasritamig149-character summaryedit file
- ProductFlotufolastat F-18137-character summaryedit file
- TrialPRECISION144-character summaryedit file
- TrialCHAARTED (E3805)114-character summaryedit file
- TrialLATITUDE62-character summaryedit file
- TrialARCHES95-character summaryedit file
- TrialARASENS92-character summaryedit file
- TrialPEACE-1129-character summaryedit file
- TrialPROfound137-character summaryedit file
- TrialCAPItello-281147-character summaryedit file
- TrialALSYMPCA65-character summaryedit file
- TrialproPSMA102-character summaryedit file
- TrialTheraP (ANZUP 1603)119-character summaryedit file
- TrialSPLASH140-character summaryedit file
- TrialECLIPSE127-character summaryedit file
- CompanyIpsen119-character summaryedit file
- CompanyElicio Therapeutics131-character summaryedit file
- CompanyDay One Biopharmaceuticals125-character summaryedit file
- CompanyNorthwest Biotherapeutics97-character summaryedit file
- CompanyPuma Biotechnology150-character summaryedit file
- TrialHER2CLIMB-02144-character summaryedit file
- TrialREFLECT147-character summaryedit file
- TrialRESORCE68-character summaryedit file
- TrialCELESTIAL55-character summaryedit file
- TrialLEAP-002146-character summaryedit file
- TrialABC-02137-character summaryedit file
- TrialTOPAZ-1156-character summaryedit file
- TrialKEYNOTE-966108-character summaryedit file
- TrialFIGHT-202131-character summaryedit file
- TrialFOENIX-CCA266-character summaryedit file
- TrialClarIDHy103-character summaryedit file
- TrialHERIZON-BTC-302159-character summaryedit file
- TrialFIRST-30870-character summaryedit file
- TrialPROMID102-character summaryedit file
- TrialCLARINET121-character summaryedit file
- TrialRADIANT-3 and RADIANT-4132-character summaryedit file
- PairingBeta PRRT → alpha PRRT133-character summaryedit file
- TrialEXTREME131-character summaryedit file
- PairingEGFR-directed bispecific + PD-1 blockade157-character summaryedit file
- TrialLUME-Meso134-character summaryedit file
- CompanyCG Oncology95-character summaryedit file
- CompanyImmunityBio114-character summaryedit file
- CompanyFerring Pharmaceuticals134-character summaryedit file
- CompanyBicycle Therapeutics138-character summaryedit file
- TrialLITESPARK-005138-character summaryedit file
- CompanyAVEO Oncology (LG Chem)118-character summaryedit file
- TrialfrontMIND153-character summaryedit file
- TrialL-MIND132-character summaryedit file
- TrialwaveLINE-003147-character summaryedit file
- TrialSUNMO143-character summaryedit file
- TrialGOLSEEK-184-character summaryedit file
- PairingCD20 bispecific + CD79b ADC (mosunetuzumab + polatuzumab)77-character summaryedit file
- PairingEarly relapse: CAR-T before transplant158-character summaryedit file
- TrialCEPHEUS119-character summaryedit file
- TrialIMROZ95-character summaryedit file
- TrialCARTITUDE-4157-character summaryedit file
- TrialKarMMa-3146-character summaryedit file
- TrialMagnetisMM-397-character summaryedit file
- TrialMonumenTAL-1143-character summaryedit file
- TrialLINKER-MM196-character summaryedit file
- TrialDREAMM-8115-character summaryedit file
- TrialiMMagine-1155-character summaryedit file
- TrialKEYNOTE-204117-character summaryedit file
- TrialAHOD2131 (COG / NCTN)154-character summaryedit file
- TrialAETHERA126-character summaryedit file
- PairingPD-1 blockade + AVD chemotherapy98-character summaryedit file
- CompanyDeciphera Pharmaceuticals (Ono)153-character summaryedit file
- CompanySpringWorks Therapeutics (Merck KGaA)139-character summaryedit file
- ProductPazopanib150-character summaryedit file
- TrialANNOUNCE155-character summaryedit file
- TrialINVICTUS84-character summaryedit file
- TrialVOYAGER117-character summaryedit file
- TrialDeFi124-character summaryedit file
- TrialMOTION133-character summaryedit file
- TrialEuro Ewing 2012150-character summaryedit file
- IdeaIntermittent or stop-and-restart nirogacestat in desmoid tumours131-character summaryedit file
- TrialCOG ANBL0032155-character summaryedit file
- TrialNaxitamab Study 201140-character summaryedit file
- TechnologyPET/MRI158-character summaryedit file
- TargetLAG-3157-character summaryedit file
- ProductTisotumab vedotin153-character summaryedit file
- ProductRaludotatug deruxtecan125-character summaryedit file
- ProductZilovertamab vedotin107-character summaryedit file
- ProductSonesitatug vedotin140-character summaryedit file
- ProductCemiplimab135-character summaryedit file
- ProductLorlatinib132-character summaryedit file
- ProductAdagrasib130-character summaryedit file
- ProductTalazoparib131-character summaryedit file
- ProductInavolisib137-character summaryedit file
- ProductVorasidenib106-character summaryedit file
- ProductTalimogene laherparepvec143-character summaryedit file
- CompanyDaiichi Sankyo147-character summaryedit file
- CompanyAmgen147-character summaryedit file
- CompanyEli Lilly (incl. Loxo)139-character summaryedit file
- CompanyGSK142-character summaryedit file
- CompanyBayer136-character summaryedit file
- CompanyAstellas106-character summaryedit file
- CompanyTakeda108-character summaryedit file
- CompanyBoehringer Ingelheim96-character summaryedit file
- CompanyRegeneron123-character summaryedit file
- CompanyServier71-character summaryedit file
- CompanySichuan Kelun-Biotech143-character summaryedit file
- CompanySystImmune / Sichuan Biokin109-character summaryedit file
- CompanyAkeso75-character summaryedit file
- CompanySummit Therapeutics112-character summaryedit file
- CompanyADC Therapeutics90-character summaryedit file
- CompanyZymeworks140-character summaryedit file
- CompanyJazz Pharmaceuticals77-character summaryedit file
- CompanyBeOne Medicines (formerly BeiGene)72-character summaryedit file
- CompanyRemeGen85-character summaryedit file
- CompanyDuality Biotherapeutics130-character summaryedit file
- CompanyMediLink Therapeutics81-character summaryedit file
- CompanyAvenzo Therapeutics76-character summaryedit file
- CompanyArvinas119-character summaryedit file
- CompanyNuvalent78-character summaryedit file
- CompanyCelcuity106-character summaryedit file
- CompanyMenarini / Stemline46-character summaryedit file
- CompanyCorcept Therapeutics94-character summaryedit file
- CompanySyndax Pharmaceuticals56-character summaryedit file
- CompanyModerna110-character summaryedit file
- CompanyReplimune78-character summaryedit file
- CompanyImmunocore111-character summaryedit file
- CompanyIovance Biotherapeutics125-character summaryedit file
- CompanyLegend Biotech70-character summaryedit file
- CompanyCARsgen Therapeutics94-character summaryedit file
- CompanyAdaptimmune94-character summaryedit file
- CompanyLantheus131-character summaryedit file
- CompanyRayzeBio (BMS)75-character summaryedit file
- CompanyFusion Pharmaceuticals (AstraZeneca)84-character summaryedit file
- CompanyITM Isotope Technologies Munich150-character summaryedit file
- CompanyTerraPower Isotopes94-character summaryedit file
- CompanyOrano Med102-character summaryedit file
- CompanyFoundation Medicine (Roche)116-character summaryedit file
- CompanyGuardant Health140-character summaryedit file
- CompanyNatera137-character summaryedit file
- CompanyGRAIL100-character summaryedit file
- CompanyExact Sciences (Abbott)76-character summaryedit file
- CompanyTempus AI151-character summaryedit file
- CompanyCaris Life Sciences91-character summaryedit file
- CompanyBostonGene122-character summaryedit file
- CompanyIllumina112-character summaryedit file
- Company10x Genomics114-character summaryedit file
- CompanyArtera95-character summaryedit file
- CompanyPaige AI104-character summaryedit file
- CompanyPathAI104-character summaryedit file
- CompanyOwkin88-character summaryedit file
- CompanyNovocure90-character summaryedit file
- CompanyIntuitive Surgical147-character summaryedit file
- CompanyHistoSonics81-character summaryedit file
- CompanyInsightec104-character summaryedit file
- CompanyVarian (Siemens Healthineers)109-character summaryedit file
- CompanyElekta59-character summaryedit file
- CompanyRefleXion Medical76-character summaryedit file
- CompanyIBA (Ion Beam Applications)85-character summaryedit file
- CompanyMevion Medical Systems65-character summaryedit file
- CompanyGE HealthCare123-character summaryedit file
- CompanySiemens Healthineers92-character summaryedit file
- CompanyUnited Imaging131-character summaryedit file
- CompanyCancer Commons109-character summaryedit file
- CompanyMORE Health149-character summaryedit file
- InstitutionSamsung Medical Center125-character summaryedit file
- InstitutionAsan Medical Center99-character summaryedit file
- InstitutionGustave Roussy136-character summaryedit file
- InstitutionSeoul National University Hospital121-character summaryedit file
- InstitutionPrincess Margaret Cancer Centre117-character summaryedit file
- InstitutionIEO – European Institute of Oncology113-character summaryedit file
- InstitutionCharité – Universitätsmedizin Berlin133-character summaryedit file
- InstitutionPeter MacCallum Cancer Centre138-character summaryedit file
- InstitutionMassachusetts General Hospital Cancer Center137-character summaryedit file
- InstitutionHospital Israelita Albert Einstein139-character summaryedit file
- InstitutionHospital Sírio-Libanês91-character summaryedit file
- InstitutionCleveland Clinic Taussig Cancer Institute154-character summaryedit file
- InstitutionInstitut Curie145-character summaryedit file
- InstitutionSeverance Hospital, Yonsei University79-character summaryedit file
- InstitutionThe Christie NHS Foundation Trust126-character summaryedit file
- InstitutionUniversitätsklinikum Hamburg-Eppendorf95-character summaryedit file
- InstitutionCancer Institute Hospital of JFCR118-character summaryedit file
- InstitutionFondazione IRCCS Istituto Nazionale dei Tumori71-character summaryedit file
- InstitutionVall d'Hebron University Hospital / VHIO152-character summaryedit file
- InstitutionPoliclinico Universitario A. Gemelli76-character summaryedit file
- InstitutionStanford Health Care / Stanford Cancer Institute124-character summaryedit file
- InstitutionLMU Klinikum München103-character summaryedit file
- InstitutionUniklinik Köln (CIO)147-character summaryedit file
- InstitutionThe Mount Sinai Hospital / Tisch Cancer Institute101-character summaryedit file
- InstitutionHospital Universitario La Paz71-character summaryedit file
- InstitutionKarolinska University Hospital134-character summaryedit file
- InstitutionHospital General Universitario Gregorio Marañón54-character summaryedit file
- InstitutionFred Hutchinson Cancer Center133-character summaryedit file
- InstitutionAbramson Cancer Center, University of Pennsylvania159-character summaryedit file
- InstitutionCity of Hope133-character summaryedit file
- InstitutionMoffitt Cancer Center109-character summaryedit file
- InstitutionUniversity of Michigan Rogel Cancer Center117-character summaryedit file
- InstitutionUCLA Jonsson Comprehensive Cancer Center136-character summaryedit file
- InstitutionRoswell Park Comprehensive Cancer Center95-character summaryedit file
- InstitutionBroad Institute of MIT and Harvard119-character summaryedit file
- InstitutionCold Spring Harbor Laboratory87-character summaryedit file
- InstitutionThe Francis Crick Institute134-character summaryedit file
- InstitutionThe Institute of Cancer Research155-character summaryedit file
- InstitutionCancer Research UK139-character summaryedit file
- InstitutionGerman Cancer Research Center (DKFZ)94-character summaryedit file
- InstitutionSun Yat-sen University Cancer Center112-character summaryedit file
- InstitutionFudan University Shanghai Cancer Center149-character summaryedit file
- InstitutionCancer Hospital, Chinese Academy of Medical Sciences102-character summaryedit file
- InstitutionTata Memorial Centre145-character summaryedit file
- InstitutionAmerican Society of Clinical Oncology (ASCO)98-character summaryedit file
- InstitutionEuropean Society for Medical Oncology (ESMO)114-character summaryedit file
- InstitutionAmerican Association for Cancer Research (AACR)123-character summaryedit file
- InstitutionInternational Agency for Research on Cancer (IARC / WHO)138-character summaryedit file
- TermObjective response rate (ORR)125-character summaryedit file
- TermVariant allele frequency (VAF)146-character summaryedit file
- TermCompanion diagnostic130-character summaryedit file
- TermTNM staging157-character summaryedit file
- TrialTROPION-Breast01114-character summaryedit file
- TrialTROPION-Breast05134-character summaryedit file
- TrialIZABRIGHT-Breast0173-character summaryedit file
- TrialOptimICE-pCR (A012103)132-character summaryedit file
- TrialSCARLET (SWOG S2212)127-character summaryedit file
- TrialOlympiA135-character summaryedit file
- TrialDESTINY-Breast03113-character summaryedit file
- TrialDESTINY-Breast04151-character summaryedit file
- TrialDESTINY-Breast0682-character summaryedit file
- TrialDESTINY-Breast0976-character summaryedit file
- TrialNATALEE67-character summaryedit file
- TrialmonarchE90-character summaryedit file
- TrialVERITAC-2123-character summaryedit file
- TrialADAURA63-character summaryedit file
- TrialFLAURA253-character summaryedit file
- TrialMARIPOSA154-character summaryedit file
- TrialCodeBreaK 30068-character summaryedit file
- TrialDeLLphi-30467-character summaryedit file
- TrialEV-302 / KEYNOTE-A39159-character summaryedit file
- TrialVISION70-character summaryedit file
- TrialPSMAfore88-character summaryedit file
- PairingKRAS G12C inhibitor + anti-EGFR antibody (colorectal)135-character summaryedit file
- PairingPlatinum chemotherapy in HRD tumours159-character summaryedit file
- PairingPSMA PET → PSMA radioligand therapy148-character summaryedit file
- PairingGermline BRCA test → adjuvant PARP inhibitor138-character summaryedit file
- PairingAI pathology → androgen deprivation duration148-character summaryedit file
- PairingPD-1 failure → TIL therapy159-character summaryedit file
- IdeaCD8 PET to stop or switch immunotherapy early147-character summaryedit file
- IdeaStructured exercise prescribed like a drug in all curative-intent cancer care134-character summaryedit file
- CollectionClinicalTrials.gov158-character summaryedit file
- CollectionOncoKB150-character summaryedit file
- CollectionCIViC116-character summaryedit file
- CollectioncBioPortal for Cancer Genomics84-character summaryedit file
- CollectionTCGA / NCI Genomic Data Commons109-character summaryedit file
- CollectionDepMap (Cancer Dependency Map)83-character summaryedit file
- CollectionOpen Targets Platform87-character summaryedit file
- CollectionCOSMIC (Catalogue of Somatic Mutations in Cancer)101-character summaryedit file
- CollectionClinVar90-character summaryedit file
- CollectionDrugBank & ChEMBL98-character summaryedit file
- CollectionTherapeutic Target Database (TTD)62-character summaryedit file
- CollectionADCdb / ADC Review101-character summaryedit file
- CollectionNCCN Guidelines115-character summaryedit file
- CollectionESMO Clinical Practice Guidelines & MCBS86-character summaryedit file
- CollectionFDA Oncology Approvals (OCE) & Novel Drug Approvals89-character summaryedit file
- CollectionSEER (Surveillance, Epidemiology, and End Results)82-character summaryedit file
- CollectionGLOBOCAN / Global Cancer Observatory81-character summaryedit file
- CollectionNCI PDQ Cancer Information Summaries103-character summaryedit file
- Collectionawesome-cancer-variant-resources51-character summaryedit file
- CollectionAACR Project GENIE101-character summaryedit file
- CollectionHuman Protein Atlas86-character summaryedit file
- CollectionCPTAC (Clinical Proteomic Tumor Analysis Consortium)68-character summaryedit file
- CollectionCZ CELLxGENE / Human Cell Atlas66-character summaryedit file
- CollectionCancer Models (PDCM Finder) & HCMI91-character summaryedit file
- CollectionPubMed & Europe PMC53-character summaryedit file
- CollectionEU Clinical Trials Register / CTIS51-character summaryedit file
- CollectionNewsweek/Statista World's Best Specialized Hospitals – Oncology141-character summaryedit file
- CollectionNature Index – Healthcare and Cancer institutions158-character summaryedit file
- CollectionSCImago Institutions Rankings – Oncology93-character summaryedit file
- CollectionNCI-Designated Cancer Centers68-character summaryedit file
- PersonRuth Plummer158-character summaryedit file
- PersonCaroline Dive154-character summaryedit file
- PersonAndrew Wardley157-character summaryedit file
- PersonAndreas Trumpp139-character summaryedit file
- PersonSteven Le Gouill140-character summaryedit file
- PersonSergio Roman-Roman146-character summaryedit file
- PersonOlivier Delattre158-character summaryedit file
- PersonRoberto Orecchia134-character summaryedit file
- PersonPier Giuseppe Pelicci147-character summaryedit file
- PersonFilippo de Braud136-character summaryedit file
- PersonMarco Guzzo117-character summaryedit file
- PersonElena Garralda147-character summaryedit file
- PersonAngelika Eggert147-character summaryedit file
- PersonPeter Bartenstein148-character summaryedit file
- PersonClaus Belka158-character summaryedit file
- PersonReinhard Büttner154-character summaryedit file
- PersonGiampaolo Tortora132-character summaryedit file
- PersonVincenzo Valentini125-character summaryedit file
- PersonPer Hall156-character summaryedit file
- PersonRolf Kiessling137-character summaryedit file
- PersonSabine Linn153-character summaryedit file
- PersonJaime Feliu139-character summaryedit file
- PersonEnrique Espinosa136-character summaryedit file
- PersonBeatriz Castelo106-character summaryedit file
- PersonSara López-Tarruella138-character summaryedit file
- PersonDenis Lacombe154-character summaryedit file
- PersonAndrés Cervantes138-character summaryedit file
- PersonEvandro de Azambuja141-character summaryedit file
- PersonThomas Bachelot149-character summaryedit file
- PersonAnthony Gonçalves146-character summaryedit file
- PersonHye Ryun Kim144-character summaryedit file
- PersonJoohyuk Sohn145-character summaryedit file
- PersonArtur Katz157-character summaryedit file
- PersonWenfeng Fang154-character summaryedit file
- PersonJin Li152-character summaryedit file
- PersonEileen M. O'Reilly153-character summaryedit file
- PersonSaad Z. Usmani143-character summaryedit file
- PersonJudy E. Garber157-character summaryedit file
- PersonKeith T. Flaherty133-character summaryedit file
- PersonJustin F. Gainor154-character summaryedit file
- PersonRyan J. Sullivan159-character summaryedit file
- PersonWilliam G. Nelson140-character summaryedit file
- PersonKenneth W. Kinzler159-character summaryedit file
- PersonDrew M. Pardoll121-character summaryedit file
- PersonPatrick M. Forde140-character summaryedit file
- PersonKellie N. Smith146-character summaryedit file
- PersonSusan M. Domchek148-character summaryedit file
- PersonCharu Aggarwal147-character summaryedit file
- PersonRobert H. Mach154-character summaryedit file
- PersonDavid L. Porter141-character summaryedit file
- PersonJames L. Gulley143-character summaryedit file
- PersonNirali N. Shah151-character summaryedit file
- PersonRamon E. Parsons141-character summaryedit file
- PersonSundar Jagannath120-character summaryedit file
- PersonMatthew D. Galsky132-character summaryedit file
- PersonNina Bhardwaj135-character summaryedit file
- PersonThomas U. Marron138-character summaryedit file
- PersonCandace S. Johnson99-character summaryedit file
- PersonIgor Puzanov114-character summaryedit file
- PersonEunice S. Wang147-character summaryedit file
- PersonPawel Kalinski148-character summaryedit file
- PersonGad Getz152-character summaryedit file
- PersonAndrew J. Aguirre147-character summaryedit file
- PersonBradley E. Bernstein152-character summaryedit file
- PersonBruce W. Stillman123-character summaryedit file
- PersonSemir Beyaz146-character summaryedit file
- PersonTimothy J. Eberlein128-character summaryedit file
- PersonTimothy J. Ley157-character summaryedit file
- PersonLi Ding142-character summaryedit file
- PersonMalachi Griffith106-character summaryedit file
- PersonObi L. Griffith100-character summaryedit file
- PersonJohn F. DiPersio137-character summaryedit file
- PersonRamaswamy Govindan144-character summaryedit file
- PersonRobert D. Schreiber154-character summaryedit file
- PersonEric R. Fearon139-character summaryedit file
- PersonShaomeng Wang140-character summaryedit file
- PersonTheodore S. Lawrence154-character summaryedit file
- PersonCostas A. Lyssiotis155-character summaryedit file
- PersonJame Abraham145-character summaryedit file
- PersonJustin D. Lathia151-character summaryedit file
- PersonJaroslaw P. Maciejewski150-character summaryedit file
- PersonNathan A. Pennell111-character summaryedit file
- PersonPatrick Hwu139-character summaryedit file
- PersonAmod A. Sarnaik142-character summaryedit file
- PersonFrederick L. Locke136-character summaryedit file
- PersonEric B. Haura151-character summaryedit file
- PersonHatem Soliman142-character summaryedit file
- PersonChristine H. Chung130-character summaryedit file
- PersonShari Pilon-Thomas134-character summaryedit file
- PersonA. Keith Stewart152-character summaryedit file
- PersonPamela S. Ohashi158-character summaryedit file
- PersonNatasha B. Leighl140-character summaryedit file
- PersonAmit M. Oza149-character summaryedit file
- PersonTrevor J. Pugh155-character summaryedit file
- PersonMichael A. Teitell150-character summaryedit file
- PersonRobert W. Stone147-character summaryedit file
- PersonPrimo N. Lara Jr.148-character summaryedit file
- PersonKathy S. Albain146-character summaryedit file
- PersonMark R. Litzow150-character summaryedit file
- CollectionNature Cancer118-character summaryedit file
- CollectionCancer Cell146-character summaryedit file
- CollectionJAMA Oncology111-character summaryedit file
- CollectionBlood101-character summaryedit file
- CollectionCancer Research38-character summaryedit file
- CollectionClinical Cancer Research123-character summaryedit file
- CollectionJNCI: Journal of the National Cancer Institute21-character summaryedit file
- CollectionESMO Open26-character summaryedit file
- Collectionnpj Precision Oncology68-character summaryedit file
- CollectionmedRxiv152-character summaryedit file
- CollectionbioRxiv34-character summaryedit file
- CollectionEMA news and CHMP meeting highlights121-character summaryedit file
- CollectionNICE technology appraisals156-character summaryedit file
- CollectionThe ASCO Post154-character summaryedit file
- CollectionOncLive100-character summaryedit file
- CollectionTargeted Oncology34-character summaryedit file
- CollectionCancerNetwork (ONCOLOGY)30-character summaryedit file
- CollectionThe Cancer Letter111-character summaryedit file
- CollectionEndpoints News100-character summaryedit file
- CollectionFierce Biotech31-character summaryedit file
- CollectionSTAT News106-character summaryedit file
- CollectionBioCentury119-character summaryedit file
- CollectionEvaluate Vantage85-character summaryedit file
- CollectionADC Review94-character summaryedit file
- CollectionUroToday97-character summaryedit file
- CollectionOncoDaily103-character summaryedit file
- CollectionHealio Hematology/Oncology23-character summaryedit file
- CollectionMedscape Oncology34-character summaryedit file
- CollectionBioPharma Dive31-character summaryedit file
- CollectionASCO Meeting Library139-character summaryedit file
- CollectionESMO Congress110-character summaryedit file
- CollectionAACR Annual Meeting121-character summaryedit file
- CollectionASH Annual Meeting45-character summaryedit file
- CollectionSan Antonio Breast Cancer Symposium28-character summaryedit file
- CollectionASTRO Annual Meeting45-character summaryedit file
- CollectionSNMMI Annual Meeting99-character summaryedit file
- CollectionASCO Daily News69-character summaryedit file
- CollectionNature Briefing: Cancer28-character summaryedit file
- CollectionAmerican Cancer Society (cancer.org, incl. former Cancer.Net)70-character summaryedit file
- CollectionCancer Research UK: About Cancer66-character summaryedit file
- CollectionMacmillan Cancer Support48-character summaryedit file
- CollectionLiving Beyond Breast Cancer106-character summaryedit file
- CollectionBreast Cancer Research Foundation22-character summaryedit file
- CollectionPancreatic Cancer Action Network (PanCAN)52-character summaryedit file
- CollectionTriple Negative Breast Cancer Foundation71-character summaryedit file
- CollectionSemantic Scholar122-character summaryedit file
- CollectionDimensions32-character summaryedit file
- TermHallmark: enabling replicative immortality157-character summaryedit file
- TermHallmark (2022): senescent cells132-character summaryedit file
- CompanyCytiva (Danaher)152-character summaryedit file
- CompanyOXB (Oxford Biomedica)125-character summaryedit file
- CompanyThermo Fisher Scientific157-character summaryedit file
- CompanyCharles River Laboratories140-character summaryedit file
- CompanyAldevron (Danaher)128-character summaryedit file
- CompanyTouchlight151-character summaryedit file
- CompanySamsung Biologics147-character summaryedit file
- CompanyPiramal Pharma Solutions95-character summaryedit file
- CompanyAbzena120-character summaryedit file
- CompanyCatalent (Novo Holdings)137-character summaryedit file
- CompanyPETNET Solutions (Siemens Healthineers)124-character summaryedit file
- CompanyCardinal Health Nuclear & Precision Health Solutions91-character summaryedit file
- CompanyJubilant Radiopharma103-character summaryedit file
- CompanyNorthStar Medical Radioisotopes125-character summaryedit file
- CompanySHINE Technologies133-character summaryedit file
- CompanyPacBio136-character summaryedit file
- CompanyOxford Nanopore Technologies157-character summaryedit file
- CompanyUltima Genomics125-character summaryedit file
- CompanyElement Biosciences66-character summaryedit file
- CompanyMGI Tech119-character summaryedit file
- CompanyBruker (Bruker Spatial Biology)116-character summaryedit file
- CompanyVizgen103-character summaryedit file
- CompanyAkoya Biosciences118-character summaryedit file
- CompanyLeica Biosystems (Danaher)108-character summaryedit file
- CompanyHamamatsu Photonics101-character summaryedit file
- Company3DHISTECH122-character summaryedit file
- CompanyPhilips106-character summaryedit file
- CompanySectra95-character summaryedit file
- CompanyProscia120-character summaryedit file
- CompanyIndica Labs118-character summaryedit file
- CompanyRaySearch Laboratories104-character summaryedit file
- CompanySun Nuclear (Mirion)106-character summaryedit file
- CompanyBrainlab107-character summaryedit file
- CompanyLimbus AI99-character summaryedit file
- CompanyMIM Software (GE HealthCare)109-character summaryedit file
- CompanyTheraPanacea90-character summaryedit file
- CompanyMVision AI84-character summaryedit file
- CompanyConcertAI115-character summaryedit file
- CompanyCOTA85-character summaryedit file
- CompanyTriNetX96-character summaryedit file
- CompanyKomodo Health94-character summaryedit file
- CompanyDatavant88-character summaryedit file
- CompanyMedidata (Dassault Systèmes)92-character summaryedit file
- CompanyVeeva Systems88-character summaryedit file
- CompanyOracle Health (Cerner) & Oracle Life Sciences75-character summaryedit file
- CompanyEpic Systems102-character summaryedit file
- CompanyMedable52-character summaryedit file
- CompanyScience 37 (eMed)110-character summaryedit file
- CompanyMcKesson / The US Oncology Network85-character summaryedit file
- CompanyOneOncology84-character summaryedit file
- CompanyFlorida Cancer Specialists & Research Institute78-character summaryedit file
- CompanySarah Cannon Research Institute105-character summaryedit file
- CompanyIQVIA118-character summaryedit file
- CompanyICON plc71-character summaryedit file
- CompanyParexel91-character summaryedit file
- CompanyFortrea60-character summaryedit file
- CompanyMedpace64-character summaryedit file
- CompanyCalyx91-character summaryedit file
- CompanyClario107-character summaryedit file
- CompanyDiscovery Life Sciences90-character summaryedit file
- CompanyIndivumed119-character summaryedit file
- CompanyHUB Organoids84-character summaryedit file
- CompanyLabcorp145-character summaryedit file
- CompanyQuest Diagnostics75-character summaryedit file
- CompanyNeoGenomics104-character summaryedit file
- CompanyAgilent Technologies (Dako)135-character summaryedit file
- CompanyCanon Medical Systems92-character summaryedit file
- CompanyKaiku Health (Elekta)92-character summaryedit file
- CompanyOmnicell91-character summaryedit file
- CompanyBD (Becton, Dickinson and Company)114-character summaryedit file
- CompanyMicrosoft (Health & Life Sciences)103-character summaryedit file
- CompanyGoogle (Health, DeepMind, Verily)137-character summaryedit file
- CompanyCivica Rx90-character summaryedit file
- CompanyTerumo Blood and Cell Technologies97-character summaryedit file
- CompanyFresenius Kabi129-character summaryedit file
- CompanyCryoport133-character summaryedit file
- CompanyBioLife Solutions97-character summaryedit file
- CompanyFUJIFILM Diosynth Biotechnologies116-character summaryedit file
- CompanyBoehringer Ingelheim BioXcellence87-character summaryedit file
- CompanyTrasis122-character summaryedit file
- CompanyComecer (ATS)95-character summaryedit file
- CompanySOPHiA GENETICS126-character summaryedit file
- CompanyQIAGEN138-character summaryedit file
- CompanyVelsera (Seven Bridges and Pierian)77-character summaryedit file
- CompanyDNAnexus83-character summaryedit file
- CompanyStandard BioTools (SomaLogic)82-character summaryedit file
- CompanyStreck77-character summaryedit file
- CompanySakura Finetek85-character summaryedit file
- CompanyBaxter International132-character summaryedit file
- CompanyB. Braun117-character summaryedit file
- CompanyBioptimus133-character summaryedit file
- CompanyAignostics136-character summaryedit file
- CompanyHistAI102-character summaryedit file
- CompanyXaira Therapeutics147-character summaryedit file
- CompanyLila Sciences144-character summaryedit file
- CompanyCradle102-character summaryedit file
- CompanyProfluent116-character summaryedit file
- CompanyLatent Labs137-character summaryedit file
- CompanyGenesis Molecular AI (formerly Genesis Therapeutics)89-character summaryedit file
- CompanyIambic Therapeutics113-character summaryedit file
- CompanyChan Zuckerberg Initiative (Biohub)134-character summaryedit file
- CollectionThe Cancer Imaging Archive (TCIA)124-character summaryedit file
- CollectionNCI Imaging Data Commons (IDC)124-character summaryedit file
- CollectionAll of Us Research Program106-character summaryedit file
- CollectionFlatiron Health–Foundation Medicine Clinico-Genomic Database88-character summaryedit file
- CollectionNCI CDAS: NLST and PLCO screening trial data89-character summaryedit file
- CollectionPathology AI benchmarks (CAMELYON, PANDA, TCGA slide tasks)122-character summaryedit file
- CollectionTahoe-100M123-character summaryedit file
- CollectionArc Virtual Cell Atlas86-character summaryedit file
- TechnologyCHIEF (Harvard, Yu Lab)158-character summaryedit file
- TechnologyH-optimus (Bioptimus)148-character summaryedit file
- TechnologyHibou (HistAI)114-character summaryedit file
- TechnologyMidnight (kaiko.ai)154-character summaryedit file
- TechnologyAtlas (Aignostics, Mayo Clinic, Charité)130-character summaryedit file
- TechnologyPhikon / Phikon-v2 (Owkin)124-character summaryedit file
- TechnologyRadFM (generalist radiology foundation model)96-character summaryedit file
- TechnologyCT-FM (whole-body CT foundation model)102-character summaryedit file
- TechnologySybil (MIT/MGH lung cancer risk from CT)124-character summaryedit file
- TechnologyMirai (MIT breast cancer risk from mammograms)130-character summaryedit file
- TechnologyAidoc CARE (clinical radiology foundation model)139-character summaryedit file
- TechnologyscGPT146-character summaryedit file
- TechnologyUniversal Cell Embedding (UCE)134-character summaryedit file
- TechnologyscFoundation (BioMap)149-character summaryedit file
- TechnologyNicheformer (spatial single-cell)140-character summaryedit file
- TechnologyCellFM138-character summaryedit file
- TechnologyChai-1 / Chai-2125-character summaryedit file
- TechnologyESM3 (EvolutionaryScale)135-character summaryedit file
- TechnologyBioEmu (Microsoft)147-character summaryedit file
- TechnologyNucleotide Transformer (InstaDeep)97-character summaryedit file
- TechnologyEnformer and Borzoi (DeepMind, Calico)159-character summaryedit file
- TechnologyAlphaMissense107-character summaryedit file
- TechnologyNVIDIA BioNeMo139-character summaryedit file
- TechnologyChemistry42 and Pharma.AI (Insilico)147-character summaryedit file